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Non-invasive measures of central blood pressure through pulse wave analysis may be key to 
future management of cardiovascular disease risk in currently healthy and clinical 
populations. One device that can non-invasively estimate central blood pressure is the 
SphygmoCor XCEL. The validity of this device has been demonstrated compared to invasive 
measures, but the reliability has previously only been demonstrated in younger, non-clinical 
populations. In day-to-day life, blood pressure measures are taken in a variety of postures 
and fasting states depending on user preference, clinician preference, time of day and 
environment. The acute effects of posture and fasting state on these central measures have 
not been widely investigated.  
Therefore the purpose of the first and second studies in this thesis was to focus on a) reporting 
the between-day reliability of the SphygmoCor XCEL in an older, non-clinical sample (age 
>50y) and a hyper-acute stroke sample, and b) report the individual and combined effects of 
posture and fasting state on a variety of peripheral and central blood pressure measures in 
these populations.  
The SphygmoCor XCEL was demonstrated to have generally excellent between-day reliability 
(using an intra-class correlation coefficient > 0.75 as the criterion excellence value) in fasted 
and non-fasted, and seated and supine states in both populations. Posture had a significant 
effect on diastolic pressures in both populations (p < .05), whereas fasting state had a 
significant effect on the majority of peripheral and central systolic and diastolic pressures, as 
well as measures of arterial stiffness (Augmentation Index, Augmentation Index at a heart 
rate of 75 b·min-1; p < .05). These studies demonstrate that the SphygmoCor XCEL is a reliable 
tool for use in population demographics where its findings are particularly pertinent (those 
14 
 
over the age of 50 or those suffering from stroke), and that posture and fasting state should 
both be taken into consideration when interpreting peripheral and central blood pressure 
measures. 
Increased levels of sedentary time and reduced physical activity are common after stroke, 
potentially due to the perception that sedentary time is a normal and an important way of 
relaxing after stroke. The third study in this thesis investigated the effects of sedentary time 
on peripheral and central blood pressure measures and measures of arterial stiffness, thereby 
investigating whether low level physical activity (intermittent heel raises) could prevent this 
damaging process. Three hours of sedentary time was sufficient to cause significant increases 
in peripheral and central blood pressure (p < .05). Intermittent heel raises significantly 
mitigated this damage but did not prevent it (increases of 10.7 mmHg peripheral systolic 
blood pressure and 9.6 mmHg central blood pressure in the three-hour sedentary condition 
compared with increases of 5.2 mmHg and 5.6 mmHg respectively in the three-hour heel raise 
condition). Due to the significant effects observed in study 3, a pilot ‘heel raise intervention’ 
trial was undertaken (the fourth study of this thesis). Participants completed a heel raise 
protocol on six days per week for ten weeks to determine whether the acute effects 
demonstrated in the third study could be replicated chronically. This study found no 
significant improvements in any body composition, central and peripheral haemodynamic, 
arterial stiffness or cognitive variables (p > .05).  
This thesis has demonstrated the reliability of the SphygmoCor XCEL in new populations and 
demonstrated the effect of posture and fasting state on peripheral and central measures. It 
has also reported that three hours of sedentary time is sufficient to cause significant increases 
in BP but this can be mitigated through lower limb physical activity. Although this lower limb 
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physical activity causes acute improvements in blood pressure, this does not translate into 
chronic improvements over the course of a ten-week exercise programme, although these 
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Chapter 1: Introduction 
1.1 Introduction to stroke 
Cardiovascular disease (CVD) is related to significant morbidity and mortality (World Health 
Organisation, 2018) and is the cause of death for over 18 million people each year, one in 
three of all deaths worldwide (Roth et al., 2017). Generally, the umbrella term of CVD refers 
to chronic heart disease, congestive heart failure and stroke; this thesis focuses on the latter. 
Each year in England, there are 57,000 first strokes (Public Health England, 2018), and 
approximately 30,000 stroke-related deaths (Office for National Statistics, 2017). At time of 
writing, there are approximately 1.2 million stroke survivors in the United Kingdom (Stroke 
Association, 2018). 
Mortality as a result of stroke has decreased worldwide over the last two decades (Feigin et 
al., 2014) due to improved medical care in the hyper-acute setting and, as a result, more 
people are surviving stroke to experience its long-term consequences (Crichton et al., 2016). 
Although CVD mortality is declining in the United Kingdom, the burden of the disease also 
involves those living with it (Bhatnagar et al., 2016). Therefore, the requirement for effective 
stroke rehabilitation is likely to remain a key aspect of stroke care for the foreseeable future 
(Winstein et al., 2016). 
Once an individual has suffered from stroke, they are immediately at an increased risk of 
further events. A key aspect of chronic stroke treatment is therefore the prescription of anti-
hypertensive medication to minimise this risk. However, adherence to medication is low. Up 
to 25% of patients are reported to not even fill in initial prescriptions for anti-hypertensive 
medication (Whelton et al., 2018) and other research reports 14% of participants admitting 
to not adhering to their prescriptions (Bushnell et al., 2011).  
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One key method used to track recovery and recurrent stroke risk is through the management 
and modification of blood pressure (BP). In fact, treating increased BP may be the most 
important intervention when attempting to prevent recurrent strokes (Kernan et al., 2014).  
Blood pressure is traditionally assessed using the brachial artery, which does not directly 
reflect BP at the central organs. Differences in the composition of the arterial wall of the 
brachial artery compared to central arteries leads to brachial BP overestimating BP at the 
heart itself, whereas central blood pressure (cBP) represents the pressure on the heart itself 
(Agabiti-Rosei et al., 2007; Yadav et al., 2018). This assessment of BP is measured in a range 
of different circumstances (e.g. time of day, room temperature, stress, posture, fasting state). 
There is interest in identifying risk factors of CVD to allow high-risk individuals to be targeted 
by interventions (Wong et al., 2018) and to reduce the risk of recurrent CVD, including stroke. 
The non-invasive assessment of cBP is a potentially crucial tool in identifying risk factors of 
incident and recurrent stroke, above and beyond traditional BP. This is a technique which has 
not been widely investigated in clinical populations. 
A further contemporary focus of research in stroke is the reduction of sedentary time. After 
stroke has occurred, increased levels of sedentary behaviour are common. This may be 
because sedentary time is perceived as normal and seen as an important way of relaxing after 
stroke (Ezeugwu et al., 2016). The latest American Heart Association guidelines for stroke 
survivors now recommend reductions in sedentary behaviour (Billinger et al., 2014) and 
reducing sedentary time after stroke is now seen as a promising intervention target (Morton 





The studies in this thesis develop an understanding of non-invasive measurement of cBP 
through oscillometric pulse wave analysis. This thesis initially investigates the reliability of the 
SphygmoCor XCEL in providing these measures for an older, non-clinical population and 
determining the effects of posture and fasting state on peripheral and central 
haemodynamics (Chapter 3). The population over the age of 50 are a population demographic 
to which cBP may be particularly pertinent in terms of reducing risk of CVD. 
Similar parameters are then investigated in a hyper-acute stroke population (Chapter 4). The 
monitoring of cBP in acute stroke patients is expected to become the norm in the future but 
this cannot take place until the reliability of devices like the SphygmoCor XCEL has been 
demonstrated. As pharmacological decisions are at least partly based on BP readings in 
hospital settings and BP is recorded in a range of postures and fasting states, this work also 
investigates the influence that these variables have on peripheral and central 
haemodynamics. 
As reported in the introduction, sedentary time is linked to poorer outcomes after stroke. As 
a response to this, this investigation develops the theory that low-intensity intermittent lower 
limb movements reduce the damage caused by extended sedentary time. As such, the effect 
of sedentary time on peripheral and central haemodynamics as well as executive function is 
observed, before ascertaining whether heel-raises throughout a three-hour time course are 
able to acutely mitigate the potential damage taking place through sedentary time (Chapter 
5). 
Finally, the thesis investigates whether these heel raises are of a sufficient intensity to elicit 
physiological benefits over the course of a ten-week training plan. In a pilot study, 
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oscillometric peripheral and central haemodynamics are investigated alongside executive 
























Chapter 2: Literature review 
2.1 Stroke pathology 
The brain depends on a continuous supply of blood to maintain neurological function and is 
passively perfused through the cardiac cycle (O’Rourke & Safar, 2005). When this vascular 
supply is interrupted due to ischaemia or haemorrhage, a stroke occurs, causing an abrupt 
impairment of brain function involving one or several cerebral blood vessels (Sjogren et al., 
2013). Stroke is typified by rapidly developing signs of focal or global disturbance of cerebral 
functions lasting more than 24 hours, or these disturbances resulting in death (WHO, 1978).  
Strokes are broadly divided into two primary categories. Ischaemic strokes are vascular events 
caused by a blockage of cerebral blood vessels (Alberts & Atkinson, 2004) with a consequent 
interruption in blood supply to the brain (American Heart Association, 2012). This disturbance 
in delivery causes cell necrosis (Zoerink & Carter, 2015) and, consequently, a sudden decrease 
in human function. Ischaemic strokes are the most common form of cerebral event, 
comprising ~88% of all strokes (Gordon et al., 2004; Go et al., 2014; Zoerink & Carter, 2015) 
and are divided into five categories: large artero-atherosclerosis (~19% of ischaemic strokes), 
cardio-embolism (up to ~26%), small vessel occlusion (~44%), strokes of other determined 
aetiology (~5%) and stroke of undetermined aetiology (~6% worldwide; Adams et al., 1993; 
O’Donnell et al., 2010). The most common underlying cause of ischaemic stroke is 
atherosclerosis (Gordon et al., 2004), causing a narrowing of the cerebral arteries (Figure 2.1). 
This figure displays the chronic stages of atherosclerotic plaque formation, potentially leading 
to complete occlusion (leading to a thrombotic stroke) or an unstable plaque fragmenting 
(potentially leading to an embolic stroke). The second broad category of stroke is 
haemorrhage. Cerebral haemorrhages occur due to arterial bleeds or ruptures increasing the 
24 
 
pressure on the brain (CDC, 2013) and can be classified as intracerebral or subarachnoid 
haemorrhages (Stroke Association, 2015). Intracerebral haemorrhages form 11% of all strokes 
and can cause a rapid deterioration in patient welfare (Royal College of Physicians, 2016). 
Subarachnoid haemorrhages occur due to aneurysm or vascular malformation in the 
subarachnoid space and, although haemorrhagic strokes tend to have poor short- and long-
term prognoses (Krishnamurthi et al., 2014), levels of mortality due to haemorrhage have 





Figure 2.1: Steps involved in atherosclerosis progression, from Rodella & Rezzani, 2012 
 
Transient ischaemic attack (TIA) is a transient period of neurological dysfunction caused by 
focal brain, spinal cord or retinal ischaemia but without acute infarction (Spurgeon, James & 
Sackley, 2013). These “mini strokes” share pathological mechanisms of stroke but prognoses 
differ widely depending on severity (Kernan et al., 2013). TIA are under 24 hours in duration 
but usually last under an hour (Horer et al., 2011; Faulkner et al., 2015). All symptoms are 
resolved 24 hours post-TIA (Hillsdon, Kersten & Kirk, 2013) but the occurrence of a TIA is a 
warning sign of future stroke. Patients who have suffered a TIA are at a heightened risk of 
early stroke (Easton et al., 2009) with 5% of TIA patients suffering a stroke within seven days 
(Perry et al., 2016) and 20% suffering a stroke within a month (Fisher, 2008). Around 15% of 
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ischaemic strokes are preceded by a TIA (Hankey, 1996) but prevention strategies for incident 
stroke and TIA are extremely similar (Easton et al., 2009). 
 
2.2 Symptoms of stroke 
Symptoms of stroke commonly include numbness, weakness or paralysis, slurred speech, 
blurred vision, confusion and severe headaches (NICE, 2008) and these symptoms first 
manifest outside of the hospital setting in 95% of patients (Royal College of Physicians, 2016). 
As a result, time is critical for improving overall outcomes, and quick identification and 
assessment is vital to reduce secondary damage during transport to hospital (Kobayashi et al., 
2017). The most common screening tool of stroke is FAST (Face, Arms, Speech, Time to call 
[Harbison et al., 2003]) and, following admission to hospital, brain imaging should take place 
within one hour (Royal College of Physicians, 2016). The National Institute of Health Stroke 
Scale (NIHSS) is then used to determine the severity of stroke-induced neurologic deficit 
(Brott et al., 1989; Furlanis et al., 2018). Quantifying TIA severity takes place using the ABCD2 
scale, with a score of four or above classifying an individual as having a high risk of stroke 
(NICE, 2008).  
 
2.3 Incidence of stroke 
For the purpose of this thesis, cardiovascular diseases (CVD) refer to chronic heart disease, 
congestive heart failure and stroke. CVD kills more than 18 million people worldwide per year, 
constituting one in three of all deaths (Roth et al., 2017) and is the leading individual cause of 
death worldwide (Benjamin et al., 2017). Stroke is the third leading cause of death in western 
societies (Aquilani et al., 2011); however, an increasing proportion of those presenting with 
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stroke symptoms actually have stroke mimics, with only 45% of a sample of 1881 admissions 
resulting in a stroke diagnosis and 38.2% resulting in a diagnosis of stroke mimics (other 
conditions presenting with stroke-like symptoms [Faiz et al., 2017]). There are between 
129,000 and 150,000 reported strokes or TIA per year in the United Kingdom with ~46,000 
people suffering a first TIA and 1.2 million people living with the consequences of stroke 
(National Audit Office, 2005; Scarborough et al., 2009; Kirk et al., 2014; Stroke Association, 
2015). Around 85,000 stroke admissions are reported in England per year resulting in 32,000 
stroke-related deaths (Office for National Statistics, 2017; Public Health England, 2018). Less 
adequate stroke management in low-income countries is linked to higher mortality rates 
(Feigin et al., 2014) and, by 2030, it is estimated that annual global deaths due to stroke will 
rise from a current 6.7 million to 7.8 million, with an estimated 77 million people living with 
the effects of stroke (Strong, Mathers & Bonita, 2007; WHO, 2014). Around the world, people 
are living longer but with an increased proportion of this time spent in ill health (Newton et 
al., 2015). The significance of stroke increases as populations age (Ingall, 2004). Due to this 
ageing population and changing demographic, the incidence of stroke worldwide is expected 
to rise (White et al., 2013). The number of younger people (aged 20-64y) who had a stroke 
also increased by 25% between 1990 and 2010 (Feigin et al., 2014). Stroke is projected to be 
one of the leading causes of morbidity and mortality for the foreseeable future (WHO, 2011), 
whether it be in high- or low-income countries, or in a young or old population. 
Mortality rates after stroke vary depending on a variety of factors, particularly stroke subtype, 
concurrent morbidities, medication, body composition, lifestyle and the quality of healthcare 
provision. There is reported to be a 10-23% risk of 30-day mortality post-stroke which rises to 
30% after six months and 25-50% after one year (Hankey et al., 1998; Jamrozik et al., 2000; 
Stroke Association, 2015). Recent decreases in stroke mortality have been observed across 
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both sexes and in all ethnic groups (Lackland et al., 2014). This may be due to positive 
advances in acute stroke care (Edwards et al., 2017), although apparent trends in stroke 
mortality may be due to a high error rate in issuing cause of death and the definition of “stroke 
mortality” differing between studies (Lackland et al., 2014). Regardless of this, the number of 
people surviving first stroke seems to be on the rise, resulting in greater pressure on 
rehabilitation services and increased numbers of total strokes due to a greater number of 
repeated strokes taking place. 
The direct cost of stroke care annually in the United Kingdom is estimated to be £4 billion, 
which rises to £9 billion when taking into account health and social care costs (49%), informal 
care costs (27%), productivity losses (15%) and benefit payments (9% [Saka et al., 2009; Stroke 
Association, 2012a]). By 2020, the total cost of stroke care is predicted to represent 6.2% of 
the total illness burden in industrialised countries (Demaerschalk, Hwang & Leung, 2010), 
including losses in work productivity due to disability and death, currently estimated to be 
£1.5 billion per year in the UK (Saka et al., 2009). 
 
2.4 Risk factors for stroke 
Up to 80% of strokes are preventable (Chiuve et al., 2008; Gorelick, 2008) through the control 
of a variety of risk factors (discussed below). However, individuals are unaware of, and give 
little attention to, their stroke warning signs and risk factors (White et al., 2016). In around 
25% of strokes, no cause is immediately evident, particularly in young patients (Royal College 
of Physicians, 2016), but risk factors can be categorised into three major groups (Figure 2.2). 
The first are non-modifiable risk factors, the second are medically-modifiable risk factors and 
the third are behaviourally-modifiable risk factors (Billinger et al., 2014). Over 90% of stroke 
28 
 
burden may be attributed to modifiable risk factors (Huangfu et al., 2017). Risk factors for 
CVD tend to occur in combinations, with more than three risk factors observed in 17% of 
stroke patients (Wilson et al., 1999). The presence of more than two CVD risk factors causes 
a lifetime risk of CVD death, non-fatal myocardial infarction and fatal or non-fatal stroke that 
is substantially higher than in those with only one risk factor (Wilson et al., 1999; Berry et al., 
2012). This thesis will categorise risk factors based on Billinger and colleagues’ work (2014). 
Some measures are controllable through both medical and lifestyle interventions (e.g. 
































Figure 2.2: Key risk factors of stroke (relative risk ratios in red text, adjusted hazard ratios in blue text – 
ratios reported where available). 1 Wolf et al., 1991, 2 Ben Shlomo et al., 1992, 3 Lee, et al., 2003, 4 Yaggi 
et al., 2005, 5 Galassi et al., 2006, 6 Asplund et al., 2009, 7 Addo et al., 2012, 8 Banerjee et al., 2012, 9 Kim 
et al., 2012, 10 Jha et al., 2013, 11 Cheng et al., 2016, 12 Yu et al., 2018a, 13 Aburto et al., 2013. 
Key risk factors for stroke 
Non-modifiable: 





Atrial fibrillation (2.6 – 4.5) 1 
Elevated blood pressure (1.25 
– 1.28 per 10 mmHg) 6 
HDL cholesterol (0.58 – 0.80 
per mmol/L) 6 
Glucose metabolism 
disorder/diabetes (1.7 – 3.2) 8 
Metabolic syndrome (1.76) 5 




Physical activity (0.73) 3 
More sedentary behaviour 
(1.22) 12 
Overweight and obesity (1.0 – 
1.02 per BMI unit) 6 
Alcohol drinker (1.26) 2 
Cocaine use (6.4) 11 
Cigarette smoking (2.7 – 3) 10 
Low socioeconomic status 
(1.67) 7 
Air pollution 
Diet choices (1.24 from 
increased sodium intake) 13 
Increased caffeine 




2.5 Non-modifiable risk factors and stroke 
 
Premature birth and increasing age 
Premature birth has been linked to elevated BP in later life. A 4 mmHg higher SBP and a 3 
mmHg greater DBP has been observed in adulthood in previously premature individuals, with 
this exacerbated in females (Juhola et al., 2012; Parkinson et al., 2013). As life progresses, 
there is a clear relationship between age and stroke risk (Arzt et al., 2005) with ageing being 
the most important non-modifiable risk factor of stroke (Cocho et al., 2018). Stroke risk more 
than doubles in each successive decade over the age of 55 (Brown, et al., 1996; Wolf et al., 
1992). Increased age at stroke onset is also associated with post-stroke disability (Kelly-Hayes 
et al., 2003), partly due to a reduced effectiveness of anti-platelet therapies at greater ages 
(van Walraven et al., 2009). Systolic and diastolic BP increases linearly until the fifth or sixth 
decade of life where DBP begins to decrease (Duprez, 2008). Because of these natural 
increases, 90% of adults who are normotensive aged 55-65 develop hypertension in their 
lifetimes (Vasan et al., 2002). The average age of first stroke has dropped from 71 years in 
men and 77 years in females (Lee, Shafe & Cowie, 2009) to 68 years in men and 73 years in 
females (Public Health England, 2018b). In the United Kingdom, the number of individuals 
aged 100 or over has risen by 65% in the past decade (Office for National Statistics, 2016), 
demonstrating an ageing population. Alongside stroke severity scores, old age is one of the 
crucial prognostic factors of stroke (Hung et al., 2018) although it has been recently reported 
that the oldest-old patients have recovery potential equal to their younger counterparts 
(Cocho et al., 2018). The number of older adults worldwide is rising (Cohen, 2003) and due to 
this ageing population in western society, the burden of stroke will continue to grow in the 




Females suffer only 37% of global cases of stroke (O’Donnell et al., 2010). Males are also more 
likely to suffer stroke at a younger age due to a combination of lifestyle-based and 
physiological factors (Appelros, Stegmayr & Terent, 2009). Males are more likely to smoke 
and abuse alcohol than females (Hung et al., 2018) and oestrogen can counteract some 
unfavourable effects of the poor lifestyle choices that females do make. The benefits of 
oestrogen secretion include improving insulin sensitivity and decreased inflammation (Guo et 
al., 2018). This is a potential mechanism for hypertension being less common in females until 
around the fifth decade of life but becoming more common in old age (Benjamin et al., 2017). 
Carotid plaque specimens in males have also been reported to contain less smooth muscle, 
more macrophages and greater fat content than specimens found in females (Hellings et al., 
2007). This may lead to atherosclerotic plaques being less stable in males than females 
(Stoberock et al., 2016). Although males may suffer strokes earlier than females, more 
dependency is caused after stroke in females (Appelros et al., 2009) and poorer stroke 
outcomes at 90 days are observed when compared with males (Hung et al., 2018); potentially 
due to the average increased age of stroke in females. 
 
Ethnicity 
Ethnicity is also a non-modifiable stroke risk factor. Racial differences in BP levels have long 
been documented (Gillum, 1979), with elevated BP observed in all decades of life in the black 
population compared to other races and ethnicities (Whelton et al., 2018). This is potentially 
due to greater BP increases after salt intake (Wright et al., 2003) and greater risk of refractory 
hypertension (uncontrolled BP despite the use of three or more antihypertensive agent 
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classes [Lackland, 2014; Calhoun et al., 2008]). Sickle cell anaemia is also a major risk factor 
for stroke, particularly in the black population (Adams et al., 1997). This erythrocyte 
abnormality causes a 333-fold increase of stroke risk in children (Verudzco & Nathan, 2009) 
but is a major cause of stroke in all ages for those who have the condition (Platt et al., 1994). 
As a result of these factors, the black population have a 1.3–2-fold increased risk of stroke 
compared to the white population (Wang, Rudd & Wolfe, 2013; Benjamin et al., 2017) and 
African-Americans are more impacted by stroke than any other racial group (Kleindorfer, 
2009). In individuals diagnosed with hypertension, control of the condition is better in the 
white population than any other race (Yoon et al., 2015). The south Asian population have 
strokes significantly younger than white individuals (Rees, Williams & Gladwin, 2010), where 
Japanese individuals have a larger morning BP surge than Europeans (Hoshide et al., 2015). 
The average age of stroke has been reported to be around eight years younger in African 
populations than high-income countries (O’Donnell et al., 2010). The extent to which some of 
these figures are skewed by poorer quality of medical care rather than physiological variables 
is not always clear, but a trend is unmistakeable.  
 
Family history 
A family history of stroke is an independent risk factor for all stroke other than cardioembolic 
and undetermined stroke types (Polychronopoulos et al., 2002), particularly in ischaemic 
stroke before the age of 70 (Jood et al., 2005). Over 25 rare mutations and 120 single-
nucleotide polymorphisms have been linked to elevated BP (Lifton et al., 2001; Dominiczak & 
Kuo, 2017), and several genes have been linked to stroke – particularly intracerebral 
haemorrhage (Woo et al., 2014). A meta-analysis from Yu and colleagues (2018b) 
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demonstrates pooled risk ratios of 1.4 (CI: 1.18-1.67) for paternal history and 1.36 (CI: 1.20-
1.53) demonstrating increased susceptibility to stroke in children of stroke patients. Seshadri 
et al. (2010) also observed a parental history of stroke as being associated with elevated risk 
of incident stroke in offspring, speculating that this may be due to familial susceptibility to 
hypertension and stroke (Flossman & Rothwell, 2005) or shared physical environments (Liao 
et al., 1997).  
 
2.6 Medically-modifiable risk factors and stroke 
 
Dysrhythmias 
Atrial dysrhythmias are associated with an increased risk of ischaemic stroke (Al-Kawaz et al., 
2018). Atrial fibrillation (AF) is an atrial tachyarrhythmia that leads to blood pooling in the 
ventricles and an increased risk of potential clotting (Stroke Association, 2015) and affects 
over 30 million people worldwide (Mulukutla et al., 2018). The likelihood of AF varies due to 
age (Benjamin et al., 1994), ethnicity (Davis et al., 2012), diabetes (Benjamin et al., 1994), 
obesity (Watanabe et al., 2008), hypertension (Schoonderwoerd et al., 2008) and left atrial 
size (Mulukutla et al., 2018). Hypertension is frequently found alongside AF due to its 
association with left ventricular hypertrophy, impaired diastolic function with impaired left 
ventricular filling, increased left atrial pressures with left atrial hypertrophy, increased atrial 
fibrosis, and the slowing of intra-atrial and inter-atrial conduction velocities (Healey & 
Connolly, 2003; Whelton et al., 2018). These side effects of hypertension increase the 
prevalence of AF, which in turn increases the stroke risk of an individual by five times 
(Savelieva, Baipai & Camm, 2007). This condition is reported to be the most common cause 
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of thromboembolism and ischaemic stroke worldwide (O’Donnell et al., 2010; Anca, Mirela & 
Florina, 2015) and presents in 29% of hospital admissions in the United Kingdom where the 
patient is > 65 years of age (Rizos et al., 2012). Strokes related to AF in females have higher 
mortality than similar strokes in males (Friberg et al., 2004) but the presence of AF raises the 
risk of recurrent stroke indiscriminately between the sexes after an initial event (Sposato et 
al., 2015). Anti-coagulants are recommended for those with AF (January et al., 2014; Kirchof 
et al., 2016) but in one ten-year time analysis, only 25% of stroke patients with AF were given 
anti-coagulants before stroke (Lee, Shafe & Cowie, 2011). As much as 30% of the population 
suffering with AF may be yet undiagnosed (Public Health England, 2017), leading to 
uncontrolled risk factors for stroke and CVD. 
 
Elevated blood pressure and hypertension 
Uncontrolled elevated BP leading to hypertension is the single greatest risk factor of early 
mortality worldwide (Lim et al., 2012). Although hypertension cannot be classified solely by 
discrete BP thresholds (Giles, Kostis & Fernandez, 2018), elevated BP represents the onset of 
hypertension in the body. This increase in BP is caused by an increase in cardiac output and/or 
an increase in vascular resistance (Clark, Zahradka & Taylor, 2015). The presence of 
hypertension is one of the most prevalent chronic diseases (Werneck et al., 2018), is the most 
common condition seen in primary care (James et al., 2014), and is the cause of death of more 
than ten million people per year worldwide (Frieden & Jaffe, 2018). The estimated number of 
adults with raised BP increased from 594 million in 1975 to 1.13 billion in 2015 (Zhou et al, 
2017) – predominantly due to population growth and ageing. Increased BP is the leading risk 
factor for death and disability worldwide (Lim et al., 2012) and a large review involving 1.25 
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million individuals has demonstrated that the existence of hypertension raises risk of CVD 
from 46.1% to 63.3% (Rapsomaniki et al., 2014). However, hypertension control is only 
around 14% worldwide (Mills et al., 2016). This highlights the importance of elevated BP as a 
global public health concern (Briet & Schiffrin, 2013). This is particularly the case as the 
greatest levels of hypertension worldwide are now found in low-income and middle-income 
countries (Zhou et al, 2017). Hypertension is a condition which frequently coincides with 
other CVD risk factors (Whelton et al., 2018) and usually develops with age. Shihab and 
colleagues (2012) reported hypertension rates of 0.3%, 6.5% and 37% at ages 24, 45 and 65 
respectively in a longitudinal study design. Isolated systolic hypertension (leading to increased 
pulse pressure [PP]) is the most common form of hypertension seen in those over 50 years of 
age (Franklin, 1999; Franklin et al., 2001).  
The cut off point for the onset of hypertension has traditionally been set at > 140/90 mmHg 
(Pickering et al., 2005; Table 2.1). Further decreases in the marker designating the beginning 
of hypertension were predicted due to the wide prevalence of elevated BP (Touyz & 
Dominiczak, 2016), before new guidelines were introduced (Whelton et al., 2018). These 
guidelines, outlined in Table 2.2, lower the onset of elevated BP and the onset of hypertension 
even further and change the status of millions of “healthy” people to “hypertensive patients” 







Table 2.1: Traditional blood pressure categories (pre- July 2018) 
BP Category SBP  DBP 
Optimal < 120 mmHg and < 80 mmHg 
Normal 120-129 mmHg and/or 80-84 mmHg 
High-normal 130-139 mmHg and/or 85-89 mmHg 
Grade I HT 140-159 mmHg and/or 90-99 mmHg 
Grade II HT 160-179 mmHg and/or 100-109 mmHg 
Grade III HT ≥ 140 mmHg and ≥ 110 mmHg 
Abbrevs: BP – Blood pressure, DBP – Diastolic blood pressure, HT – Hypertension, SBP – 
Systolic blood pressure 
 
Table 2.2: Advised blood pressure categories as of July 2018 from the American College of 
Cardiology/American Heart Association 
BP Category SBP  DBP 
Normal < 120 mmHg and < 80 mmHg 
Elevated 120–129 mmHg and < 80 mmHg 
Hypertension    
Stage 1 130–139 mmHg or 80–89 mmHg 
Stage 2 ≥ 140 mmHg or ≥ 90 mmHg 
Abbrevs: DBP – Diastolic blood pressure, SBP – Systolic blood pressure 





Both Guo and colleagues (2013) and Huang and colleagues (2013) have reported increased 
risk ratios for CVD (including stroke) in patients with a BP of 130–139/85–89 mmHg compared 
to 120–129/80–84 mmHg. Previous work has also noted that two thirds of individuals with 
what was previously defined as pre-hypertension (SBP > 130 mmHg) developed hypertension 
within four years (Julius et al., 2006). As a result, categorising individuals as hypertensive 
earlier may reduce this seemingly natural progression towards even more elevated BP if 
effective treatments are available. Decreasing BP significantly reduces vascular risk and 
lowering BP to < 130 mmHg should be the goal (Ettehad et al., 2015). Nevertheless, the 
categories outlined in Table 2.2 have received criticism. Bakris and Sorrentino (2018) suggest 
that these changes may be problematic due to over-burdening the primary physician work 
force and that for non-high-risk patients, it may be sensible to continue defining hypertension 
using the 140/90 mmHg guidelines. The SPRINT group (2015) also note that achieving BP goals 
of < 120 mmHg would be more demanding for consumers and providers than the previous < 
140 mmHg targets and may cause increased costs of medications. It is also worth noting that 
an increase in prevalence of hypertensive medications may lead to a greater prevalence of 
side-effects and polypharmacy. These new guidelines were, however, created to assist rather 
than dictate decision making (Schwartzbard et al., 2018). 
Hypertension exposes the brain to excessive haemodynamic stress (Pase et al., 2013). This 
excess stress is a risk factor for reductions in cognitive function in those free from stroke. This 
takes place because of metabolic imbalances, atherogenesis, altered distribution of cerebral 
blood flow and demyelination or microinfarction in cerebral white matter (Elias et al., 2003). 
Elevated BP also leads to atherosclerosis and causes blood vessels in the brain, heart and 
limbs to harden and weaken (Tang et al., 2017). Links between hypertension and a range of 
clinical conditions can be seen in Table 2.3. Hypertension is the most relevant and prevalent 
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risk factor of stroke (SPS3, 2013). This relationship was first identified in the 1920s (Society of 
Actuaries, 1959) and it is now accepted that hypertension is positively and continuously 
related to the risk of stroke (Chalmers & Chapman, 2001; Chatterjee, Roberts & Boden-Albala, 
2015). 
Table 2.3: Key conditions linked with elevated blood pressure and hypertension 
Hypertension linked with: Reference 
Stroke McManus & Liebeskind, 2016 
Transient ischaemic attack Khare, 2016 
Coronary artery disease Weber et al., 2016 
Chronic kidney disease Ravera et al., 2006 
Retinopathy Van Leiden et al., 2002 
Osteoporosis Varenna et al., 2013 
Metabolic syndrome Mendizabal, Llorens & Nava, 2013 
Sleep apnoea Bradley & Floras, 2009 
Vascular dementia Nagai, Hoshide & Kario, 2010a 
 
 
Approximately 50% of ischaemic strokes are caused by hypertension and the condition is the 
main risk factor for intracerebral haemorrhage (Royal College of Physicians, 2016). Raised BP 
is associated with left atrial hypertrophy, impaired diastolic function, cardiac structure and 
subclinical markers of left ventricular systolic function (Whelton et al., 2018) and, as a result, 
a BP < 120/80 mmHg substantially lowers the lifetime risk of CVD (SPRINT, 2015). The risk of 
CVD increases in a linear fashion from SBP < 115 mmHg to > 180 mmHg (Lewington et al., 
2002). Blood pressure is elevated by CVD risk factors through activation of the renin-
angiotensin-aldosterone system, activation of the sympathetic nervous system, inhibition of 
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the cardiac natriuretic peptide system and endothelial dysfunction (Grassi et al., 1995; Kim et 
al., 2006; Sarzani et al., 2008). There is a strong and positive correlation between BP and 
target organ damage risk (Carretero & Oparil, 2000) and, therefore, lowering BP is likely to 
prevent stroke and death in those with grade I hypertension (Sundstrom et al., 2015). 
Conversely, increases of 20 mmHg systolic or 10 mmHg diastolic BP double the risk of stroke 
and CVD (Lewington et al., 2002) and so accurate measurement is of vital importance.  
Blood pressure variability is also an independent predictor of stroke, coronary heart disease, 
cognitive dysfunction and all-cause mortality (Epstein et al., 2013; Muntner et al., 2015). 
Elevated arterial stiffness due to hypertension and ageing may amplify random BP changes 
and increase BP variability (Yang et al., 2018).  
When treating hypertension in a population without a history of heart disease or stroke, 
intense treatments have been reported to be preferable to avoid future major cardiovascular 
events including myocardial infarction, coronary syndromes, stroke and premature death 
(SPRINT Research Group, 2015; Xie et al., 2016), even compared to less intense therapy 
(Thomopolous et al., 2016). Intensive BP lowering (to < 120 mmHg) has been shown to reduce 
all-cause mortality by 27% and cardiovascular mortality by 43% (SPRINT, 2015) and large 
decreases in left ventricular hypertrophy (Soliman et al., 2015). This has led to the “lower is 
better” attitude being adopted with patients at high risk of CVD (Bundy et al., 2017). Adverse 
events are, however, more frequently reported after intense BP lowering therapy, including 
hypotension, syncope, electrolyte abnormalities and acute kidney injury (SPRINT, 2015). 
Nevertheless, intensive interventions are recommended to prevent strokes and improve the 





Hyperlipidaemia is caused by high-fat diets, smoking, lack of exercise, excessive alcohol 
intake, kidney disease, liver disease and genetic predisposition (Stroke Association, 2015) and 
is characterised by increased cholesterol; particularly low-density lipoproteins. Total 
cholesterol/high density lipoprotein-C ratio may best predict stroke risk in males whereas 
triglyceride levels may be the strongest predictor of stroke risk in females (Liu, Yan & Xue, 
2019). This increase in cholesterol is directly associated with an increased risk of ischaemic 
stroke (Tirschwell et al., 2004; Cui et al., 2012; Zhang et al., 2012) and relatively small 
reductions in total cholesterol have an impact on vascular health. A decrease of 1 mmol/l in 
total cholesterol is linked to a 21% reduction in stroke risk. These decreases in cholesterol can 
be achieved through lipid lowering treatments (Royal College of Physicians, 2016). 
Modifications to lifestyle also have the potential to reduce hyperlipidaemia, and telephone-
based education about the subject has been demonstrated to lead to non-significant 
reductions in cholesterol (Adie & James, 2010). Even reductions in cholesterol which do not 
meet statistical significance may have meaningful impact on the lives of individuals with 
hyperlipidaemia.  
 
Glucose metabolism disorders 
Glucose metabolism disorders include type one diabetes mellitus, pre-diabetes mellitus and 
type two diabetes mellitus (Kernan et al., 2014). Type one diabetes mellitus occurs in 
genetically predisposed individuals due to the destruction of insulin depleting cells (Type 1 
Diabetes Study Group, 2002) and is generally diagnosed at a young age. Pre-diabetes mellitus 
encompasses impaired fasting blood glucose, impaired glucose tolerance and intermediate 
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elevations in haemoglobin A1C (Kernan et al., 2014) but without the development of type two 
diabetes. Type two diabetes is a chronic disorder characterised by hyperglycemia and later 
development of vascular and neuropathic complications (Inzucchi et al., 2011). Around one 
in sixteen people in the UK is diabetic (3.9 million; Diabetes UK, 2015) with an estimated 
850,000 currently undiagnosed individuals (Department of Health, 2013). Diabetes mellitus 
as a whole is one of the most common chronic diseases (Guo et al., 2018) and significantly 
increases cardiovascular morbidity and mortality risk (Beckman, Creager & Libby, 2002). 
Diabetic individuals have a greatly increased risk of incident ischaemic stroke (Goldstein et 
al., 2011), with double the risk of stroke even after correcting for other risk factors in 
comparison to those without diabetes mellitus (Luitse et al., 2012). This increase in risk is 
particularly prevalent in females (Peters, Huxley & Woodward, 2014). Seventy-one percent of 
adults who have been diagnosed with diabetes mellitus are hypertensive (CDC, 2014). It is not 
clear whether or not the elevated stroke risk associated with glucose metabolism disorders is 
due directly to the lack of blood glucose control or due to frequent co-existing conditions 
(such as elevated BP) in metabolic syndrome.  
 
Metabolic syndrome 
Metabolic syndrome is the presence of a variety of abnormalities including being overweight, 
hypertriglyceridaemia, low HDL-C, elevated BP and hyperglycaemia (Kernan et al., 2014). This 
presents as visceral fat accumulation, insulin resistance, hyperinsulinaemia and 
hyperlipidaemia (Whelton et al., (2018). A three-fold risk of stroke exists in those presenting 
with metabolic syndrome (Isomaa et al., 2001) but whether or not this is clinically useful as a 
medical term is uncertain as its pathogenesis is debatable (Kernan et al., 2014), due to the 
42 
 
wide range of physiological variables contributing to its contraction. Insulin resistance may be 
the core defect, leading to the development of other conditions associated with the syndrome 
(Kernan et al., 2014). Recent recommendations have outlined lifestyle modification as the 
cornerstone of treating metabolic syndrome (Whelton et al., 2018) – with the focus on 
lifestyle changes in these recommendations being unprecedented (Schwartzbard et al., 2018). 
Dietary modification and weight reduction are the two primary means of reducing the burden 
of metabolic syndrome and the consequent elevated risk of incident stroke. 
 
Obstructive sleep apnoea 
Obstructive sleep apnoea (OSA) is a condition characterised by upper airway obstructions due 
to reductions in pharyngeal muscle tone during sleep (Turkington et al., 2002). Recurrent 
collapses of the upper airway cause intermittent apnoea, hypoxaemia and a resulting 
disruption in sleep (Parati et al., 2012). This condition is the most common form of sleep-
disordered breathing (Dong et al., 2018) and is present in 2-7% of the general adult population 
(Lattanzi, Brigo & Silvestrini, 2018a). The presence of OSA is linked to a heightened risk of 
hypertension (Marin et al., 2012) and, once the condition begins to manifest nocturnally, 
derangements may begin to take place during the daytime too; causing alterations to 
circadian rhythms (Lattanzi et al., 2018a). Prominent risk factors of OSA include age, being of 
the male sex, snoring, increased body mass index and increased neck circumference 
(Turkington et al., 2002). The presence of OSA increases the risk of cerebrovascular disease 
and the end-point of stroke and death (Yaggi et al., 2005; Redline et al., 2010; Dong et al., 
2018). Whilst OSA is only present in 2-7% of the general population (Lattanzi et al., 2018a), it 
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was reported in 72% of a sample of stroke patients (Johnson & Johnson, 2010), with 63% 
suffering > 10 reductions in air flow per hour and 38% suffering > 20 events per hour.  
 
2.7 Behaviourally modifiable risk factors and stroke 
 
Physical activity 
Physical activity is defined as “any bodily movement produced by skeletal muscles that results 
in energy expenditure” (Caspersen, Powell & Christenson, 1985), whereas physical inactivity 
is “the presence of insufficient physical activity levels to meet present physical activity 
recommendations” (Morton et al., 2018). These physical activity guidelines are outlined in 
Table 2.4. Recommendations from the Department of Health and Social Care (2011) are 
similar between adults and older adults but a stronger rationale is offered for the need for 











Table 2.4: Physical activity guidelines for adults and the older adults 
19-64 65+ 
Be active daily. 150 minutes of moderate 
intense activity in bouts of 10 minutes or 
more per week 
Be active daily. 150 minutes of moderate 
intensity activity in bouts of 10 minutes or 
more per week 
75 minutes of vigorous intense activity 
across the week  
For those who can, 75 minutes of vigorous 
intense activity across the week 
Physical activity to improve muscle strength 
≥ 2 days per week 
Physical activity to improve muscle strength 
on two days per week 
Minimising sedentary time Minimising sedentary time 
 If at a risk of falls, incorporate balance and 
co-ordination skills on two days per week 
Adapted from Department of Health and Social Care, 2011 
 
Incorporating sufficient physical activity to meet guidelines is associated with a decrease in 
stroke, other CVD risk, and all-cause mortality, particularly in terms of ischaemic stroke (Thrift, 
Donnan & McNeil, 2002; Reimers et al., 2009; O’Donnell et al., 2010; Department of Health, 
2011; Li & Siegrist, 2012; Autenrieth et al., 2013; Aidar et al., 2014). According to a meta-
analysis of 23 studies, individuals who are very physically active have a 27% lower risk of 
incident stroke than those with low levels of low physical activity (Lee, Folsom & Blair, 2003) 
with physical activity interventions seen as a viable option for stroke prevention in the > 80 
years old demographic (Willey et al., 2017). Introducing physical activity as a lifestyle choice 
is the cornerstone of risk reduction therapy for the prevention and treatment of stroke 
(Gordon et al., 2004) and provides a non-pharmacological option to slow age-related 
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cognitive decline and disease-related impairment in the older population (Kirk-Sanchez & 
McGough, 2014).  
Physical activity is beneficial to vascular health due to the reduction of peripheral resistance 
(Kokkinos et al., 2009) and increases in nitric oxide release (Zanesco & Atunes, 2007) and a 
systematic review reports that undertaking physical activity has a positive influence on key 
variables relating to the progression of atherosclerosis (Palmefors et al., 2014). However, 
although physical activity may attenuate the stresses placed on the body by overweight and 
obesity through hypertension, it does not eliminate them entirely (Werneck et al., 2018). 
Undertaking physical activity may help incident stroke prevention through improving 
traditional vascular risk factors (such as BP) but may also improve the human response to 
stroke, potentially reducing infarct size and minimising severity (Middleton et al., 2013).  
 
Physical inactivity and sedentary time 
Physical inactivity is a major risk factor for chronic diseases (Jones et al., 2018), including 
increased risk of incident and recurrent stroke (McDonnell et al., 2013; Feigin et al., 2014) by 
around 50% (World Health Organisation, 2004). Most research studies use the term ‘inactive’ 
to describe those who are performing less moderate-vigorous intensity physical activity than 
guidelines recommend (van der Ploeg & Hillsdon, 2017). Distinguishing between physical 
inactivity and sedentary time is vital when addressing lifestyle changes (Morton et al., 2018). 
Sedentary time is “any waking behaviour characterised by an energy expenditure < 1.5 METs 
while in a sitting or reclining posture” (Barnes et al., 2012) and there is growing concern about 
the amount of time people spend sedentary (Martin et al., 2015). Sedentary individuals are 
25-30% more likely to have a stroke than less sedentary peers (Goldstein et al., 2011) and less 
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likely to take part in exercise outside of their sedentary time. Even if individuals do take part 
in exercise, extended time spent in sedentary behaviours is associated with poor health, 
regardless of the level of outside physical activity (Martin et al., 2015). For example, for every 
five hours of extra television viewing per week, there is a significant increase in the 
biomarkers for diabetes risk (Hansen et al., 2012) and consequently stroke risk. This may be 
due to the association between prolonged television viewing time and increased BP (Beijer et 
al., 2018).  Sedentary behaviours are associated with lower cognitive performance (Falck, 
Davis & Liu-Ambrose, 2017), decreased verbal memory (Kesse-Guyot et al., 2014), executive 
function (Steinberg et al., 2015) and all-cause dementia risk (Kivipelto et al., 2008). For every 
25-30 minutes of sedentary behaviour per day, the risk of CVD increases by 1% (Fitzgerald et 
al., 2015) and prolonged bouts of sedentary time are particularly harmful to the body (Healy 
et al., 2008; Healy et al., 2011). 
 
Exercise 
The concept that taking part in exercise is beneficial to health is not a new one, with 
reductions in resting heart rate (Levy et al., 1998), BP (Whelton et al., 2002), and 
improvements in heart rate variability (Malfatto et al., 1996) noted after exercise 
programmes. Exercise is defined as a “subset of physical activity that is planned, structured 
and repetitive and has a final or an intermediate objective of the improvement or 
maintenance of physical fitness” (Caspersen et al., 1985, p. 126). Exercise is associated with a 
higher quality of life and better health compared to sedentary individuals (Naci & Ioannidis, 
2013) with those who exercise enough to fall in the highest quartile of energy expenditure 
having a 15% lower risk of dementia than those in the lowest quartile of energy expenditure 
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(Podewils et al., 2005). Aerobic exercise and resistance exercise have both been shown to 
reduce BP (Cornelissen et al., 2011; Rossi et al., 2013; Cornelissen & Smart, 2013). Running 
has been shown to increase brain derived neurotrophic factor – a growth factor key in terms 
of contributing to cell survival and neurite growth (Thomas et al., 2012) and therefore 
particularly pertinent to stroke. Nevertheless, only 14% of adults in the United Kingdom 
exercise regularly (Townsend et al., 2012) but those who run more than 8km per day have a 
60% reduced risk of stroke compared to individuals who run fewer than 2km per day. Whilst 
running over 8km per day may not be a feasible option for most people, even running more 
than 2km per day significantly reduces the risk of stroke (Williams, 2009). The picture is 
becoming clearer and clearer that lifestyle choices are the first line of defence against CVD 
(Croymans et al., 2014).  
 
Overweight and obesity 
The prevalence of overweight and obesity (body mass index > 25kg·m2 and body mass index 
> 30kg·m2 respectively) is on the rise. Although there are criticisms of the system, including 
the lack of classification of where fat is situation (Nuttall, 2015) , this is still a widely used 
classification tool in the general population. In the United Kingdom, 58% of females and 65% 
of males are either overweight or obese and the average body mass index (BMI) for the 
population is 27.2kg·m2, an overweight BMI classification (Health and Social Care Information 
Centre, 2016). As the prevalence of overweight and obesity grows, there is potential for 
elevated BP to follow (Forouzanfar et al., 2017). This condition is a major health and societal 
problem (Chrysant, 2018), accounting for one in five deaths worldwide (Masters et al., 2013) 
due to its links with elevated BP (Hall et al., 1999; Hall, 2003; Saydah et al., 2014; Werneck et 
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al., 2018), atherosclerosis (Roberts & Barnard, 2005) and OSA (Romero-Corral et al., 2010). 
Overweight and obesity are directly linked to stroke (Kurth et al., 2005; Strazzullo et al., 2010) 
with 18-44% of stroke patients reported to be obese by available estimates using BMI as a 
categoriser (Kernan et al., 2013). Being overweight or obese increases stroke risk by 22% and 
50% respectively (Strazullo et al., 2010) whilst a possible linear relationship exists between 
BMI and stroke with every increase of 1kg·m2 above 20kg·m2 representing a 5% increase in 
stroke risk (Kernan et al., 2014). This is due to the activation of systemic inflammation and 
increased oxidative stress, potentiating endothelial dysfunction and vascular hypertrophy 
(Dorresteijn, Visseren & Spiering, 2012). When trying to reduce BP, weight loss is one of the 
most important interventions available, with decreases in BP observed after successful weight 
loss interventions (THOP Phase II, 1997; Neter et al., 2003) and a 1 mmHg reduction in brachial 
BP expected for each 1kg of body mass reduction (Whelton et al., 2018). 
 
Alcohol intake 
Low alcohol intake has been reported to reduce the risk of ischaemic stroke, moderate alcohol 
intake to have little effect on stroke risk and heavy alcohol intake to have an increased risk of 
stroke with an apparent dose/response relationship (Zhang et al., 2014). There is a school of 
thought, however, that light alcohol consumption may reduce the risk of ischaemic stroke 
(Reynolds et al., 2003). This may occur due to increased levels of HDL-C, decreased fibrinogen 
levels and lower platelet aggregation (Mukamal et al., 2005; Brien et al., 2011), with these 
factors leading to fewer atherosclerotic plaques (Sundell et al., 2008). Nevertheless, a number 
of research studies have reported that BP increases linearly with alcohol intake (Taylor et al., 
2009) and that reducing alcohol intake is associated with significant reductions in BP (Xin et 
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al., 2001). There seems to be a predictable and direct relationship between alcohol intake and 
BP, particularly when alcohol intake goes above three drinks per day (Whelton et al., 2018). 
The two habits which seem particularly damaging to stroke risk are drinking over thirty 
alcoholic drinks per month and binge drinking (Reynolds et al., 2003; Sundell et al., 2008; 
O’Donnell et al., 2010). Binge drinking is defined as males consuming six or more drinks of the 
same beverage on one occasion or females consuming four or more drinks on one occasion 
(Sundell et al., 2008). The risk of ischaemic stroke is increased among infrequent drinkers and 
occasional binge drinkers compared to those who do not drink at all (Hansagi et al., 1995) and 
drinking large amounts of alcohol on one occasion may increase BP more than the same 
volume over a greater length of time (Wannamathee & Shaper, 1991). These sudden 
consumptions of a large amount of alcohol that amount to binge drinking may cause 
temporary BP spikes which may lead to potential ruptures of the small arteries or to an 
aneurysm (Sundell et al., 2008).  
 
Illegal drug use 
Illegal drug use is also linked directly to stroke and may be the most common behaviour 
leading to stroke in those under 35 years old (Esse, Fossati-Bellani & Traylor, 2011). Drug users 
aged 15-44 years are 6.5 times more likely to have a stroke at an early age than non-drug 
users (Kaku & Lowenstein, 1990) and around 12% of young adult stroke patients report illegal 
drug use (Sloan et al., 1998) – a number which may underestimate the true figure. Using 
cocaine, amphetamines, ecstasy, heroin, phencyclidine, lysergic acid diethylamide and 
marijuana may all start mechanisms that increase the likelihood of stroke (Sloan et al., 1998), 
with cocaine and amphetamines specifically reported to be strong risk factors for stroke 
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(Petitti et al., 1998), although Dutta and colleagues argue against the link between marijuana 
and stroke (Dutta et al., 2014). 
 
Tobacco smoking 
One in four strokes in England can be attributed to tobacco smoking, as smokers have up to 
three times the risk of stroke compared to non-smokers (Royal College of Physicians, 2016). 
Around half of participants (52%) under the age of 45 in research from de los Rios and 
colleagues (2012) were active smokers at the time of stroke. Cigarette smoking has long been 
recognised as an independent risk factor for stroke (Wolfe et al., 1988; O’Donnell et al., 2010) 
with a dose-response relationship observed between the number of cigarettes smoked and 
level of stroke risk (Shinton & Beevers, 1989). The primary mechanism relating smoking to 
stroke seems to be AF, as the risk of AF is increased five-fold in those who smoke (Savelieva 
et al., 2007; Albertsen et al., 2015). It is the co-existence of smoking and hypertension, 
however, which seems to create the greatest risk of ischaemic stroke (Huangfu et al., 2017). 
However, the popularity of cigarette smoking is on the decline. Only 19% of adults in Great 
Britain are smokers (down from a peak of 46% in 1974) and 19% of adults in the USA are 
smokers (down from a peak of 42% in 1965 [CDC, 2012; Office for National Statistics, 2014]). 
The short-term and long-term effects of vaping and passive vaping have not yet become clear 
and longitudinal data must be collected to relate this to stroke risk as this form of smoking 






Being exposed to particulate air pollution is linked to higher stroke risk.  This is perhaps one 
of the reasons why people from more deprived socioeconomic backgrounds are at higher risk, 
with those who live in economically deprived parts of the UK two to three times more likely 
to have a stroke than those in the least deprived areas (Scarborough et al., 2009; Public Health 
England, 2013). Socio-economic status is directly linked to an increased likelihood of stroke 
(Kerr et al., 2011). On a global level, people in low and middle-income countries have strokes 
five years younger than in higher income countries (Feigin et al., 2014). Incidence and thirty-
day fatality rates are also higher in India compared to more developed countries (Das et al., 
2007; Dalal et al., 2007). Although socio-economic status is only modifiable to a certain 
extent, it plays a large part in deciding stroke risk for an individual. 
 
Air pollution 
One potentially related variable to socio-economic status is air pollution and stroke. Inhaling 
air pollution may lead to a pro-inflammatory response, increasing blood coagulation. This 
increase in air pollution and blood coagulation may lead to increased BP (Liang et al., 2014) 
and a rise in ischaemic stroke risk (Brook et al., 2010). Work from Sjogren and colleagues 
(2013) suggests that after adjusting for age, socioeconomic status and population density, 
participants exposed to small pollutant particles (e.g. machine drivers) or large particles (e.g. 
engineering workers, construction workers, welders) have an increased risk of ischaemic 
stroke compared to those unexposed (e.g. nurse assistants, show assistants). A combination 
of low socio-economic status and employment in physically degraded environments 
therefore seems likely to predispose cerebrovascular events. Physical activity in the 
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workplace may give even more protection from stroke than leisure time physical activities 
(Wendel-Vos et al., 2004) but when this physically active work is in an environment with high 
levels of air pollution, it is extremely detrimental to an individual’s health and drastically 
increases stroke risk. 
 
Diet 
A healthy lifestyle involves consuming a nutritious diet and balance of macro and 
micronutrients. This combination of beneficial foods and nutrients may reduce inflammatory 
cytokines and reduce the risk of cardiovascular alterations (Hu, 2002).  
The Mediterranean diet is optimal for improving BP control, decrease inflammation and 
maximise endothelial function (Nordmann et al., 2011; Kernan et al., 2014; Schwingshackl & 
Hoffman, 2014; Ruiz-Canela et al., 2015). This diet is characterised by high levels of oily fish, 
fruits, nuts and seeds (O’Donnell et al., 2010; Ndanuko et al., 2017). Table 2.5 displays key 









Table 2.5: Studies presenting the influence of diet on chronic disease risk 
Authors Dietary aspect examined Key findings 
O’Donnell et al., 2010 Increased intake of red meat, 
eggs, fried foods, salty snacks, 
foods containing lard 
Consumption related to 
increased overall stroke risk 
Mangat et al., 2013 Excess dietary fat intake Increased fat intake leads to 
greater risk of hypertension 
Van Dam et al., 2003 Red meat, coffee, potatoes, 
beer and saturated fats 
Consumption of these 
products related to elevated 
systolic blood pressure 
Abete et al., 2018 Lifestyle incorporating semi-
skimmed dairy products, fish, 
fruit and vegetables, 
wholemeal cereals and olive 
oil 
These foodstuffs may favour 
the control of C-reactive 
protein and HDL-C 
Campbell et al., 2012 Fish oil supplementation Fish oil supplementation may 
cause significant decreases in 
systolic blood pressure 
Jaaskelainin et al., 2012 Vegetable consumption as a 
child 
Increased vegetable 
consumption at a young age 
decreases risk of elevated 
blood pressure in later life 
Fung et al., 2004 Intake of fruit and vegetables, 
fish and whole grains 
Consuming these foodstuffs 
may protect against stroke 
He, Nowson & MacGregor, 
2006 
Fruit and vegetable 
consumption 
Increased consumption of fruit 
and vegetables reduces the 
risk of stroke 
Boeing et al., 2012 A critical review examining 
fruit and vegetable intake and 
chronic disease 
Fruit and vegetable 
consumption throughout life is 
related to a reduced risk of 
chronic diseases including 
CVD, stroke, cancer, eye 
diseases and osteoporosis 
 
 
Flavonoids found in fruit suppress rises in BP in those with hypertension and metabolic 
syndrome through restoring endothelial function (Clark et al., 2015). One class of flavonoid 
are anthocyanins – found in fruits such as blueberries and raspberries. Improvements in long-
term health prognoses after fruit intake may take place due to anthocyanin induced decrease 
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in arterial stiffness. Fruits high in anthocyanins may improve vascular function through 
increasing the bioavailability of nitric acid – a vasodilator (Jennings et al., 2012).  
Sugar sweetened beverages are strongly linked to obesity (Hu, 2013) and artificially 
sweetened soft drink consumption is also associated with an elevated risk of stroke (Pase et 
al., 2017). Coffee is one of the most commonly consumed drinks in the world (Crippa et al., 
2014) and has been linked to decreased rates of cancer, cardiovascular disorders, 
cardiovascular mortality and all-cause mortality (Beaudoin & Graham, 2011; Crippa et al., 
2014). The substance has also been linked with a decreased risk of ischaemic stroke, but not 
haemorrhagic stroke (Lopez-Garcia et al., 2009). The overall picture is not clear as smoking 
and caffeine consumption tend to take place concurrently (Bjorngaard et al., 2017) but 
heavier daily coffee consumption may be linked to lesser stroke prevalence, although 
causality is unclear (Liebeskind et al., 2016). As with alcohol intake, naïve coffee drinkers 
double their risk of stroke in the next hour compared to regular coffee drinkers (Mostofsky et 
al., 2010) due to this sudden spike in BP after consumption. 
 
Prescription drugs 
The use of prescription drugs has risen sharply in the United Kingdom (NHS, 2012) and the 
medical research landscape increasingly favours drug interventions over lifestyle modification 
(Naci & Ioannidis, 2013). Funding of pharmacological interventions is more likely to be 
provided by wealthy corporations than behavioural change studies which may be less 
financially profitable. Yusuf and collaegues (2005) listed nine key factors: hypertension, 
current smoking, abdominal obesity, physical activity, diet, diabetes mellitus, alcohol intake, 
psychosocial factors and apolipoproteins. These nine factors are narrowed down to five by 
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O’Donnell and colleagues (2010): hypertension, current smoking, abdominal obesity, diet and 
physical activity. O’Donnell and colleagues concluded that hypertension is the strongest risk 
factor for all stroke (Odds ratio (99% confidence interval: 2.64 [2.26 – 3.08]; 34.6% population-
attributable risk {30.4-39.5}). They claim that the main target of interventions aiming to 
reduce the global burden of stroke should involve reducing hypertension, smoking cessation, 
physical activity instigation and a healthy diet. The factors listed in this thesis, whether they 
are non-modifiable (e.g. age, ethnicity), medically modifiable (e.g. OSA, metabolic syndrome) 
or behaviourally modifiable (e.g. sedentary time, physical activity, exercise, diet, alcohol) all 
relate back to vascular health, elevated BP and hypertension.  
 
2.8 Stroke occurrence 
After ischaemic stroke occurs, protein synthesis is completely suppressed in the tissue 
adjacent to the infarct (the ischaemic penumbra [Xie et al., 1989]). There is a lowering of 
adenosine triphosphate in the immediately surrounding area as the cellular pH decreases 
(Hossmann et al., 1985) and this decrease in protein synthesis leads to cell death if not quickly 
reversed (Aquilani et al., 2011). 
Managing risk factors after stroke through pharmacological methods and lifestyle changes is 
the cornerstone of strategies intending to reduce the likelihood of recurrent stroke (Kono et 
al., 2013). Due to the fact that treatment of incident stroke is constantly improving, more 
patients are surviving their strokes than ever before. This leads to a larger number of patients 
being discharged with an elevated risk of future strokes, greater burden being placed on 
rehabilitation services and more pressure on those services trying to prevent recurrent 
strokes from taking place. Understanding and acting on the consequences of having and 
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surviving a stroke is vital. The consequences of stroke can be broken down broadly into 
physiological and psychological/psychosocial categories depending on the individual and the 
precise location of the stroke. 
 
2.9 Treatment after stroke 
Immediately following stroke, the use of thrombolysis (using alteplase, reteplase [r-tPA] or 
tenecteplase and tissue plasminogen activator [tPA]) is administered to ischaemic patients. A 
systematic review by Qin and colleagues (2018) reported reduced long-term mortality in 
ischamic stroke patients who were treated with intravenous r-tPA, although a greater risk of 
death in the first 7-10 days has been demonstrated due to increased occurrence of fatal ICH 
(Wardlaw et al., 2014). This treatment is permitted up to 4.5 hours post ischaemic stroke in 
the United Kingdom (SIGN, 2008; NICE, 2012) and should be prescribed with a dosage of 
0.9mg·kg-1 (Furlanis et al., 2018). Only a small proportion of stroke patients are treated with 
tPA (Lackland et al., 2014) due to the narrow window of safe and effective treatment. As only 
one in nine patients with acute stroke receive thrombolysis (Intercollegiate Stroke Working 
Party, 2016) and older patients with higher NIHSS scores have longer door to needle time 
(Birnbaum et al., 2016), there is now a focus on minimising pre-hospital and in-hospital delay 
(Faiz et al., 2017).  
Anti-platelet therapy is one of the most important methods of reducing secondary stroke risk 
(Antithrombotic Trialists’ Collaboration, 2002; Royal College of Physicians, 2016). The intake 
of aspirin within 48 hours of ischaemic stroke may reduce mortality risk between one and 
three-months post-stroke (Sandercock et al., 2008), but an increased risk of bleeding 
(Morgan, 2005) and of future haemorrhagic stroke (Morgan & Elwood, 2011) have been 
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observed. Although the largest beneficial effect of aspirin has been observed at 325mg per 
day, between 75mg and 100mg per day balances efficacy and safety (Singer et al., 2008; 
Kernan et al., 2014). Clopidogrel is a second anti-platelet drug which is effective for ischaemic 
stroke prevention (Ikeda-Sakai, Sasaki & Nakase, 2017). 
Whilst using these drugs in isolation is beneficial, combination therapy trials have yielded 
mixed results. Although a combination of the two drugs has been suggested to reduce the 
risk of stroke compared to aspirin alone (Zhou et al., 2012), the effectiveness may be ‘modest 
at best’ (Connolly et al., 2011). There is an increased risk of haemorrhage widely reported 
after this combination therapy (Diener et al., 2004; Geraghty et al., 2010; Lackland et al., 
2014). Guidelines therefore advise against the use of the two drugs in tandem (Furie et al., 
2011). Other anti-platelet treatments include dipyridamole, which, when combined with 
aspirin, has been reported to reduce the risk of recurrent stroke compared with aspirin alone 
(Diener et al., 1996) and ticlopidine, which has been reported to reduce the risk of major 
events compared with aspirin but with greater safety concerns (Antithrombotic Trialists’ 
Collaboration, 2002).  
Anti-coagulant therapy is now usually restricted to long-term secondary prevention (Royal 
College of Physicians, 2016). The most common prescribed therapy is warfarin which may 
reduce fatal and non-fatal stroke by around 50% in those with AF (Aguilar, Hart & Pearce, 
2007). Earlier research suggests that the use of warfarin may reduce annual risk of recurrent 
stroke from 12% to 4% (EAFT Study Group, 1993). However, there may be an increased risk 
of bleeding after the use of warfarin (Shah et al., 2014) – these authors suggesting that the 
drug may not even be useful in reducing stroke risk in those with AF undergoing dialysis.  
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Statins (most commonly atorvastatin) are frequently used for individuals suffering from 
ischaemic strokes. Discharge statin therapy is linked with a lower risk of major adverse 
cardiovascular events (O’Brien et al., 2015) and may risk the risk of dementia (Pan et al., 2018) 
but must not be used with patients where haemorrhage is a plausible cause for stroke. A five-
fold increased risk of recurrent haemorrhage is the result of prescribing statins incorrectly 
after haemorrhagic stroke (Goldstein, Mascitelli & Pezzetta, 2009). High dose statin therapy 
is recommended to those with dyslipidaemia to prevent second strokes (Amarenco et al., 
2009a).  
Once anti-hypertensive medication is prescribed, it is usually continued for life but one in four 
patients could be successfully withdrawn for two years or more (van der Wardt et al., 2017) 
and 22-50% of patients could be withdrawn for one year or longer without elevated BP 
returning. Although achieved BP reductions have been found to be comparable between 
males and females (Turnbull et al., 2008), females are more likely to suffer adverse effects of 
the therapy (Lewis et al., 1996).  
 
2.10 Physiological consequences of stroke 
Stroke causes the largest range of disabilities of any clinical condition (Adamson et al., 2004) 
and is the leading cause of disability in the elderly (Hung et al., 2018). Immediately after 
stroke, patients are at great risk of dehydration, malnutrition, infection, hypoxia and 
hyperglycaemia (Royal College of Physicians, 2016). The vast majority of stroke survivors then 
suffer from subsequent disabilities including hemiparesis, spasticity, cognitive dysfunction 
and aphasia (Billinger et al., 2014) with neurological deficits observed in most patients 
(Kobayashi, 2015). Cognitive impairments, observed in over half of stroke survivors, may 
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impede rehabilitation and functional recovery (Swatridge et al., 2017) as well as being 
associated with increased risk of mortality (Oksala et al., 2009). The large levels of morbidity 
after stroke tend to be due to a combination of neurological impairment, the social 
consequences of the impairment and the high risk of stroke recurrence (Kernan et al., 2014). 
Table 2.6 demonstrates the frequency of a variety of physical disabilities post- stroke, 
highlighting the large prevalence of life-altering disability after stroke.  
Table 2.6: Physical disability post- stroke 
Adapted from Stroke Association, 2015 
 
Consequence of Stroke % patients affected Statistics from 
Upper limb/arm weakness ~70% Royal College of Physicians 
SSNAP, 2016 
Lower limb/leg weakness 72% Lawrence et al., 2001 
Visual problems 60% Rowe et al., 2013 
Slurred speech 50% Harwood, Huwez & Good, 
2010 
Problems with bladder control 50% Harwood, Huwez & Good, 
2010 
Problems swallowing 45% Lawrence et al., 2001 
Aphasia 20-40% Engelter et al. (2006); Berthier 
(2005); Dickey et al. (2010)  
Furlanis et al. (2018) 
Sensory Loss   Up to 80% Doyle et al., 2010 
Problems with bowel control            33% Harwood, Huwez & Good 
(2010) 
Epilepsy           2-14% Menon & Shorvon, 2009 
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Deconditioning is frequently observed after stroke (Stein et al., 2006) and the assessment of 
this is central to the rehabilitation process (Royal College of Physicians, 2016). Around 65% of 
stroke survivors report severe disability after stroke (Adamson et al., 2004) and 40% report 
difficulties with basic self-care (Mayo et al., 2002). Although rehabilitation services aim to 
recover as much original movement as possible, the condition of altered arm function persists 
in around 40% of patients (Royal College of Physicians, 2016). Up to 50% of older stroke 
patients suffer permanent loss of some physical function after stroke (Mizrahi et al., 2007) 
and half or more of stroke survivors report having one or more unmet needs between one- 
and five-years post-stroke (McKevitt et al., 2011). This is frequently due to the decreased 
cardio-respiratory and musculoskeletal fitness in the stroke population compared to age-
matched healthy controls. Some motor improvements may occur after stroke due to the 
resolution of reversible damage to neurons and ganglia including changes in membrane 
potentials, axon conduction and neurotransmission (Dobkin, 2008). However, the loss of 
movement patterns is frequent due to lesions of the corticospinal pathways, leading to 
affected co-ordination of the joints (Dobkin, 2008). 
The consequences of stroke compromise living and social activities (Aidar et al., 2014), but 
those recovering after stroke can make meaningful gains in functional movement, functional 
fitness and functional balance after interventions (Lindberg et al., 2004). Functional fitness is 
the “physical capacity of the individual to meet ordinary and unexpected demands of daily 
life safely and effectively” (Bravo et al., 1994, p. 67), whereas functional balance is “the 
capacity to maintain various positions, to make automatic postural responses to voluntary 
changes in the body and its segments to react to external disturbances” (Berg et al., 1989, p. 
304). Loss of balance and falls are frequent after stroke (Persson, Hansson & Sunnerhagen, 
2011) with as many as 48% of stroke patients falling during in-patient post- stroke care (Suzuki 
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et al., 2005). Even after discharge, between 13% and 25% of those doing exercise training 
suffer falls (Pang et al., 2005; Mead et al., 2007). These falls are due to decreases in 
proprioception and balance, decreased strength, difficulties processing information, lack of 
dual tasking and difficulties during the planning and excecution of tasks (Barros de Oliveira et 
al., 2008; Baetens et al., 2013). Disturbed alertness is also common after stroke (Royal College 
of Physicians, 2016) and may contribute to the high rate of falls. 
As a result of deconditioning due to the consequences listed in Table 2.6, chronic stroke 
patients display very low cardiovascular fitness (Michael, Allen & Macko, 2005). Survivors 
commonly present with selective muscle atrophy, decreased agonist muscle activation and 
impaired trunk muscle performance (Duncan et al., 2003; Silva-Couto et al., 2014). 
Interestingly, left hemiparesis has been reported to result in lower step counts, slower 
walking skills and greater gait asymmetries than right hemiparesis (Cassvan et al., 1976; Chen 
et al., 2014; Ezeugwu & Manns, 2016) but, across the board, fitness suffers. Peak oxygen 
uptake in sub-acute stroke patients has been reported to be only 60% of that of age- and sex-
matched normative values even in sedentary adults (Mackay-Lyons & Makrides, 2002).  
Cognitive deficits after stroke frequently include memory impairment (Novitzke, 2008) and 
reductions in concentration (Rasquin et al., 2002), cognitive control (Li et al., 2013), language 
(Pedersen et al., 2004), mental speed (Winkens et al., 2006), and executive functioning (Poulin 
et al., 2012). Dysarthria is neurological motor speech impairment with slow, weak, imprecise 
and/or un-coordinated movements of the speech musculature and is common after stroke 
(Royal College of Physicians, 2016), as is aphasia, a language disorder affecting verbal 
production or verbal comprehension, although cognitive function remains unaffected (Watila 
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& Balarabe, 2015). These cognitive deficits frequently complicate programmes to enhance 
physical recovery. 
 
2.11 Psychological and psychosocial consequences of stroke 
After stroke, a range of psychological conditions are frequently found in patients which limit 
quality of life and damage long- term prognoses. These psychological symptoms can be 
described as reactions to clinical consequences including motor disability and physical 
limitations in daily life (Kneebone & Lincoln, 2012). These symptoms may be due to cerebral 
lesions or depletion of serotonin, noradrenaline and dopamine (Bhogal et al., 2004; Buono et 
al., 2018). 
Vulnerable individuals are at risk of poor physical, psychological, and/or social health (Aday, 
1994). Vulnerability is common after stroke and mortality risk is reported to be five times 
higher in vulnerable patients than non-vulnerable patients (Gaynor et al., 2018). There is an 
argument that a stroke- specific definition of vulnerable is required, as there is a fair rationale 
that all stroke patients are vulnerable based on Aday’s more generic definition. Around 30% 
of stroke survivors experience post- stroke depression (Villain et al., 2017) which has 
characteristics including decreased interest, pessimism, lack of initiative and general fatigue 
(Li et al., 2017). The presence of this condition after stroke has been linked to continued 
smoking (Gravely-Witte et al., 2009), decreased motivation to eat healthily or be physically 
active (Lawrence et al., 2010), lowered performance in daily living activities (Kotila et al., 
1984), increased dependency (Langhorne et al., 2000), decreased quality of life (Sturm et al., 
2004) and reduced social interactions (Murrel et al., 2011). Depressive symptoms are also 
linked to increased risk of further CVD through hyperactivity of the hypothalamic-pituitary-
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adrenocortical axis, decreased heart rate variability, myocardial infarction, ventricular 
instability and changes in platelet receptors and reactivity (Musselman, Evans & Nemeroff, 
1998). Patients with depression are also at a heightened risk of death due to stroke (Razmara 
et al., 2017), particularly those under the age of 65 (Ayerbe et al., 2014). Whilst depressive 
symptoms may be alleviated by physical activity and exercise (Graven et al., 2011), physical 
limitations and fatigue may prevent this from taking place in many stroke survivors. 
Anxiety (the existence of at least one current clinically significant anxiety disorder [Sagen et 
al., 2010]) and emotionalism (the habit of weakly yielding to emotion, usually involving crying 
but sometimes laughing [Hackett et al., 2010]) have emerged as common reactions to stroke 
(Broomfield et al., 2014) and TIA (Verbraak et al., 2012). Around 18-25% of patients suffer 
from anxiety and approximately 20% suffer from emotionalism (Astrom, 1996; Hackett et al., 
2010) during recovery. This presence of post- stroke emotionalism has been linked to low 
testosterone levels (Choi et al., 2018). Anxiety and depression are both associated with 
elevated mortality after stroke (Bartoli et al., 2013) although the mechanisms behind this 
remain unclear (Razmara et al., 2017). Research into anxiety is less extensive than post-stroke 
depression but a combination of anxiety, depression, emotionalism and a lack of physical 
ability can lead to losses of confidence. Confidence, a positive mood state (Doyle, 2002), is 
lacking in 73% of stroke patients (Stroke Association, 2013). This lack of confidence relates to 
carrying out every-day functions, social interactions, physical activity, and a lack of trust in 
the patient’s own body (Hare et al., 2006; Spurgeon et al., 2013). Stroke survivors have 
reported that there may be little reason in treating physical problems during recovery if a 
patient does not have the confidence to leave the house even when they are physically able 
to (Pollock et al., 2012). A combination of these conditions may lead to overall low mood, 
with impulsive behaviours, verbal aggression and hostility seen after stroke (Choi et al., 2018). 
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Low mood may be the cause and consequence of low physical activity which may have a 
consequential damaging effect on self-efficacy, motivation and self-determination (Morris et 
al., 2012). The Stroke Association (2013) report that 63% of stroke survivors live in fear of 
another stroke, 44% find it hard to talk about stroke and 44% either break up or consider 
breaking up with their significant other. When considering how late in life strokes tend to 
occur, this proportion of patients considering breaking up with, or actually breaking up with, 
a significant other demonstrates the psychological difficulties encountered after stroke. One 
in four survivors live alone (Stroke Association, 2012a) and 69% of 25-59 year-old survivors 
are unable to return to work (Stroke Association, 2012b). This isolation in the chronic stage 
of recovery follows in-patient stays where patients spend most of their time alone (West & 
Bernhardt, 2012). A combination of these situations, combined with 18% of stroke survivors 
having access to care services reduced or withdrawn (Stroke Association, 2012a), can lead to 
a lack of social interaction. Decreased social interactions can, in turn, combine with losing 
self-identity to produce low levels of independence and negative health outcomes (Horne et 
al., 2014).  
 
2.12 Predisposition to second stroke 
Survivors of stroke and TIA naturally have a high risk of recurrent stroke (Gordon et al., 2004; 
Phillips et al., 2015) whether the incident stroke was ischaemic, haemorrhagic or a TIA (Wu, 
McLaughlin & Lorenzetti, 2007 Rutten-Jacobs et al., 2013). Three in ten stroke survivors suffer 
a recurrent stroke or TIA (Stroke Association, 2015), although Dawes (2012) and Hardie et al. 
(2004) report a 43% likelihood of recurrent event after an initial stroke and van Wijk and 
colleagues suggest a 10-year risk of 44.1% after a minor stroke or TIA. After initial minor 
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stroke, cerebrovascular accidents and coronary heart disease are the most frequent causes 
of death (Clark, Murphy & Rothwell, 2003) but the prescription of anti-platelet and anti-
coagulant agents and lipid lowering treatments lower the risk of secondary events (Amarenco 
et al., 2009b; Lennon et al., 2013). When recurrent stroke does occur, the likelihood of fatality 
within 30 days of the event is almost double that of a first stroke (Hankey, 2003), with a 
reported 41% case mortality after recurrent stroke, compared with 22% after an initial stroke 
(Hardie et al., 2004). Improvements in secondary prevention have the potential to reduce 
recurrent events by as much as 80% (Hackham & Spence, 2007) but risk factor control for 
chronic disease in conditions such as stroke remains poor (Ellis & Breland, 2014). As discussed 
previously, risk factors for incident stroke include medically modifiable and behaviourally 
modifiable risk factors. The same risk factors can be applied to recurrent stroke in a vulnerable 
population.  
 
2.13 Medically modifiable risk factors and recurrent stroke 
 
Atrial fibrillation 
Observing AF in stroke care is common, with 29% of stroke patients presenting with this 
symptom and around 10% of stroke patients developing AF during their time as in-patients 
(Rizos et al., 2012), although this number is reported to be lower (6%) in ICH patients (Prats-
Sanchez et al., 2018). The existence of AF in a stroke patient is an independent early risk factor 
for recurrent stroke (Moroney et al., 1998), with the risk of ischaemic stroke recurrence within 
14 days of the initial event as high as 8% (Berge et al., 2000). As a result, treating AF in those 
with a history of stroke is now a strong focus of neurology care (Kernan et al., 2014). 
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Blood pressure after stroke 
Sudden increases in BP are common during stroke and occur in 75-80% of patients before a 
decrease and plateau within 90 minutes of symptom onset (Leoo et al., 2008; Whelton et al., 
2018). The relationship between high BP variables (including PP) and stroke recurrence and 
poor outcomes is strong (Aslanyan, Weir & Lees, 2004; Sacco et al., 2006; Tang et al., 2017; 
Whelton et al., 2018) and treating elevated BP may be the most important intervention when 
preventing second strokes (Kernan et al., 2014). Appropriate BP lowering therapies may cause 
a 30% decrease in the risk of recurrent stroke (Lakhan & Sapko, 2009; Whelton et al., 2018) 
but this requires engagement with patients, families, providers and healthcare systems (Go 
et al., 2014). The prescription of appropriate BP lowering therapies must consider both the 
timing and aggression of the dose; both of which have received attention in the literature. 
Reducing BP immediately after stroke through anti-hypertensive therapy has been linked to 
reductions in haematoma growth after ICH and may be well tolerated (Anderson et al., 2008), 
leading to better BP control two weeks post-stroke but may be ineffective in preventing death 
or major disability (Robinson et al., 2010; He et al., 2014; Wang et al., 2014). This may be due 
to the fact that early interventions may lead to brain hypoperfusion (He et al., 2018) and that 
BP in the low-normal range may be linked to poorer mortality outcomes compared to 
elevated BP (Kim et al., 2014; Lin et al., 2015). General consensus is now that anti-
hypertensive treatment is only required in the first 24 hours after stroke in extreme situations 
(e.g. BP > 220/120 mmHg [Kernan et al., 2014]). Research including a Cochrane review by 
Zonneveld and colleagues (2018) reported pooled risk ratios for recurrent stroke of 0.81 after 
BP lowering medications (95% confidence interval = 0.70 – 0.93) in a sample of 38,742 
patients from eight research studies.   
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The intensity of BP reduction after stroke, however, remains controversial. Both high and low 
BPs have been associated with poor outcomes after ischaemic stroke (Ntaios et al., 2010) and 
the optimal range of BP after stroke in hypertensive individuals is controversial (He et al., 
2018). Elevated BP after stroke may cause cerebral vasospasm, leading to decreased cerebral 
flow and negative outcomes (Ishitsuka et al., 2014) and some research reports that the use 
of a BP target of less than 130mm Hg is likely to be beneficial after stroke (SPS3 Study Group, 
2013). After intracerebral haemorrhage, Tsivgoulis and colleagues (2014) and Anderson and 
colleagues (2013) suggest that intensive lowering of BP may lead to better functional 
outcomes. However, Qureshi et al. (2016) argue that there is no benefit of lowering SBP to 
less than 140 mmHg in this population and that doing so may be harmful, with twice the 
likelihood of renal adverse events in the intensely treated group. The overwhelming 
consensus for stroke is that aggressive reductions in BP after stroke are advised against (NICE, 
2008; Ovbiagele et al., 2011a; Williamson et al., 2016; Whelton et al., 2018). There may be no 
benefit of achieving a brachial SBP < 120 mmHg versus < 140 mmHg (ACCORD Study Group, 
2010) in stroke as a whole and doing so may expose patients to elevated risk of harm 
(Ovbiagele et al., 2011a). Optimal neurofunctional recovery has been observed with SBP of 
161-177 mmHg and DBP of 103-114 mmHg in a recent sample of 732 hypertensive stroke 
patients (He et al., 2018). The debate as to optimal and appropriate BP lowering immediately 
after stroke continues. 
 
Hyperlipidaemia 
Modifying blood serum lipid biomarkers is important when reducing recurrent stroke risk 
(Kernan et al., 2014) as 56% of those suffering from recurrent stroke have been reported to 
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present with hyperlipidaemia (Leoo et al., 2008). Even in children, a significant relative risk of 
second stroke is present in those with elevated lipoprotein levels (Strater et al., 2002), 
potentially due to the fact that low HDL-C levels are suggested to contribute to neurological 
deterioration after ischaemic stroke (Ryu et al., 2016). Reducing LDL-C by > 50% is associated 
with a 35% decrease in the risk of recurrent fatal or non-fatal stroke (Amarenco et al., 2007) 
and this may be achieved through exercise after stroke (Rimmer et al., 2009) – something 
which should be advised to stroke patients presenting with or without hyperlipidaemia. 
 
Glucose metabolism disorders 
Diabetes mellitus, reported in 24% of stroke patients recruited by Leoo and colleagues (2008), 
is related to poor prognosis after stroke (Tanaka et al., 2013) – in particular new-onset 
diabetes mellitus (Mapoure et al., 2018). Even hyperglycaemia on admission is a predictor of 
poor clinical outcomes (Mapoure et al., 2018) and glucose metabolism disorders as a whole 
are linked to an elevated risk of recurrent stroke (Hankey et al., 1998; Callahan et al., 2011). 
Aggressive management of blood glucose is vital in reducing death and improving functional 
outcomes (Mapoure et al., 2018). Metabolic syndrome, a condition involving low blood 
glucose control, may also be linked to the risk of recurrent stroke (Ovbiagele et al., 2006), 
although other published literature has not discovered a link between metabolic syndrome 






Obstructive sleep apnoea 
The presence of OSA is frequent after stroke and may lead to drowsiness during the day 
(Dobkin, 2008), complicating attempts to be physically active and complete physiotherapy 
sessions. Stroke patients who lie in a supine position will suffer significantly more respiratory 
disturbances than in any other body position (Turkington et al., 2002), with these 
disturbances leading to increased rates of recurrent AF (Kanagala et al., 2003). Patients with 
OSA tend to have worse outcomes after stroke, spend longer in hospital and have a greater 
risk of secondary stroke (Kaneko et al., 2003; Rola et al., 2008). The best predictors of upper 
airway obstruction after stroke are body mass index and neck circumference (Turkington et 
al., 2002). Prevention of OSA through weight loss is therefore a useful strategy in lowering 
the risk of recurrent events. 
 
2.14 Behaviourally modifiable risk factors and second stroke 
Changing unhealthy behaviours is of huge importance when trying to reduce the 
consequences of stroke and minimise the risk of future events (McCarthy et al., 2013). Non-
pharmacological therapy is the preferred therapy for adults with hypertension (Whelton et 
al., 2018), making lifestyle changes even more important. 
 
Medication adherence 
Even when incorporating lifestyle modification strategies, pharmacological interventions are 
important when reducing recurrent stroke risk and the first behaviourally modifiable factor is 
prescription adherence. Unsurprisingly, high adherence to anti-hypertensive therapy is 
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associated with a 38% decrease in the risk of cardiovascular events (Mazzaglia et al., 2009). 
Somewhat more surprisingly, low adherence to anti-hypertensive therapy is one of the major 
contributors to low rates of BP control (Peck, 2018). Up to 25% of patients do not fill in an 
initial prescription for anti-hypertensive treatment (Whelton et al., 2018) and 14% of 
participants, in work by Bushnell and colleagues (2011), admitted to not adhering to their 
prescribed medications. Up to 50% of patients with chronic disease as a whole do not take 
their medications as prescribed (Brown & Bussell, 2011), and the average hypertensive 
patient only takes their anti-hypertensive therapy 50% of the time, with only one in five 
patients adhering to their regimen strictly enough to achieve benefits seen in clinical trials 
(Petrilla et al., 2005; Gwadry-Sridhar et al., 2013). Research into non-adherence has been 
sparse (Phillips et al., 2015) but reasons may include negative perceptions about the 
medications, forgetting or being unable to take prescriptions and real or perceived side 
effects (Tong et al., 2010). Adherence has been reported to be greatest with once-daily dosing 
and decreases as daily dosing frequency increases (Claxton, Cramer & Pierce, 2001; Iskedjian 
et al., 2002; Schroeder et al., 2004). Involving third parties in terms of accountability also has 
positive effects on adherence, with pharmacists and nurses being involved in interventions 
likely to increase BP control (Carter et al., 2009). Telephone-based case management has 
been demonstrated to improve BP control for one year before control decreased (Bosworth 
et al., 2011) and the use of the internet to increase accountability reduced BPs significantly 
compared to usual care (Liu et al., 2013). These low levels of pharmacological adherence 





Physical activity and inactivity levels 
After stroke, low levels of physical activity are common (Field et al., 2013; Saunders et al., 
2016) with individuals who have suffered from stroke likely to accrue half the daily step 
counts of their healthy counterparts (English et al., 2014). Stroke patients are more likely to 
report inabilities to meet physical activity recommendations (Butler & Evenson, 2014), suffer 
cardiovascular deconditioning (Leoo et al., 2008; Prout et al., 2017) and subsequently have 
lower fitness levels (Ivey, Hafer-Macko & Macko, 2008), leading to fitting the profile of high 
sitting time and very low physical activity (English et al., 2018).  
Increased physical activity soon after stroke can promote better long-term outcomes (Askim 
et al., 2014). For example, stronger walking ability is associated with higher physical activity 
levels after stroke (Field et al., 2013). Early mobilisation is a key element of acute stroke care 
due to benefiical effects on oxygenation and reductions in complications (NICE, 2008). 
Mobilisation within 24 hours of stroke may result in earlier walking and functional recovery 
(Cumming et al., 2011) whilst reducing the risk of vascular dementia (Verdelho et al., 2012) 
and, when used alongside exercise, may lower BP (Millen et al., 2013) even more than dietary 
interventions (Nordstrand et al., 2013). However, this early mobilisation has been reported 
to lead to greater disability at three months after stroke in the AVERT Trial (Bernhardt et al., 
2015). This may mean that too much, too soon is detrimental to long-term health. Frequent 
short episodes of physical treatment should be the predominant pattern in the first fortnight 
after stroke (Royal College of Physicians, 2016). Physical activity is low after stroke but 
increases between three- and six- months post-stroke but not from six months onwards 
(Persson et al., 2016). As such, there is an obvious need to encourage stroke survivors to 
increase physical activity, but the best way of going about this is not yet clear (Nicholson et 
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al., 2013). One barrier to increasing activity after discharge is that access to community 
rehabilitation services is poor, with up to 57% of stroke survivors not receiving recommended 
therapy after hospital discharge (Hall et al., 2016). 
Physical activity may be the most important modifiable risk factor preventing recurrent 
events and improving quality of life after stroke (Wolf & Koster, 2013), reducing neural injury 
and stroke severity after the incident (Middleton et al., 2013). However, many stroke 
survivors are physically able to undertake some physical activity but still choose not to do so 
(Rand et al., 2009). This decision to be physically inactive post- stroke leads individuals into a 
destructive cycle of physical inactivity leading to medical complications which result in further 
inactivity (Billinger et al., 2014).  
A frequently cited rationale for physical inactivity is fatigue. Fatigue is described as a chronic, 
debilitating, persistent and profound sense of tiredness resulting from physical and mental 
exertion (Lerdal et al., 2009). It is a disproportionate lack of energy triggered by simple 
activities (Lagogianni, Thomas & Lincoln, 2018) and can be related to both acute (Christensen 
et al., 2008) and chronic (Schepers et al., 2006) time frames. Although fatigue only affects 
11% of the general population (Mahon et al., 2018), it may be experienced by up to 85% of 
ischaemic stroke patients (Chestnut, 2011) and was listed by 40% of stroke patients as their 
worst or one of their most debilitating symptoms in work by Ingles, Eskes and Phillips (1999). 
Stroke-related fatigue influences the life of an individual for years after the event (Hackett et 
al., 2005) and many stroke survivors remain inactive, whether it is due to fatigue, physical 
inabilities or a lack of confidence in their body. The presence of fatigue is linked to an 
increased risk of mortality (Glader et al., 2002) and is one of the top priorities for research on 
life after stroke (Pollock et al., 2014). 
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The three main rehabilitation goals for a stroke patient are preventing complications of 
prolonged inactivity, decreasing recurrent stroke and cardiovascular events, and increasing 
aerobic fitness (Gordon et al., 2004). Physical activity interventions have the potential to 
target all three of these goals and are therefore key to stroke recovery. The key elements of 
a physical activity intervention are the number of sessions, the mode of delivery, the type of 
follow up and monitoring (Billinger et al., 2014). These should all be taken into consideration 
for any individual patient before suggestions are made as to their rehabilitation schedule. As 
well as improving functional skills, functional capacity, daily activities and quality of life after 
stroke (Mobily, 2009; Billinger et al., 2014), physical activities provide the opportunity for 
chronic stroke patients to interact with therapists and caregivers (Karthikabu et al., 2017) and 
are psychosocially beneficial. 
 
Sedentary time 
After stroke, survivors spend almost 11 hours per day (75% of waking hours) sitting (English 
et al., 2016), with estimates ranging up to 80% of the day being spent sedentary, compared 
to 50-60% for healthy adults (Rand et al., 2009; Matthews et al., 2012; Paul et al., 2016). 
Sedentary periods after stroke are often longer compared to age-matched healthy controls 
(English et al., 2016) – a particular concern when bearing in mind that prolonged sitting may 
be particularly bad for health (Dunstan et al., 2012). However, less is known about sedentary 
behaviour and stroke, particularly extended sitting, although it is believed to slow recovery 
(Butler & Evenson, 2014). There is limited awareness of the risks of sedentary behaviour 
amongst stroke survivors (Ezeugwu, Garga & Manns, 2016) but current American Heart 
Association guidelines for stroke survivors now include reducing sedentary behaviours 
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(Billinger et al., 2014). Focusing on reducing sedentary time after stroke is a promising 
intervention target (Morton et al., 2018) because if sedentary behaviour interventions are 
not put in place, advances made during inpatient rehabilitation may be lost (Ezeugwu et al., 
2016). Further research is necessary to determine whether light intensity activities to break 
up prolonged sitting have benefits for those with stroke (English et al., 2016). 
Increased sedentary behaviour after stroke may be perceived as normal and even an 
important way of relaxing after stroke (Ezeugwu et al., 2016). However, whilst adequate sleep 
maintains body function, prevents adverse cardiovascular outcomes and  is fundamental to 
health (Lattanzi, Brigo & Silvestrini, 2018b; Lo et al., 2018), too much time in bed and too 
much sleep is related to poor outcome, recovery and increased stroke risk (Langhorne, de 
Villiers & Pandian, 2012; Fang, Wheaton & Ayala, 2014). Sleeping too much is associated with 
increased C-reactive protein – a biomarker of inflammation (Patel et al., 2009) and white 
matter sensitivity (Ramos et al., 2014), both markers of elevated stroke risk. Chronic sleep 
deprivation has been linked with an elevated risk of stroke, heart disease, reduced cognitive 
function and all-cause mortality (Cappuccio et al., 2011; Ferrie et al., 2011) and is one of the 
most common sleep-related conditions in the west with individuals sleeping an average of 90 
minutes fewer per night than 100 years ago (Nagai, Hoshide & Kario, 2010b). Sleep quality is 
also related to cardiovascular health. Low sleep quality and duration are contributors to 
increased fasting plasma glucose levels (Lee, Ng & Chin, 2017) which, in turn, are related to 
increased cardiovascular mortality in those with hypertension (Henry et al., 2002). Sleep 
structure disruption also causes episodic hypoxemia and general stress, leading to 
catecholamine surge and baroceptor sensitivity impairment (Lattanzi, Brigo & Silvestrini, 
2018c; Lesske et al., 1997). 
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Exercise and physical fitness 
The fitness levels of stroke patients are well below age-matched average non-stroke 
individuals (Ivey et al., 2008) and, due to this, few people exercise after stroke with even 
fewer commencing long-term exercise programmes (Simpson et al., 2017). Lower levels of 
exercise due to disability can increase other risk factors for recurrent stroke (Dobkin, 2008) 
but a lack of information describing how to exercise safely has been reported after stroke 
(Nicholson et al., 2014). A lack of exercise after stroke may be due to barriers including 
environmental factors (e.g. transport, cost) or personal factors (impairments, 
embarrassment, fear [Nicholson et al., 2013]). These impairments result in deconditioning 
and a more sedentary lifestyle (Gordon et al., 2004). Exercise may have similar effectiveness 
to drug interventions in cardiovascular conditions other than in heart failure (Naci & Ioannidis, 
2013); therefore, incorporating exercise programmes into stroke rehabilitation is of the 
utmost importance. Increasing aerobic fitness naturally aids the body of an individual 
recovering from stroke to carry out daily living exercises but there is a lack of research 
addressing how soon after a stroke it is safe to run a graded exercise test to determine fitness 
(Billinger et al., 2014). An analysis by Stoller and colleagues (2012) suggests that aerobic 
exercise post-stroke is feasible between seven days and six months after event with a low 
relative risk of adverse effects but < 7 days is more of an unknown quantity. This is an 
extremely broad range of suggested feasibility. The concept of exercise after stroke is that 
the health benefits must outweigh the risks involved (Billinger et al., 2014) and each case 




After stroke, exercise is linked with improved glucose tolerance (Ivey et al., 2007), 
improvements in peak VO2 (Lennon et al., 2008), improved mobility, balance and endurance 
(Duncan et al., 2003), muscle strength and gait (Weiss et al., 2000), improved attention 
(Swatridge et al., 2017) and community integration (Karthikbabu et al., 2017). In healthy 
subjects, exercise training has also been demonstrated to improve arterial stiffness (Tanaka 
et al., 2000; Currie, Thomas & Goodwin, 2009) – a measure of key importance in stroke 
prevention. Training is also known to reduce resting heart rate, particularly in the morning. 
This is something that may be of particular relevance to those with cardiovascular risk as 
strokes are most likely to occur in the morning (Shiotani et al., 2009). When prescribing 
exercise after stroke, it is important for patients to continue long-term. The beneficial effects 
of a 12-week training programme appear to diminish six months post-treatment after a stroke 
trial conducted by Duncan and colleagues (2003).  
 
Underweight, overweight and obesity 
Around 2% of adults in England are underweight (Baker, 2018) and this condition is associated 
with an increased risk of mortality after stroke (Dehlendorff et al., 2014). The prevalence of 
overweight and obesity is far greater. As previously discussed, overweight and obesity are 
directly linked to stroke (Kurth et al., 2005; Strazzullo et al., 2010), with these conditions 
increasing stroke risk by 22% and 50% respectively (Strazzulo et al., 2010). After stroke occurs, 
there is a school of thought that increased adiposity may have a protective effect. Overweight 
and obese patients are suggested to have a lower mortality rate after stroke (Scherbakov, 
Dirnagl & Doehner, 2011; Doehner et al., 2013), with obese patients presenting a 27% lower 
mortality rate than stroke patients with a “normal” body mass (Olsen et al., 2008); a concept 
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referred to as the obesity paradox (Gruberg et al., 2002; Ovbiagele et al., 2011b). Obesity may 
also be linked with a reduction in the likelihood of readmission for recurrent stroke (Andersen 
& Olsen, 2015). This pattern has also been observed in overweight patients who demonstrate 
lower mortality after sudden cardiac arrest in the presence of a shockable rhythm (Jain et al., 
2010), although the reasons for this are speculative (Matinrazm et al., 2017). One plausible 
explanation is that in the cases of cancer and kidney disease, overweight patients may live 
longer due to increased body weight and caloric reserves to sustain an individual through 
treatment (Park et al., 2014; Schlesinger et al., 2014). Higher body mass index may also allow 
use of higher doses of cardio-protective medications thus leading to better outcomes (Sharma 
et al., 2014).  
This “obesity paradox” may have been observed due to study bias (Hennekens & Andreotti, 
2013) but it has led to uncertainty about secondary prevention (Dehlendorff, Andersen & 
Olsen, 2014), with some authors suggesting the term should be abandoned due to its lack of 
definition, oversimplification and cause of misunderstanding in the field (Flegal & Ioannidis, 
2017). Criticism of the concept of the paradox has been frequent, with the suggestion that if 
this is to be believed, the wrong message is being given to obese individuals, damaging efforts 
to reduce obesity rates (Chrysant, 2018), and resulting in inappropriate weight guidelines for 
diseased patients (Flegal & Ioannidis, 2017). The concept is in direct opposition to reports that 
weight loss in 12 months following stroke is associated with lower cardiovascular mortality 
(Caterson et al., 2012) and argues against decades of literature suggesting that a “normal” 
body mass index is optimal for health in all states. Suggestions have even been made that 
journals should not accept articles relating to the obesity paradox (Peeters, 2018) due to the 
damage it could do to stroke recovery services, although the ethics behind suppressing 
literature is clearly questionable.  
78 
 
Alcohol consumption and cigarette smoking 
Poor lifestyle habits such as alcohol and smoking are common after stroke. Increased alcohol 
consumption is frequent, with patients potentially drinking due to the stress relieving effects 
(Lawrence et al., 2010). Modest alcohol intake after stroke or TIA may have a protective effect 
against further ischaemic stroke (Mostofsky et al., 2010), possibly due to the blood thinning 
properties of alcohol. However, consumption of the substance as a whole increases the risk 
of stroke recurrence (Lawrence et al., 2010). Research into drug use after stroke is sparse, but 
cannabis use has been associated with recurrent stroke on a case study basis (Mateo et al., 
2005). Smoking cigarettes after stroke is a substantial risk factor for recurrent stroke and poor 
overall health outcomes (Kaplan et al., 2005; Kammersgaard, 2006; Lawrence et al., 2010) 
and smoking cessation after stroke has been linked to lower all-cause mortality (Towfighi, 
Markovic & Ovbiagele, 2012). Although serious health events can be a wake-up call and 
inspire individuals to adopt healthier lifestyles (McCarthy et al., 2013), over three quarters of 
those who smoke before a stroke continue to smoke up to two years after the event (Newsom 
et al., 2011). This may be due to the use of cigarettes as stress relievers after stroke (Lawrence 
et al., 2010). Demographic factors have been identified which predispose an individual to 
continue smoking after stroke has taken place. These include youth, being male, Caucasian 
ethnicity, lower economic standing and better physical fitness (Bak et al., 2002; Ives et al., 
2008; Redfern et al., 2000; Sienkiewicz-Jarosz et al., 2009). Factors which have been 
suggested to increase smoking cessation after stroke include a longer time spent in hospital 
(McCarthy et al., 2013) and the assistance of family members (Lawrence et al., 2010). A 
written intention to quit smoking may be twice as successful as verbal intentions after 





An unhealthy diet increases the risk of recurrent stroke (Lawrence et al., 2010) but almost 
50% of stroke sufferers report receiving no dietary advice (Stroke Association, 2005). 
Although there is no gold standard method for diagnosing under-nutrition (Kernan et al., 
2014), the condition is associated with poor prognoses after stroke (FOOD Trial Collaboration, 
2003), causing increased incidences of cardiovascular events, infectious diseases and all-
cause mortality after stroke (Maruyama et al., 2017). Malnutrition is more common after 
stroke in the rehabilitation stage (after discharge) than the acute stage (Foley et al., 2009): 
patients may not consume the diet which optimises their recovery plan. This can result in rises 
in BP, sustained hyperlipidaemia, hyperglycaemia, poor functional recovery and a consequent 
elevation in recurrent stroke risk. 
Despite the risk of recurrent stroke and the increased mortality rates after recurrent stroke 
compared to incident, survivors tend to continue unhealthy lifestyle behaviours (Cheng et al., 
2005). A combination of exercise, diet modification and use of cholesterol-lowering, 
hypertension-lowering and aspirin medications has the potential to lower the risk of recurrent 
stroke by as much as 80% (Hackam & Spence, 2007). Much like the range of risk factors of 
incident stroke, the vast proportion of factors predicting recurrent stroke are directly related 
to rises in BP and sustained hypertension. Assessments of BP therefore hold the key to 
measuring and reducing the likelihood of incident and recurrent strokes. These blood 
pressures can be reduced using medical interventions, lifestyle modifications or a 





2.15 Brachial blood pressure 
The brachial cuff sphygmomanometer was introduced over a century ago (McEniery et al., 
2004) and allows clinicians to identify patients with hypertension (a brachial SBP of > 130 
mmHg or a brachial DBP of > 80 mmHg [Whelton et al., 2018]). These recent 
recommendations are lower than previous boundaries (140/90 mmHg [Pickering et al., 2005]) 
and have been introduced to attempt to lower the long-term global burden of elevated BPs. 
Brachial SBP is determined primarily by arterial compliance and total peripheral resistance 
(Smulyan & Safer, 1997; Stergiopulos & Westerhof, 1998) and is a more useful predictor of 
heart disease in those aged over 50 than DBP (Franklin et al., 2001). Hypertension is the most 
common condition seen in primary care (James et al., 2014) and a major risk factor for CVD 
and organ damage (Hansson et al., 1998; Rudic & Fulton, 2009) with brachial hypertension 
indicating a raised risk of CVD from 46.1% to 63.3% in a longitudinal observation of 1.25 
million patients (Rapsomaniki et al., 2014). Elevated BP is the leading cause of death and 
disability worldwide (Lim et al., 2010) and affects a billion people globally, with nine million 
deaths occurring annually due to hypertension (Yarmolinsky et al., 2015). Lowering BP 
reduces the likelihood of cardiovascular events (Lewington et al., 2002; Blood Pressure 
Lowering Treatment Trialists’ Collaboration, 2003) due to ongoing hypertension exposing the 
brain to haemodynamic stress (Pase et al., 2013), but hypertension control is only estimated 
to be 14% worldwide (Mills et al., 2016). 
Increased BP is a major risk factor for stroke (Chatterjee et al., 2015), with hypertension 
positively and continuously related to stroke risk (Chalmers & Chapman, 2001). As life 
progresses, alterations to large arterial walls lead to increased arterial stiffness. These 
changes include overproduction of collagen, underproduction of elastin, medial smooth 
muscle hypertrophy, increased intimal permeability, migration of monocytes and 
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macrophages, and fibrosis of the adventitia (Zieman et al., 2005). Approximately 45% of all 
strokes may be because of uncontrolled BP (Li et al., 2005) as an increase of 20 mmHg in 
brachial SBP may increase the risk of death due to stroke two-fold (Lewington et al., 2002). 
Decreasing brachial SBP by just 4.7 mmHg may reduce the risk of stroke mortality by 17.5% 
(Lackland et al., 2008), whilst reductions of 10 mmHg could reduce incident stroke risk by 41% 
(Law, Morris & Wald, 2009). Reductions in SBP of 12-13 mmHg have also been reported to 
cause reductions of 37% in stroke mortality (He & Whelton, 1999). As such, a combination of 
improving hypertension control to 50%, reducing sodium intake by 30% and eradicating 
artificial trans-fats could save around 100 million lives worldwide in the next thirty years 
(Frieden & Jaffe, 2018). 
A wide range of variables cause variations in brachial BP measures. Long-term fasting has a 
significant influence on brachial BP, with significant drops in BP reported after a 48-hour fast 
(Andersson et al., 1988). Longer term fasting may also lead to decreases in BP due to weight 
reduction (Neter et al., 2003). Cardiovascular responses to altered posture rely on 
interactions between the autonomic nervous system and cerebral autoregulation (Olufsen et 
al., 2005). Blood pressures increase in a seated compared to supine position (Cavelaars et al., 
2004) and are higher still in standing positions (Beevers, Lip & O’Brien, 2001). Brachial 
measures are also altered due to acute and chronic stress. An exaggerated acute response to 
stress may be an indicator of a heightened risk of hypertension (Steptoe et al., 2016), whilst 
chronic stress is associated with increased BP and cardiovascular problems (Hawkley et al., 
2006; Birditt et al., 2016). 
Alongside SBP and DBP measures, brachial PP may be indicative of cardiovascular health. 
Pulse pressure is calculated as the difference between SBP and DBP and is determined by 
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arterial compliance and stroke volume (Dart & Kingwell, 2001; Tang et al., 2017). These 
pressures are particularly relevant as a diagnostic marker in older populations (Balietti et al., 
2018) and males (Tadic et al., 2018). This measure is associated with increased afterload and 
myocardial oxygen demands (Takahashi et al., 2018) and an increased PP reflects large arterial 
stiffness (Lima, 2018), causing pressure overload on the heart, leading to cardiac dysfunction 
(Boutouyrie et al., 1995). Elevated PP reflect increases in arterial stiffness due to 
atherosclerosis and arteriosclerosis (Verdecchia et al., 1998) and, as a result, may be related 
to the risk of poor cardiovascular outcomes independent of other risk factors (Palmieri et al., 
2006; Selvaraj et al., 2016). It is important to differentiate between arteriosclerosis and 
atherosclerosis. The former represents the degenerative stiffness of arterial beds (Cavalcante 
et al., 2011), whereas the latter is due to hardening fatty deposits on the inner walls of the 
arteries, making the vessels vulnerable to blockage (Royal College of Physicians, 2016). The 
assessment of PP may even be superior to traditional SBP and DBP at predicting ventricular 
wall stress (Takahashi et al., 2018) and cardiovascular death (Lee, Rosner & Weiss, 1999). A 
PP cut-off point of 60 mmHg is suggested to be a marker of elevated arterial stiffness and 
asymptomatic organ damage in older hypertensive individuals (Mancia et al., 2013) and the 
measure has been significantly related to brain atrophy and cognitive decline (Nation et al., 
2016). 
It has long been accepted that BP exhibits a circadian rhythm in humans (Millarcraig, Bishop 
& Raftery, 1978) with pressures rising during the day and falling during the night (Rudic & 
Fulton, 2009). The increase in BP immediately after waking is known as a BP surge and both 
myocardial infarction and stroke are more likely to occur in the morning due to this daily spike 



















Figure 2.3: Occurrence of stroke throughout the day, from Casetta et al., 2002a; 2002b in Manfredini et 
al., 2005 
 
Morning surges in BP and nocturnal dips occur after activation of the sympathetic nervous 
system due to varying levels of catecholamine, vasoactive intestinal peptide and melatonin 
(Ignarro et al., 1987; Albers et al., 1991; Scheer et al., 2004; Rudic & Fulton, 2009; Juhanoja 
et al., 2016). Blood pressure dips nocturnally by 10-20% in a healthy individual (Rodrigues et 
al., 2018) but those with abnormal circadian BP patterns can be classified as non-dippers 
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(O’Brien, Sheridan & O’Malley, 1988), extreme dippers (Kario et al., 1996) and reverse dippers 
(Kario et al., 2001). Non-dippers present with a < 10% nocturnal reduction in SBP and extreme 
dippers with a > 20% nocturnal reduction in SBP (Rodrigues et al., 2018). Whilst regular 
dippers have significantly better blood pressure than non-dippers (Lo et al., 2018), extreme 
dipping status results in the highest left ventricular mass and the greatest likelihood of early 
morning blood pressure surges. This nocturnal hypotension may reduce myocardial perfusion 
pressure, causing hypoxemia and myocardial inflammation and leading to myocardial 
hypertrophy (Rogrigues et al., 2018). Non-dipping individuals may have the worst prognosis 
of all abnormal classifications (Verdecchia et al., 1994; Ben-Dov et al., 2007). Non-dipping 
status presents with increased sympathetic nervous system activity and decreased para-
sympathetic nervous system activity (Nakano et al., 2001) and may be associated with low 
quality of sleep and sleep disruption (Lo et al., 2018). This demonstrates a potential causative 
link between OSA (resulting in disrupted and low-quality sleep) and elevated nocturnal blood 
pressure. Even aside from dipping status, lower sleep efficiency (asleep for < 85% of time 
spent in bed) has been linked to hypertension (Javaheri et al., 2008). Nocturnal blood pressure 
and blood pressure variability may be even more closely associated with target-organ damage 
risk than awake blood pressure and blood pressure variability (Boggia et al., 2007; Palatini et 
al., 2014). It is perhaps for this reason – the control of nocturnal BP rather than diurnal BP – 
that ramipril, an angiotensin-converting enzyme inhibitor, has been reported to significantly 
reduce rates of death, myocardial infarction and stroke (Yusuf et al., 2000). Rather than 
controlling blood pressure during the day, ramipril has been suggested to reduce clinical 
events through lowering nocturnal blood pressure rather than daytime blood pressure 
(Svensson et al., 2001). Consequently, it may be equally as important to control and monitor 
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nocturnal blood pressure as it is to manage daytime blood pressure, although the latter is the 
usual focus of research. 
Although assessment of brachial (peripheral) blood pressures have been the clinical standard 
for assessing CV risk and have a dose-response relationship with mortality (Burns et al., 2018), 
they are a compromised measure due to technical limitations (Cheng et al., 2013) and do not 
directly measure blood pressure at the heart. 
 
2.16 Central blood pressure 
Although brachial blood pressures are directly related to vascular mortality (Lewington et al., 
2002), blood pressure is augmented in the periphery compared to the aorta (Nichols & 
O’Rourke, 2005). This augmentation is due to distal arteries becoming progressively stiffer 
due to increased predominance of collagen fibres rather than elastin in the periphery 
compared to the aorta (Cavalcante et al., 2011). 
In contrast, cBP represent the pressure exerted on the heart and brain and are not the same 
as blood pressure in limbs such as the arms (Yadav et al., 2018). Due to differing composition 
of the arterial wall, such as peripheral measures tend to overestimate blood pressure at the 
heart itself (Agabiti-Rosei et al., 2007), with blood pressure up to 40 mmHg higher in the 
brachial artery than the aorta (McEniery et al., 2014). The dissociation between peripheral 
and central measures is higher in those with greater baseline blood pressures (Williams, 2012) 
and central pressures may be more influenced by accelerated aging and hypertension than 
traditional brachial measures (Avolio et al., 1983; McEniery et al., 2005). The systemic large 
arteries more than double in stiffness with age (Butlin & Avolio, 2014) and these central 
pressures have been reported to be more relevant to the work load of the ventricles and 
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coronary arteries (Croymans et al., 2014; Burns et al., 2018), cardiovascular risk and mortality 
(Roman et al., 2007; Ott et al., 2017) and organ damage (Booysen et al., 2013; Zeigler et al., 
2018), 
The relevance of recording cBP is highlighted by McEniery and colleagues (2014) who note 
that 30% of peripherally normotensive men and 10% of normotensive women may have 
central pressures in common with those in stage I peripheral hypertension. These figures are 
based on more traditional hypertension guidelines (> 140/90 mmHg) so these percentages 
may be even greater using new recommendations. If this is the case, individuals presenting 
with normotensive brachial blood pressure may be more at risk of cardiovascular events than 
their peripheral blood pressures may suggest. An example of this can be seen in Figure 2.4. 
This is of particular relevance when considering that increased cBP is associated with an 










Figure 2.4: An example of two central blood pressure waveforms from individuals with identical 







Different blood pressure lowering drugs may have substantially different effects on cBP, 
despite similar influences on brachial blood pressure (Williams et al., 2006), with reductions 
in brachial blood pressure not always mirrored in cBP (McGauhey et al., 2015). As such, 
peripheral blood pressure assessments are not necessarily an appropriate surrogate for 
measuring the effects of anti-hypertensive medication on central haemodynamics (Williams 
et al., 2006). Only measuring blood pressure at the brachial artery neglects valuable 
information (Williams et al., 2006) and, consequently, cBP assessment is expected to become 
standard clinical practice in the future (Shoji et al., 2016). 
Traditionally, cBP measurement has been an invasive procedure involving catheterisation of 
the aorta. This process is usually contraindicated in healthy populations (Dawson et al., 2009) 
but central measures can now be measured using non-invasive methods (Agabiti-Rosei et al., 
2007), such as pulse wave analysis (PWA). cBP is determined by the stiffness of conduit 
arteries and the timing and magnitude of wave reflections (Williams et al., 2006). When the 
wall of an aorta is stiff, increased systolic and pulse pressures occur after faster backward 
travelling pressure waves. This causes increased wall tensions and alterations to the elastic 
components in the artery (Vlachopoulos et al., 2000). These factors play a key role in the 
pathogenesis and progression of hypertension.  
Whilst elevated peripheral blood pressure is now recognised as > 130/90 mmHg (Whelton et 
al., 2018), no such cut-off point has been determined for cBP assessments (McEniery et al., 
2014). Cheng and colleagues (2013) have proposed an optimal cBP reading of 110/80 mmHg 
with significantly higher cardiovascular risk in those with central pressures of 130/89 mmHg. 
Small changes in cBP can have large effects on cardiovascular risk, with a cSBP of 125 mmHg 
associated with a 10-30 mmHg increase in risk when compared to 121 mmHg (Williams et al., 
88 
 
2006). This demonstrates the importance of the recognition of normative values and cut-off 
points for central hypertension. These must be determined before the non-invasive methods 
of cBP can be integrated into clinical settings. 
Other than cSBP and cDBP, non-invasive measurement of other central variables may offer 
further insight into cardiovascular health than previously possible before technological 
advances. A central pulse pressure (cPP) of > 50 mmHg in those without CVD may indicate an 
increased likelihood of poor cardiovascular outcomes (Roman et al., 2009). Central pulse 
pressures tend to increase more than peripheral PP due to aging (McEniery et al., 2005), and 
may be superior to peripheral SBP in predicting cardiovascular events (Shoji et al., 2016). 
Central pulse pressures have also been associated with poor cognition, including low memory 
scores (Hanon et al., 2005; Scuteri et al., 2005; Mitchell et al., 2011) - measures particularly 
relevant to the acute and chronic stroke population. 
The aorta naturally stiffens with age, a process which takes place at a greater speed when 
arterial hypertension exists (Cavalante et al., 2011). Gradual damage occurs through changes 
in the cross-linking of extra-cellular matrix components, medial elastocalcinosis and the 
degeneration of elastin fibres (Dao et al., 2005; Payne et al., 2009). Increased arterial stiffness 
reduces the ability of an artery to contract and relax (Sherlock et al., 2014) and PWA can also 
provide measures of AIx. This is an indirect measure of arterial stiffness relating to how much 
of the central pressure is accounted for by the reflected pulse wave (Zeigler et al., 2018). The 
assessment of AIx is calculated as a ratio of amplitude of the pressure wave above its systolic 
shoulder to the total PP expressed as a percentage (P2-P1/PP*100 [Sherlock et al., 2014]), as 
visualised in Figure 2.5. Assessment of arterial stiffness is of importance due to its link with 
insulin resistance (Lee et al., 2007), diabetes (Wadwa et al., 2010), blood pressure (Kaess et 
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al., 2012; Diaz et al., 2017), cognitive impairment (Muela et al., 2017) and cardiovascular risk 
(Weber et al., 2004; McEniery et al., 2010; Ben Shlomo et al., 2014; Doumas et al., 2018). As 
a tool to represent arterial stiffness, a ten percent increase in AIx has been linked to a 1.5-
fold increased risk of cardiovascular events or death (London et al., 2001). The stiffening of 
arteries and subsequent increase in AIx may lead to increased pulse wave velocity, leading to 








Abbrevs: AP – Augmentation pressure, AIx – Augmentation index, PP – Pulse pressure 
Figure 2.5: AIx calculation using a central pressure pulse wave, from AtCor, 2017 
 
2.17 Pulse wave velocity 
The assessment of pulse wave velocity (PWV) is the gold standard for measuring arterial 
stiffness due to its simplicity, accuracy, reproducibility and predictive value (Laurent et al., 
2006; Diaz et al., 2017). Measures of PWV depend on vessel size and the elastic properties of 
the aortic wall (Muela et al., 2017). Pulse waves travel faster in sclerotic vessels (Vlachopoulos 
et al., 2015). As a result, PWV has an important role in identifying increased left ventricular 
load (Cavalcante et al., 2011), vascular target organ injury (Persu & De Plaen, 2004), risk of 
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later hypertension development (Naijar et al., 2008), cognitive impairment (Muela et al., 
2017), endothelial dysfunction (Wallace et al., 2007), atherosclerosis (Persu & De Plaen, 
2004), coronary heart disease, stroke and overall mortality (Mattace-Raso et al., 2006). The 
use of PWV is therefore crucial to the identification of high-risk populations for CVD risk factor 
management (Ben-Shlomo et al., 2014; Brinkmann, Jordan & Tank, 2015). A cut-off value of 
10 m·s-1 has been suggested as the cut-off for the diagnosis of altered arterial stiffness 
(Mancia et al., 2013) but a single “normal” limit of PWV may not be useful due to PWV 
changing with age and the rate of change varying in the older population (Diaz et al., 2017). 
 
2.18 SphygmoCor XCEL 
One novel device allowing for the non-invasive estimate of cBP is the SphygmoCor XCEL 
(AtCor Medical, Sydney, Australia). SphygmoCor products are widely used in clinical studies 
and the XCEL uses a novel algorithm to assess aortic measurements using a brachial cuff. After 
being cleared by the USA Food and Drug Administration as substantially equivalent to 
previously validated systems (FDA, 2012) the SphygmoCor XCEL entered the market and is a 
fast, accurate and a trouble-free way to measure PWA and PWV (Yadav et al., 2018). 
After an initial brachial blood pressure measure, the XCEL completes a second sub-systolic 
recording. As a pulse wave travels forward in circulation, a combination of changes in vessel 
calibre, plaque and areas of arterial stiffness in the wall generate wave reflection (Townsend 
et al., 2015; Burns et al., 2018). As the outward waves and reflected waves sum together, an 
aortic pressure wave is created. The XCEL then reports the inflection point between the 
forward and reflected waveforms, producing validated measures of cBP without the need for 
a traditionally invasive procedure. The forward and reflected wave interaction is influenced 
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by the speed of the waves. The faster the waves travel, the less separation between the two 
as they interact. Data outputs for PWA can be seen in Figure 2.6. 
Figure 2.6: Full pulse wave analysis output from the SphygmoCor XCEL 
 
The SphygmoCor XCEL is also able to assess PWV. This involves a cuff being placed around the 
femoral artery, a tonometer pressure sensor being placed to collect a carotid waveform and 
pulse transit time denotes the pulse time required to travel from the carotid to femoral artery 
between the initial upstroke of the recorded waveforms at each site (Cavalcante et al., 2011; 
92 
 
Rezk-Hanna et al., 2018; Yadav et al., 2018). Figure 2.7 demonstrates the key measures when 













Abbrevs: c – Carotid; C – Cuff; d – Distances; f – Femoral; fC – Femoral cuff; s – Suprasternal 
notch; tt – Transit time 
Figure 2.7: SphygmoCor XCEL PWV setup, from Butlin & Qasem, 2016 
 
The XCEL provides comparable estimations of central pressures with radial applanation (Peng 
et al., 2016), and has been shown to be a valid method of assessing central haemodynamics 
in healthy populations (Butlin et al., 2012; Hwang et al., 2014). Previous work has reported 
that the SphygmoCor XCEL exceeds the criterion for acceptable reliability in a young, healthy 
population in a range of fasting and postural states (Young et al., 2015). As such, the 
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SphygmoCor XCEL device is a useful device in both research and clinical arenas (Hwang et al., 
2014) and can reliably assess central haemodynamic variables (Young et al., 2015). While 
calculating PWV, the SphygmoCor has also been shown to be valid when compared against 
the widely validated SphygmoCor MM3 in a clinically healthy population (Hwang et al., 2014).  
Most reliability studies thus far have been conducted in non-clinical populations, although 
Peng et al. recruited a hypertensive population to their research. The reliability of the 
SphygmoCor XCEL and other tools non-invasively estimating central pressures outside of the 
healthy groups previously mentioned must be determined before they can be fully adopted 
into clinical environments.  
The majority of research into blood pressure and stroke has focused on peripheral blood 
pressure. Elevated peripheral blood pressure accounts for 62% of stroke (He, Pombo-
Rodrigues & MacGregor, 2014) so it is unsurprising that there has been a large scope for 
research in the area. However, central pressures are of great importance with regards to 
stroke as it is the large central arteries which supply blood to the brain, not the brachial 
arteries (Pase et al., 2013). As peripheral pressures may not completely reflect the heath of 
central organs (Protogerou et al., 2007), central measures may offer a more accurate 
reflection of the condition of the heart (Croymans et al., 2014). The use of central measures 
in stroke may be of particular importance as anti-hypertensive drugs, frequently prescribed 
after stroke, may cause differing effects on peripheral pressures than central pressures 
(McEniery et al., 2014). It may therefore be the case that central pressures respond differently 
to external factors (e.g. posture and fasting state) than peripheral measures. Further 
understanding of these variables and the consequences of reliable non-invasive 
measurements in clinical groups may lead to dramatic improvements in both the acute and 
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chronic care of stroke patients and prevention of recurrent events days, months and years 
after incident stroke.  
2.19 Synthesis of review 
The vast majority of the risk factors for stroke discussed in this literature review are related 
to one overriding theme: elevated BP and hypertension. Although age and ethnicity are non-
modifiable risk factors (Duprez, 2008; Whelton et al., 2018), the medically modifiable and 
lifestyle modifiable risk factors for disease are all prevalent alongside hypertension, including 
AF (Schoonderwoerd et al., 2008), hyperlipidaemia (Ames, 1991), impaired glucose 
metabolism (Mahfoud et al., 2011), OSA (Marin et al., 2012), excess alcohol intake (Taylor et 
al., 2009), Illicit drug use (Ferdinand, 2000), cigarette smoking (Virdis et al., 2010) and air 
pollution (Liang et al., 2014). This recurrent theme is also due to physical inactivity (Aljadhey, 
2012), sedentary behaviours (Beunza et al., 2007) and overweight and obesity (Forouzanfar 
et al., 2016). As such, it is unsurprisingly that hypertension is regarded as the strongest risk 
factor for all stroke (O’Donnell et al. 2010). 
For this reason, it is of the utmost importance to monitor BP reliably and accurately. 
Traditionally, the assessment of BP has been recorded using the brachial artery, but pressures 
are augmented in the periphery due to an increased predominance of collagen fibres rather 
than elastin in the periphery (Cavalcante et al., 2011). Brachial pressures therefore may not 
truly reflect the health of the central organs and, specifically the aorta. This is particularly 
pertinent in stroke patients as it is the aorta that supplies the brain with oxygenated blood, 
not the brachial artery. It is only recently that measures of central BP have become possible 
without invasive aortic catheterisation taking place. One technique to do this is through 
oscillometric PWA using the SphygmoCor XCEL, as previously described. 
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Focusing on sedentary time after stroke is now an extremely important target for 
interventions (Morton et al., 2018). Stroke survivors complete half the daily steps of non-
stroke survivors (English et al., 2014), with bouts of sedentary time taking place in longer 
bouts after stroke than in a healthy population (English et al., 2016). As a result, acute and 
chronic interventions to alleviate the potential damage caused by sedentary time to both 
peripheral and central BP must be addressed. The mechanisms behind sedentary time and 
poor health are not completely understood, but they may be linked to increases in BP, which 
have also been linked to poor executive function. It is therefore of importance to examine 
blood pressure over a course of sedentary time and whether activities improving blood 
pressure through this time-course translate into improved executive function which could be 
applied to a rehabilitation setting. 
The non-invasive assessment of central blood pressures may hold the key to future 
cardiovascular risk management. It is vital to determine whether or not the measurement of 
these variables can be done reliably in populations where they are of particular importance 
(i.e. the older population and clinical groups). Addressing sedentary time after stroke is also 
a strong focus in contemporary research. Most interventions relating to sedentary time are 
of an intensity that may not be viable for a stroke population who struggle with sit-stand 
transitions, so the acute and chronic benefits of physical activities such as intermittent heel 
raises to interrupt sedentary time are of importance. This thesis will therefore aim to 
demonstrate the between-day reliability of the SphygmoCor XCEL in an older, healthy 
population and an acute stroke population, before examining the efficacy of a heel-raise 
protocol to interrupt sedentary time both acutely, and over a ten-week programme. 
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Chapter 3: Study one – Reliability of oscillometric central blood pressure and arterial 



























Background: The between-day reliability of oscillometric pulse wave analysis has been 
demonstrated in a young, healthy population but not in an older sample. This study examined 
the between-day reliability of the SphygmoCor XCEL in individuals over 50 years. As blood 
pressure is measured in a range of postures and fasting states (supine/seated, fasted/non-
fasted), this study also investigated the effect of these variables on central blood pressure 
and arterial stiffness. Methods: Fifty-one adults (m=21; age 57y ± 6.4y) were tested on three 
mornings in supine and seated conditions and in fasted and non-fasted states. Data was 
analysed as a whole and for normotensive (n=25) and hypertensive participants (n=26). 
Results: SphygmoCor XCEL demonstrated strong reliability in the whole sample for cSBP and 
cDBP, AIx and AIx75 (ICC=0.77–0.95). Significant interaction effects were observed in cDBP, 
cPP, AIx and AIx75 (p < 0.05; 2pη = 0.10 – 0.23). Fasting state had a greater influence on central 
pressures in a seated than supine posture, but a greater effect on arterial stiffness measures 
in a supine posture. Conclusions: The SphygmoCor XCEL is a reliable tool to assess central 
haemodynamic variables in an older population. It would be pertinent for clinicians and 
researchers to record central measures in a supine posture to minimise the effects of food 
consumption. Conversely, the assessment of arterial stiffness should occur in a seated 







Hypertension is the most common condition seen in primary care worldwide (James et al., 
2014) and the major cause of death across the globe (He et al., 2007). Due to non-modifiable, 
behaviourally modifiable and medically modifiable risk factors, over 29% of adults in the 
United Kingdom and United States present as hypertensive (British Hypertension Society, 
2014; Merai et al., 2016) based on traditional cut-offs of 140/90 mmHg. Recently 
implemented guidelines suggest reducing the cut-off of stage 1 hypertension to 130/80 
mmHg (Whelton et al., 2018), therefore increasing the prevalence of hypertension even 
further. 
Although brachial BP measurement is traditionally used to monitor vascular health, cBP may 
be more closely related to the pathophysiology of end-organ damage (Protogerou et al., 
2007). Systolic blood pressure may be increased in the periphery by as much as 40 mmHg due 
to increased arterial stiffness away from the aorta (McEniery et al., 2014) due to elevated 
levels of collagen fibres compared to elastin in the periphery compared to the central arteries 
(Cavalcante et al., 2011). Therefore, cBP more directly represents the pressure exerted on the 
heart and brain and is not the same as blood pressure in the limbs (Yadav et al., 2018). Around 
30% of peripherally normotensive males and 10% of peripherally normotensive females may 
share central pressures in common with those with stage I peripheral hypertension (McEniery 
et al., 2014). Central haemodynamic parameters may therefore be a superior measure for 
clinicians than traditional peripheral BP readings (Young et al., 2015). Before these readings 
are incorporated into clinical practice, the between-day reliability of these measures in 
normal operating conditions must be assessed. 
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Traditionally, cBP assessment has been an invasive procedure involving catheterisation of the 
aorta; a procedure which is usually contraindicated in healthy populations (Dawson et al., 
2009). However, technological advances mean these measures can now be estimated non-
invasively using oscillometric-based pulse wave analysis.  
The SphygmoCor XCEL non-invasively estimates measures of central haemodynamics through 
the interaction of forward and reflected pulse waves during a sub-systolic brachial cuff 
compression. Additional variables are recorded by the SphygmoCor XCEL, including MAP (1/3 
[SBP-DBP] + DBP), AP (contribution of reflected waveform), AIx (AP/PP * 100) and AIx75 (AIx 
corrected to a HR of 75b-min-1). This device is re-calibrated at one-year intervals to ensure 
the accuracy of readings (for further information, see page 91). The SphygmoCor XCEL also 
provides measures of PWV. This measure involves a more skill-dependent technique, with 
user experience required to a greater degree than during PWA assessments. The successful 
identification of a clean carotid pulse-wave using a tonometer can be confounded by 
confounding variables including excess subcutaneous fat stores, or partial/complete 
occlusion of the carotid artery.  
Before any instruments or tools can be used in clinical settings, their reliability must be 
determined to ensure pharmacological decisions are not based on unreliable data. This 
reliability can be demonstrated as intra-class correlation coefficient (ICC); a score that reflects 
the degree of correlation and agreement between measurements (Koo & Li, 2016). Although 
devices non-invasively estimating cBP through oscillometric readings have been shown to be 
valid (Lowe et al., 2009; Butlin et al., 2012; Lin et al., 2012; Hwang et al., 2014), more research 
is required to demonstrate the reliability and optimal operating conditions for the function of 
these devices. Research by Young and colleagues (2015) demonstrated central 
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haemodynamic parameters and arterial stiffness readings to be reliable using the 
SphygmoCor XCEL in a young, healthy population (ICCs of 0.73–0.89), particularly in a supine 
and fasted state. However, the between-day reliability of these measures has not been 
demonstrated in a more aging demographic where peripheral and central pressures are more 
pertinent. Hypertension is more commonly found in later life and, as BP measures frequently 
inform medication prescription, devices recording these measures must be reliable enough 
to provide the basis for appropriate clinical decisions. 
It is also of great importance to consider the effect of posture and fasting state in older 
individuals as BP is routinely measured in a range of postures and prandial states (i.e. within 
primary and secondary care), depending on personal preference and available facilities. Both 
posture (Cavelaars et al., 2004; Eser et al., 2007) and fasting state (Andersson et al., 1988) 
have been reported to influence brachial blood pressures but the information about the 
influence that posture and fasting state have on central measures is limited. Young and 
colleagues (2015) suggested no significant difference in cBP after food consumption but, 
conversely, Ahuja, Robertson & Ball (2009) reported a significant post-prandial drop in cBP in 
a participant sample aged between 21 and 80 years; a wide-ranging age demographic. 
This study aimed to quantify measurement error of the SphygmoCor XCEL in adults over the 
age of 50 years. It was also hypothesised that posture and fasting state would cause significant 







Fifty-one participants (m=21; f=30; age 57y ± 6.4y) were recruited to the study. Participants 
were recruited through the provision of free health check-ups at the University of Winchester, 
with the collected data provided to individuals along with appropriate lifestyle advice. 
Participant demographics can be observed in Table 3.1. Ethical approval was received from 
the University of Winchester Ethics Committee (BLS/16/19). The study conformed to the 
ethical guidelines of the 1975 Declaration of Helsinki. Participants provided written informed 
consent and maintained the right to withdraw at any time. Participants were recruited if they 
were over the age of 50 and excluded if they were mentally unable to give consent. The 












Table 3.1: Participant demographic data 
  Whole sample Normotensive  Hypertensive 
  n % n %  n % 
Participants  51  25   26  
Age (y)  57.1y 
±6.4y 
 57.3y  
±7.1y 
  56.9y 
±5.8y     
 
Sex Male 21 42 9 36  12 46 
 Female 30 58 16 64  14 54 
Descent European 51 100 25 100  26 100 
Family history of CVD Myocardial infarction 14 28 8 32  6 23 
 Heart surgery 5 10 3 12  2 8 
 Stent 3 6 2 8  1 4 
 Catheter 1 2 1 4  0 0 
 Heart defect 8 16 1 4  7 27 
 Stroke 19 37 9 36  10 38 
Personal history of CVD Hypertension 14 27 2 8  12 46 
 High cholesterol 14 27 5 20  9 35 
 Diabetes 1 2 0 0  1 4 
 Heart problems 4 8 4 16  0 0 
 Artery diseases 1 2 0 0  1 4 
 Thyroid disease 3 6 1 4  2 8 
 Lung disease 1 2 0 0  1 4 
 Asthma 11 22 4 16  7 27 
 Cancer 4 8 1 4  3 12 
 Kidney disease 0 0 0 0  0 0 
 Hepatitis 3 6 1 4  2 8 
Signs and symptoms of CVD Chest pain 8 16 4 16  4 15 
 Dyspnoea 10 20 6 24  4 15 
 Heart palpitations 8 16 5 20  3 12 
 Skipped heartbeats 4 8 4 16  0 0 
 Heart murmur 5 10 5 20  0 0 
 Intermittent leg pain 9 18 3 12  6 23 
 Syncope 12 24 7 28  5 19 
 Fatigue 12 24 4 16  8 31 
 Snoring 29 57 13 52  16 62 
 Back pain 22 43 13 52  9 34 
Lifestyle factors Current smoker 4 8 2 8  2 8 
 Previous smoker 18 35 7 28  11 42 
 Current alcohol drinkers 40 78 19 76  21 81 
 Current weight loss plan 4 8 1 4  3 12 
Everyday activity Sedentary 22 43 11 44  11 42 
 Lightly active 15 29 9 36  6 23 
 Moderately active 14 27 5 20  9 34 
 Vigorously active 0 0 0 0  0 0 
Medication Statins 3 6 2 8  1 4 
 Anti-thrombotic 0 0 0 0  0 0 
 Diuretics 0 0 0 0  0 0 
 Calcium blockers 2 4 0 0  2 8 
 Alpha blockers 2 4 1 4  1 4 
 Beta blockers 2 4 1 4  1 4 
 Anticoagulants 0 0 0 0  0 0 
 Other anti-hypertensive 
medication 
7 14 2 8  5 19 
Abbrev: CVD – Cardiovascular Disease 
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3.3.2 Experimental Design 
Participants were tested on three mornings (all three visits within three weeks and between 
the hours of 07:00 and 10:00) and had consumed only water for the 12 hours before and 
refrained from intense physical activity for 24 hours preceding testing. Participants were 
allocated to either the supine first or seated first condition using a computerised random 
number generator. They then adopted the allocated posture for twenty minutes before a 
minimum of two pulse wave analysis measurements were taken using the SphygmoCor XCEL 
(AtCor Medical, Sydney, Australia) with a three-minute interval. If a difference of > 5 mmHg 
and a difference of > 4% AIx was noted under manufacturer guidelines, a third measure was 
taken and data from the two closest points were averaged, as per manufacturer guidelines. 
After twenty minutes in the other posture, these measures were repeated. A breakfast of two 
slices of white toast with butter, marmalade and orange juice was then provided (330 kcal, 
60g carbohydrate, 7g total fat, 5g protein) – a provision that was repeated during each visit. 
This meal was chosen as it closely replicated the macronutrients provided in a normal hospital 
meal in the morning (282-291kcal, 56-60g carbohydrate, 3-4g total fat, 8-9g protein [chapter 
four - see page 124]) – a setting where the SphygmoCor XCEL may be most commonly used 
in the future. The protocol was then repeated in both supine and seated non-fasted 
conditions in the same order as the fasted state, leading to final measures being 




3.3.3 Sample Size  
A minimum sample of 25 participants per group was identified using G*Power (Faul et al., 
2007) with p set at 0.05, a power of 0.80 and a moderate effect size (0.50) whilst accounting 
for a 10% drop-out.  
 
3.3.4 Statistics 
Statistical Package for Social Sciences v.22 (SPSS, Inc., Chicago, Illinois, USA) was used to 
analyse data. Statistical significance was set at p < 0.05. Analysis of variance for repeated 
measures with two within-participant factors (posture and fasting state) was used to assess 
differences in peripheral and central haemodynamic parameters (SBP, DBP, PP, cSBP, cDBP, 
cPP, heart rate (HR), AIx and AIx75. Effect sizes were reported using partial eta squared ( 2pη ) 
with 0.01, 0.06 and 0.14 representing small, medium and large effects (Cohen et al., 1969). 
Intra-class correlation coefficient (ICC), standard error of measurement (SEM) and the 
Smallest Detectable Change (SDC) were used to assess the between-day reliability of the XCEL 
(for calculations, see Young et al., 2015). Identical analysis was performed with the sample 
split into two groups: normotensive (peripheral blood pressure < 130/80 mmHg) and 









3.4.1 Central and peripheral blood pressures 
 
Whole Sample 
Tables 3.2 and 3.3 summarise the mean values for central and peripheral haemodynamic 
measures for the whole sample. Significant interaction effects were reported for cDBP and 
cPP (p < 0.05; 2pη = 0.10 - 0.23), with greater differences observed between fasted and non-
fasted whilst seated than when supine. Fasting state was found to have a significant main 
effect on cSBP and HR. For all cBP variables, ICC values were above the 0.75 criterion in each 











Table 3.2: Mean (SD) central and peripheral blood pressures and arterial stiffness values for 
the whole sample - supine and seated, fasted and non-fasted 
 
      Supine   Seated   Interaction   Posture   Fasted 
      Fast Non   Fast Non   P η2p   P η2p   P η2p 
MAP (mmHg) X   97 96   99 98   0.85 0.00   <.01 0.19   <.01 0.23 
  SD   13 13   13 14                   
SBP (mm Hg) X   133 133   133 135   0.19 0.03   0.08 0.06   0.20 0.03 
  SD   18 18   18 18                   
DBP (mm Hg) X   81 79   84 81   0.02 0.10   <.01 0.30   <.01 0.45 
  SD   11 11   12 12                   
cSBP (mm Hg) X   123 121   124 122   0.20 0.03   0.14 0.04   <.01 0.19 
  SD   17 16   16 17                   
cDBP (mm Hg) X   82 80   85 82   0.03 0.10   <.01 0.29   <.01 0.37 
  SD   11 11   12 12                   
cPP (mm Hg) X   41 41   39 40   <.01 0.23   <.01 0.16   0.40 0.01 
  SD   9 10   9 10                   
AP (mm Hg) X   14 11   12 10   <.01 0.23   <.01 0.19   <.01 0.53 
  SD   6 5   6 6                   
AIx (%) X   33 25   29 24   0.02 0.10   <.01 0.20   <.01 0.66 
  SD   10 9   12 10                   
AIx@75 (%) X   26 20   24 28   <.01 0.18   <.01 0.29   0.67 0.04 
  SD   11 10   11 12                   
HR (b·min-1) X  62 65  64 67  0.25 0.03  <.01 0.33  <.01 0.57 
 SD  8 8  8 9          
 
Abbrevs: AIx – Augmentation index, AIx75 – Augmentation index @ 75 b·min-1, AP – 
Augmented pressure, cDBP – Central diastolic blood pressure, cPP – Central pulse pressure, 
cSBP – Central systolic blood pressure, DBP – Diastolic blood pressure, Fast – Fasted, Non – 










Table 3.3: Mean (SD) central and peripheral blood pressures and arterial stiffness values for 
normotensive and hypertensive groups - supine and seated, fasted and non-fasted 
 
      Supine   Seated   Interaction   Posture   Fasted  
      Fast Non   Fast Non   P η2p   P η2p   P η2p  
Normotensive                              
MAP (mmHg) X   88 87   90 88   0.50 0.02   0.13 0.10   0.03 0.19  
  SD   7 8   7 8                    
SBP (mm Hg) X   119 120   119 120   0.62 0.01   0.76 0.00   0.47 0.02  
  SD   7 8   6 7                    
DBP (mm Hg X   74 73   77 74   0.06 0.14   0.01 0.23   <.01 0.36  
  SD   6 7   7 8                    
cSBP (mmHg) X   111 109   111 109   0.65 0.01   0.94 0.00   0.04 0.17  
  SD   8 8   7 7                    
cDBP (mmHg) X   75 74   78 75   0.03 0.18   0.02 0.20   <.01 0.28  
  SD   6 7   7 8                    
cPP (mmHg) X   37 35   34 36   0.02 0.22   <.01 0.33   0.81 0.00  
  SD   9 6   7 7                    
AP (mmHg) X   13 9   11 9   0.03 0.18   0.01 0.23   <.01 0.54  
  SD   7 4   7 5                    
AIx (%) X   32 24   29 23   0.29 0.05   0.03 0.19   <.01 0.70  
  SD   12 10   14 11                    
AIx@75 (%) X   26 19   23 26   <.01 0.74   <.01 0.53   <.01 0.99  
  SD   12 11   12 12                   
 HR (b·min-1) X  62 65  64 68  0.33 0.04  0.01 0.25  <.01 0.66 
  SD  10 9  8 10           
Hypertensive                             
MAP (mmHg) X   106 104   108 107   0.74 0.01   <.01 0.29   <.01 0.28  
  SD   11 11   12 12                    
SBP (mm Hg) X   146 146   147 148   0.22 0.06   0.06 0.13   0.28 0.05  
  SD   16 15   15 15                    
DBP (mm Hg X   87 85   91 88   0.17 0.07   <.01 0.38   <.01 0.54  
  SD   10 11   11 12                    
cSBP (mmHg) X   134 132   136 135   0.22 0.06   0.09 0.12   0.02 0.20  
  SD   15 14   14 14                    
cDBP (mmHg) X   88 86   92 89   0.31 0.04   <.01 0.38   <.01 0.48  
  SD   10 12   11 12                    
cPP (mmHg) X   46 46   44 46   <.01 0.25   0.17 0.08   0.36 0.03  
  SD   8 10   9 9                    
AP (mmHg) X   16 12   13 12   <.01 0.28   0.03 0.17   <.01 0.52  
  SD   5 5   5 6                    
AIx (%) X   33 27   30 25   0.02 0.20   0.02 0.21   <.01 0.64  
  SD   9 9   9 10                    
AIx@75 (%) X   27 22   25 30   0.05 0.29   0.07 0.20   0.01 0.19  
  SD   9 9   10 11                   
 HR (b·min-1) X  62 64  64 66  0.55 0.02  <.01 0.43  <.01 0.49 
  SD  7 8  8 8          
 
Abbrevs: AIx – Augmentation index, AIx75 – Augmentation index @ 75 b·min-1, AP – 
Augmented pressure, cDBP – Central diastolic blood pressure, cPP – Central pulse pressure, 
cSBP – Central systolic blood pressure, DBP – Diastolic blood pressure, Fast – Fasted, Non – 
Non-fasted, HR – Heart rate, MAP – Mean arterial pressure, SBP – Systolic blood pressure 
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Table 3.4: Reliability of the SphygmoCor XCEL in each sample group 
    Supine-F   Supine-NF   Seated-F   Seated-NF 
    ICC SEM SDC   ICC SEM SDC   ICC SEM SDC   ICC SEM SDC 
Whole Population                             
MAP (mmHg)   0.90 4.0 11.0   0.93 3.4 9.3   0.91 4.1 11.2   0.94 3.3 9.1 
SBP (mm Hg)   0.90 5.8 16.1   0.90 5.7 15.8   0.92 5.0 13.9   0.91 5.4 15.1 
DBP (mm Hg   0.90 3.4 9.4   0.92 3.0 8.4   0.90 3.6 10.0   0.94 3.1 8.6 
cSBP (mmHg)   0.89 5.4 15.0   0.92 4.5 12.5   0.90 5.2 14.3   0.92 4.7 13.1 
cDBP (mmHg)   0.89 3.5 9.6   0.89 3.7 10.3   0.90 3.6 10.1   0.94 3.1 8.7 
cPP (mmHg)   0.83 3.7 10.3   0.86 3.6 10.1   0.84 3.7 10.2   0.85 3.7 10.2 
AP (mmHg)   0.75 3.0 8.3   0.84 1.9 5.3   0.82 2.6 7.3   0.86 2.2 6.0 
AIx (%)   0.77 4.9 13.4   0.85 3.5 9.8   0.83 4.7 13.1   0.80 4.5 12.5 
AIx75 (%)   0.75 5.3 14.6   0.87 3.7 10.3   0.82 4.7 13.0   0.84 4.6 12.8 
HR (b·min-1)  0.86 3.1 8.6  0.84 3.3 9.2  0.86 3.0 8.4  0.80 4.0 11.0 
Normotensive                            
MAP (mmHg)   0.71 3.5 9.8   0.85 2.9 8.1   0.68 4.0 11.0   0.86 2.9 8.0 
SBP (mm Hg)   0.59 4.7 13.0   0.76 3.9 10.7   0.51 4.4 12.3   0.74 3.8 10.5 
DBP (mm Hg   0.75 2.9 8.0   0.83 2.8 7.8   0.73 3.7 10.3   0.88 2.8 7.8 
cSBP (mmHg)   0.68 4.7 13.1   0.77 3.7 10.2   0.58 4.4 12.1   0.75 3.4 9.5 
cDBP (mmHg)   0.74 3.0 8.4   0.87 2.6 7.2   0.73 3.8 10.4   0.87 2.9 8.1 
cPP (mmHg)   0.78 4.3 12.0   0.79 2.6 7.3   0.76 3.5 9.7   0.77 3.2 8.9 
AP (mmHg)   0.80 2.9 8.1   0.81 1.9 5.3   0.84 2.8 7.7   0.86 2.0 5.5 
AIx (%)   0.80 5.2 14.5   0.84 4.0 11.0   0.86 5.2 14.4   0.77 5.1 14.1 
AIx75 (%)   0.76 5.9 16.3   0.86 4.1 11.5   0.83 5.1 14.0   0.83 5.0 13.9 
HR (b·min-1)  0.88 3.3 9.3  0.80 3.8 10.6  0.85 3.1 8.7  0.84 3.9 10.7 
Hypertensive                         
MAP (mmHg)   0.88 3.9 10.9   0.89 3.6 10.0   0.91 3.6 9.9   0.92 3.4 9.5 
SBP (mm Hg)   0.87 5.7 15.8   0.86 5.6 15.4   0.87 5.4 14.9   0.82 6.3 17.4 
DBP (mm Hg   0.88 3.6 9.9   0.91 3.1 8.6   0.92 3.2 8.8   0.93 3.3 9.1 
cSBP (mmHg)   0.86 5.3 14.8   0.88 4.9 13.5   0.88 4.8 13.4   0.85 5.4 14.9 
cDBP (mmHg)   0.87 3.6 9.9   0.84 4.6 12.9   0.92 3.1 8.7   0.93 3.2 8.8 
cPP (mmHg)   0.79 3.7 10.2   0.79 4.5 12.4   0.80 3.8 10.7   0.84 3.8 10.4 
AP (mmHg)   0.67 3.0 8.2   0.85 1.9 5.2   0.78 2.5 6.9   0.84 2.3 6.4 
AIx (%)   0.73 4.5 12.4   0.87 3.1 8.6   0.79 4.3 11.8   0.83 4.0 11.0 
AIx75 (%)   0.74 4.7 12.9   0.88 3.3 9.1   0.79 4.3 12.0   0.85 4.2 11.7 
HR (b·min-1)  0.85 2.9 7.9  0.89 2.8 7.8  0.87 2.9 8.1  0.75 4.1 11.3 
 
Abbrevs: AIx – Augmentation Index, AIx75 – Augmentation index @ 75 b·min-1, AP – Augmented pressure, cDBP 
– Central diastolic blood pressure, cPP – Central pulse pressure, cSBP – Central systolic blood pressure, DBP –  
Diastolic blood pressure, ICC – Intra-class correlation coefficient, F – Fasted, HR – Heart rate, MAP – Mean arterial 
pressure, NF – Non-fasted, SBP – Systolic blood pressure, SDC – Smallest detectable change, SEM – Standard 




Significant interaction effects were observed for cDBP (p < 0.05, 2pη = 0.18) and cPP (p < 0.05; 
2
pη  = 0.22). For cDBP, greater differences were seen between prandial states (fasted vs. non-
fasted) whilst seated than supine. For cPP, a post-prandial increase was observed when 
supine, but a decrease was shown in the seated condition. Fasted state, but not posture, had 
a significantly large effect on cSBP whereas both fasting state and posture had a significant 
main effect on HR. For cBP variables, ICC values generally exceeded the criterion value of 0.75 
for the four conditions (Table 3.4), except for SBP in the supine-fasted condition between 
visits 1-2, SBP in the seated-fasted condition in visits 1-2 and 2-3 and PP in seated-fasted 
condition in visits 1-2 and 2-3 (Supp. Table; Appendix 1d). 
 
Hypertensive group 
Significant interaction effects were observed for cPP (p < 0.01; 2pη  = 0.25; Table 3.2) with 
greater differences seen between prandial states whilst seated than supine. Posture was 
shown to have a significant main effect on DBP, cDBP and HR, whereas fasted state had a 
significant effect on DBP, PP, cSBP, cDBP and HR (all p < 0.05). The between-day reliability of 
the XCEL was demonstrated by ICC values > 0.75 for all central haemodynamic variables in all 






3.4.2 Arterial stiffness 
 
Whole sample 
Mean values for arterial stiffness variables in the whole participant sample are shown in Table 
3.2. Significant interaction effects were observed for AIx and AIx75 (p < 0.05; 2pη = 0.10-0.18) 
with greater differences observed between prandial states whilst supine than seated. The 
between-day ICC of 0.75 was exceeded in all conditions for AIx and AIx75 (Table 3.4). 
 
Normotensive group 
The normotensive group presented significant interaction effects for AIx75 (p < .01; 2pη  = 0.74) 
with larger differences reported between prandial states whilst supine compared to seated. 
Posture caused a significant main effect on AIx (p < .05; 2pη  = 0.19) as did fasting state (AIx p 
< .05; 2pη  = 0.70 [Table 3.3]). ICC values exceeded 0.75 for all arterial stiffness variables in all 
conditions (Table 3.4). 
 
Hypertensive group 
Significant interaction effects were observed for AIx (p < 0.05; 2pη  = 0.20) and AIx75 (p < 0.05; 
2
pη  = 0.29). In the hypertensive group, and following food consumption, greater changes in 
AIx were demonstrated when supine compared to seated. For AIx75, food consumption 
elicited a 5.2% decrease in the supine condition whereas a 5.2% increase was observed in the 
seated condition. ICC values of ≥ 0.75 were observed in both variables in all conditions other 
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than supine-fasted (ICC = 0.73 and 0.74 [Table 3.4]), but after breaking data down, ICC values 




This study demonstrated that the SphygmoCor XCEL is a reliable tool for measuring central 
haemodynamic variables in a non-clinical participant sample > 50 years old in a range of 
normotensive and hypertensive individuals. Importantly, fasting state was shown to have a 
greater influence on central measures in a seated than a supine posture. Smaller differences 
between postures after food consumption were observed in arterial stiffness variables. 
 
3.5.1 Central and peripheral blood pressures 
The results of this study demonstrate that the SphygmoCor XCEL can reliably record central 
markers of blood pressure. The ICC values we observed for cSBP for the whole group (0.89 –
0.92) and after splitting of data (normotensive = 0.58 – 0.77; hypertensive = 0.85 – 0.88) are 
similar to previous research in a younger sample (ICC = 0.89; [Young et al., 2015]) and suggest 
that the SphygmoCor XCEL is a reliable tool for assessing cBP in non-clinical participant sample 
over the age of 50. However, despite excellent reliability between visits one and two and visits 
two and three (Supp. Table, Appendix 1d) for the whole study sample and the hypertensive 
group, moderate correlations were only reported for the normotensive sample. This may be 
due to the presence of white coat syndrome and should be considered in terms of 
recommendations for blood pressure assessment protocols. This point may be particularly 
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relevant in GP practices where blood pressure measures tend to only be completed once per 
visit, potentially giving a false indication of a patient’s blood pressure at that time. 
Significant interaction effects were observed for cDBP and cPP in the whole group, with 
similar findings generally reported for both the normotensive and hypertensive groups. The 
present study has shown smaller differences in blood pressures (cDBP, cPP) between fasted 
and non-fasted conditions when a participant is supine (mean difference of 1.4 mmHg and 
0.8 mmHg, respectively) than seated (mean difference of 2.7 mmHg and 1.5 mmHg, 
respectively). This may be due to increased speed of early-stage digestion taking place in a 
seated position because of gravity; leading to subsequent greater vasodilation and a drop in 
BP not seen in a supine position. This finding may be important in clinical environments such 
as GP practices where blood pressure is measured in a variety of fasting states but frequently 
in a seated rather than supine posture. These findings were mirrored in the normotensive and 
the hypertensive group. 
Greater variability in the cDBP and cPP response to food was seen in a seated posture than a 
supine posture, and thus the seated posture traditionally adopted in a clinical setting may be 
sub-optimal, particularly as cPP is potentially a more direct indicator of vascular aging than 
other blood pressure variables (Xiao et al., 2015). In accordance with Young and colleagues 
(2015), the SphygmoCor XCEL has optimal reliability in a supine posture with an older 
population, due to the smaller changes caused by prandial state. 
The posture of a patient is important to consider when measuring blood pressure (Cavelaars 
et al., 2004) and the role posture plays in aortic haemodynamics is less well known (Vrachatis 
et al., 2014). Our results would suggest the greater differences observed for changes in some 
central variables in fasting state in a seated posture may also be insufficiently recognised in 
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the literature. We observed a significant increase in cDBP in the seated compared to supine 
posture in the whole sample as well as the normotensive and hypertensive sub-groups. This 
agrees with previous studies investigating DBP (Cicolini et al., 2011; Shoji et al., 2017), 
although research incorporating only 1 - 5-minute postural conditions before assessments has 
shown a greater peripheral blood pressure in a supine than seated posture [Netea et al., 2003; 
Cavelaars et al., 2004); highlighting the differing acute and chronic responses to postural 
change.  
A forty-eight hour fast has been demonstrated to significantly lower peripheral blood 
pressures (Eser et al., 2007), but the acute effects of food on vascular haemodynamics have 
received less attention. Our observations of a significant drop in cBP and non-significant 
responses of peripheral SBP in a post-prandial state are in support of previous work 
(Andersson et al., 1988). These significant decreases in cSBP and cDBP in the post-prandial 
state were reported in the sample as a whole and in both sub-groups.  
 
3.5.2 Arterial stiffness 
The strong between-day reliability when measuring AIx and AIx75 (ICC > 0.75) in our older 
participant sample supports previous research undertaken with a young, healthy sample (ICC 
= 0.71 – 0.82; [Young et al., 2015]). Smaller differences were observed between visits 1 - 2 
and 2 - 3 for AIx and AIx75 than cBP measures (Supp. Table Appendix 1d), meaning that the 
physiological mechanisms resulting in potential white coat syndrome in peripheral and 
central pressures may not extend to AIx and AIx75 measures. 
The significant interaction effects observed for AIx and AIx75 for the whole sample suggested 
greater post-prandial variability in a supine posture (mean differences of 7.2% and 2.9% 
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respectively) than seated (mean differences of 5.3% and 1.8% respectively). These results are 
converse to the findings in this study with regards to cBP measures and suggest that, when 
assessing arterial stiffness, a seated posture is optimal to reduce the variability caused by food 
consumption. These interaction effects were not observed in previous research using a 
younger sample (Young et al., 2015) and suggest that arterial stiffness becomes more variable 
as a person grows older. 
Significant differences were observed in AIx and AIx75 in the whole sample due to postural 
alterations. These differences were not seen in previous work (Young et al., 2015), although 
after the calculation of AIx75, augmentation index was reported to be lower in a supine 
posture than seated in young females (Jaccoud et al., 2012). Fasting state was reported to 
cause a significant drop in AIx. This may be due to alterations of the tone of small vessel beds, 
large artery function and large artery geometry (Young et al., 2015). Vasodilation after food 
consumption may lead to a lessening of wave reflection intensity, leading to this decrease in 
arterial stiffness. 
 
3.5.3 Clinical Inference 
The present study suggests that the SphygmoCor XCEL is a reliable measure when assessing 
cBP and arterial stiffness variables. Clinicians and researchers may find it useful to measure 
cBP in a supine posture due to the reduced effect of food intake, but that arterial stiffness 




3.5.4 Limitations and Strengths 
Limitations and strengths should be noted to allow better contextualisation of the results. 
One limitation was that we recruited a mixed sex sample of healthy adults over the age of 50. 
Previous work has suggested that the effect which posture has on peripheral BP may be sex 
specific (Gerber et al., 2015) and future work should recruit unisex cohorts to similar protocols 
to determine whether this is the case for cBP measures. It is worth noting that AIx75 may be 
physiologically and statistically inappropriate as a standalone measure, due to the assumption 
being made that the relationship between HR and AIx is linear (Stoner et al., 2013). 
Consequently, our statistical analysis reports both AIx and AIx75. The structure of the present 
study did, however, involve post-prandial measures up to 45 minutes after food intake which 
is in accordance with Ahuja and colleagues’ (2009) recommendations for assessing changes 
to haemodynamic variables after food intake. Furthermore, the overnight fast undertaken by 
participants and randomised order of conditions result in a robust protocol and data 
collection was consistently undertaken at the same time of day, reducing the likelihood of 
circadian blood pressure cycles influencing results. It should be noted that two of the thirty 
female participants were pre-menopausal at the time of assessment due to the age 
demographic of our population. An international study of ~19,000 women reported the 
median age of natural menopause to be 50 (median range of 49 – 52y (Morabia & Constanza, 
1998).  Although this is a condition which causes increased prevalence of hypertension 
(Johnson et al., 2015), further analysis demonstrated that study outcomes were not 





Blood pressure assessments occur in a range of postures and fasting states depending on an 
almost endless number of variables both at home and in the clinical environment. This study 
highlights the significant effect that fasting state can have on central haemodynamic variables 
and measures of arterial stiffness. This study also notes that the influence food consumption 
has on central haemodynamics is minimised with the use of a supine posture – a position 
which has also previously been shown to cause the greatest between-day reliability of the 
SphygmoCor XCEL. Although previous work has highlighted the possibility of white coat 
syndrome and the necessity for second blood pressure measures to be recorded, this study 
suggests that more than one visit may be necessary, particularly for a normotensive 
population. The SphygmoCor XCEL is a reliable tool in assessing cBP and measures of arterial 
stiffness in a non-clinical sample over the age of 50 and trials should now begin to determine 




Chapter 4: Study two – Oscillometric central blood pressure and arterial stiffness 


















Background: Reliable measures of blood pressure are key in the treatment of acute stroke. 
This study investigated the between-day reliability of non-invasive estimates of central and 
peripheral blood pressure and markers of arterial stiffness (AIx and AIx75) and the effect of 
posture and fasting state on these variables in acute stroke patients. Methods: Twenty-two 
acute stroke patients (72y ± 10y) had blood pressure measured using the SphygmoCor XCEL 
in supine and seated postures and whilst fasted and non-fasted. Results: Excellent between-
day reliability (ICC > 0.75) was reported for all peripheral and central variables in all conditions 
(ICC = 0.77 – 0.90) and for AIx and AIx75 in both fasted postures (ICC = 0.78 – 0.81). All 
peripheral and central blood pressures were significantly lowered by food consumption (p < 
0.05; 2pη  = 0.20 – 0.55). Participants had significantly higher AIx in the seated posture than 
supine (p < 0.05; 2pη  = 0.22). Fasting state had significant main effects on AIx and AIx75 (p < 
0.05; 2pη  = 0.14 – 0.22). Conclusions: Oscillometric measures of central blood pressure can be 
recorded with excellent between-day reliability in different postures and fasting states in 
acute stroke patients. Fasting state has a large effect on central and peripheral blood 
pressures and on measures of arterial stiffness. It is important for clinicians to be aware of 
optimal assessment conditions and the importance of consistency in these conditions without 
impact on patient wellbeing. 






Hypertension is positively and continuously related to first-time stroke [Chalmers & Chapman, 
2001; Chatterjee Roberts & Boden-Albala, 2014) due to added haemodynamic stresses on the 
brain (Pase et al., 2013).  Controlling hypertension is a cornerstone of recurrent stroke risk 
reduction (Biffi et al., 2015) and can be approached from pharmacological and lifestyle 
perspectives. Increased stresses on the brain (such as those caused by hypertension) cause 
poor neurological recovery after stroke (Ishitsuka et al., 2014) and lead to elevated risk of 
stroke recurrence (Sacco et al., 2006). However, how intensive treatment should be in 
lowering blood pressure after stroke is frequently debated. The consensus now warns against 
intense lowering of blood pressure after stroke (Ovbiagele et al., 2011a; Williamson et al., 
2016; Whelton et al., 2018). Treating hypertension efficiently may be the most important tool 
in preventing recurrent strokes (Kernan et al., 2014) and maximising quality of life post-
stroke.  
Blood pressure is normally assessed by occluding the brachial artery (peripheral blood 
pressure), but cBP measures (either measured directly or derived from brachial pulse waves) 
may be more closely related to cardiovascular risk (Shimizu et al., 2015). The invasive 
measurement of cBP is usually contraindicated (Dawson et al., 2009), but novel techniques 
are now able to non-invasively estimate central pressures using oscillometric pulse wave 
analysis (PWA). There is good agreement with PWA and tonometer-based methods of 
measuring cBP in patients with atrial fibrillation (Sabahi et al., 2013), a frequent indicator of 
elevated stroke risk. Although oscillometric devices have been demonstrated to be valid 
(Lowe et al., 2009; Butlin et al., 2012; Lin et al., 2012; Hwang et al., 2014), research is required 
to report the reliability of these devices when assessing central haemodynamic variables 
before they can be used diagnostically and prognostically in clinical research and treatment 
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settings where they may have a large impact in terms of monitoring treatment plans after 
clinical events such as stroke. Further details relating to the use of the SphygmoCor XCEL can 
be found in the literature review of this thesis (page 91) and in chapter three (pages 99). 
Identifying the optimal operating conditions of devices able to non-invasively calculate central 
haemodynamic variables in terms of both posture and fasting state is an important step in 
their introduction to research and clinical use. Posture [Cavelaars et al., 2004; Eser et al., 
2007) and fasting state (Andersson et al., 1988) have been found to alter peripheral blood 
pressure measures in non-clinical populations (aged 18-62y). Whilst the acute effects of 
postural change and fasting state on cBP and arterial stiffness (AIx) have been investigated in 
both young and older non-clinical populations (Ahuja et al., 2009; Young et al., 2015; 
Mitchelmore et al., 2018 [chapter three of this thesis]), the between-day reliability of these 
variables has not been investigated in a stroke population where they are of particular 
prognostic importance. Testing these variables in different conditions is important as blood 
pressures are measured in a variety of postures and fasting states within clinical settings 
according to several environmental and situational factors.  
This study examined the effect of posture and fasting state on the between-day reliability of 
peripheral and central pressures and arterial stiffness in an acute stroke population using a 
non-invasive, oscillometric device (SphygmoCor XCEL). This will also involve investigating the 
effects that posture and fasted state have on these variables. This study hypothesised that 
posture and fasting state would have a significant effect on peripheral and cBP and markers 
of arterial stiffness. It was also hypothesised that oscillometric PWA would report high 
between-day reliability in an acute stroke population. These findings will be of importance to 
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those considering the use of the non-invasive oscillometric devices to estimate cBPs in 
research and clinical settings. 
As with chapter three, we hypothesised that the SphygmoCor XCEL would reliably measure 
peripheral and central BP and measures of arterial stiffness. We also hypothesised that 
posture and fasting state would have a significant effect on measures of peripheral and 
central BP and measures of arterial stiffness. Our null hypothesis, therefore, was that the 
SphygmoCor XCEL would not reliably report peripheral and central BP and measures of 




The methods of this study are reported in accordance with the Helsinki Declaration of 1975 
and STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) 
guidelines (von Elm et al., 2007). 
 
4.3.1 Participants 
Twenty-two stroke patients (M=16; age: 72.3 ± 10.4 y; National Institutes of Health Stroke 
Scale [NIHSS]: 8.1 ± 5.1; time after stroke: 13.2 ± 12.2 days) were initially contacted by a 
research nurse before formal consent was provided after a full description of the study and 
provision of information sheets. All patients gave written consent whilst they were in-patients 
in a hyper-acute stroke ward in a hospital in Hampshire, United Kingdom. The information 
sheet and consent form for this study can be seen as appendices 2b and 2c. Patients were 
122 
 
excluded if they were end-of-life stroke patients, had an unstable cardiac condition, were 
oxygen-dependent, had significant dementia, were unable to swallow normally, lacked 
capacity to consent, were diagnosed more than eight weeks prior to assessment, had either 
type I or II diabetes mellitus or were hypoglycaemic at hospital admission. All participants 
completed a health history questionnaire (ACSM, 2013; [Table 4.1]). Ethical approval was 
granted by the Health Research Authority (REC reference: 15/SC/0559) South Central – 
Hampshire A Research Ethics Committee. The study was registered as a clinical trial: 














Table 4.1: Participant demographic data 
   n % 
Participants   22  
Age (y)   72.3 ±10.4  
Sex  Male 16 73 
  Female 6 27 
Descent  European 22 100 
Stroke subtype  Small vessel lacunar 2 9 
  Partial anterior circulation stroke 8 36 
  Total anterior circulation stroke 3 14 
  Posterior circulation stroke 1 5 
  Intracerebral haemorrhage 6 27 
  Undetermined 2 9 
Family history of CVD  Myocardial infarction 9 41 
  Heart surgery 1 5 
  Stent 0 0 
  Catheter 1 5 
  Heart defect 1 5 
  Stroke 7 32 
Personal history of CVD  Hypertension 10 45 
  High cholesterol 6 27 
  Diabetes 0 0 
  Coronary artery disease/heart 
failure 
5 23 
  Atrial Fibrillation 8 36 
Comorbidities  Thyroid disease 2 9 
  Lung disease 0 0 
  Asthma 0 0 
  Cancer 2 9 
  Kidney disease 1 5 
  Hepatitis 2 9 
Lifestyle factors  Current smoker 2 9 
  Previous smoker 6 27 
  Current alcohol drinkers 17 77 
  Current weight loss plan 1 5 
Everyday activity  Sedentary 3 14 
  Lightly active 3 14 
  Moderately active 15 68 
  Vigorously active 1 5 
Medication  Statins 2 9 
  Anti-thrombotic 14 64 
  Diuretics 1 5 
  Calcium blockers 5 23 
  Alpha blockers 1 5 
  Beta blockers 5 23 
  Anticoagulants 1 5 
  Other anti-hypertensive medication 5 23 
  ACE-I 4 18 
  ARB 2 9 
Abbrevs: ACE-I – Angiotensin-converting-enzyme inhibitor, ARB – Angiotensin II receptor 




4.3.2 Experimental design 
Participants followed the same experimental design as those in Chapter three, with the only 
difference being the setting of a hyper-acute stroke ward in a hospital in Hampshire, United 
Kingdom. Participants were tested on three consecutive mornings, having consumed only 
water in the 12 hours prior to data collection. After random allocation to a supine-first or 
seated-first condition using a computerised random number generator, participants assumed 
this posture in a fasted state for twenty minutes. A minimum of two PWA measurements 
were completed using the SphygmoCor XCEL (AtCor Medical, Sydney, Australia) with a three-
minute interval. As described in chapter three, if SBP differed by > 5 mmHg and AIx differed 
by > 4% between the first and second measures, a third assessment was conducted. Measures 
of PWA consisted of a peripheral blood pressure measure followed by a 10-second sub-
systolic recording. The merging points of the forward and reflected waves were identified on 
the aortic pressure waveform (Young et al., 2015). Measurements were taken at heart level 
in both postures to ensure no changes in AIx were found due to alterations in arm angle. 
Participants rested for twenty further minutes in the alternative posture before these 
measures were repeated to complete the fasted condition on each morning. A standard 
hospital breakfast was consumed which constituted of cereal, milk and juice (282kcal, 60g 
carbohydrate, 3g total fat, 8g protein) or a bread roll with butter and juice (291kcal, 56g 
carbohydrate, 4g total fat, 9g protein), allowing results to be compared directly with chapter 
three of this thesis (320kcal, 60g carbohydrate, 7g fat, 5g protein). Participants consumed the 
same breakfast on all three days of participation in the study. The testing protocol was then 
repeated in the same order but in a non-fasted state. Order of fasted state was not 
randomised due to measurements occurring in a narrow timing window to avoid blood 
pressure differences caused by circadian rhythms and timing constraints in terms of days of 
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data collection per participant before discharge. This protocol led to the final measures being 
approximately 45 minutes after food intake.  
 
4.3.3 Sample size 
A priori sample size calculations were based on cSBP measures as the primary outcome and 
assumed a typical error of 6.4 mmHg adopted from a previous reliability study with healthy 
participants (Filipovsky et al., 2000). The maximum chances of a type 1 or 2 error were set at 
5% (very unlikely) and an approximate total of eight participants were required to detect a 6-
mmHg change (based on the smallest change reported in previous blood pressure studies 
[Ahuja et al., 2009]). 
 
4.3.4 Statistics 
Analyses were run using Statistical Package for Social Sciences v.22 (SPSS, Inc., Chicago, 
Illinois, USA). All presented data are means (standard deviation, SD). Statistical significance 
was set at p < 0.05 (two tailed). Analysis of variance for repeated measures with two within-
participant factors (posture and fasting state) examined differences in central and peripheral 
pressures and arterial stiffness. An independent samples t-test was run to ensure that gender 
had no significant effect on measures of blood pressure, AIx or AIx75 (p > 0.05). Effect sizes 
were reported using partial eta squared ( 2pη ) with 0.01, 0.06 and 0.14 representing small, 
medium and large effects (Cohen, 1969).  
The between-day reliability of the device was measured by calculating the intra-class 
correlation coefficient (ICC), standard error of measurement (SEM) and smallest detectable 
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change (SDC; the critical difference in a variable which must be exceeded between two 
sequential results for a statistically significant change to occur ([Fraser, 2001]). Excellent 
reliability was reported as an ICC > 0.75 (Fleiss, 1986). 
4.4 Results 
 
4.4.1 Central and peripheral blood pressures 
When measuring SBP and cSBP, the SphygmoCor XCEL reported excellent between-day 
reliability in all variables with ICCs exceeding the 0.75 criterion for excellent reliability (ICC = 
0.77 – 0.90; Table 4.2). No interaction effects were observed. Posture was reported to have a 
significant main effect on DBP and cDBP (p < 0.01; 2pη  = 0.43), with DBP and cDBP both 
significantly increasing in a seated posture relative to supine. Fasted state had a significant 
main effect on central and peripheral haemodynamics, with significant decreases in SBP, DBP, 




Table 4.2: Reliability of SphygmoCor XCEL in measuring peripheral and central blood pressures 
  Supine-F   Supine-NF   Seated-F   Seated-NF 
  ICC SEM SDC   ICC SEM SDC   ICC SEM SDC   ICC SEM SDC 
MAP (mmHg) 0.88 4.6 12.7   0.81 5.6 15.4   0.83 5.1 14.3   0.84 5.8 16.0 
SBP (mmHg) 0.84 7.3 20.4   0.84 7.8 21.7   0.83 7.3 20.3   0.85 7.6 21.1 
DBP (mmHg) 0.89 3.6 9.9   0.80 4.5 12.5   0.82 4.5 12.5   0.81 5.3 14.6 
PP (mmHg) 0.80 5.4 15.1   0.89 4.9 13.5   0.77 5.8 16.2   0.82 5.7 15.9 
cSBP (mmHg) 0.85 6.3 17.4   0.83 7.0 19.4   0.81 6.3 17.5   0.83 7.0 19.4 
cDBP (mmHg) 0.90 3.5 9.7   0.82 4.4 12.2   0.83 4.4 12.2   0.83 5.1 14.2 
cPP (mmHg) 0.84 4.1 11.4   0.88 3.8 10.4   0.79 4.5 12.6   0.83 4.3 11.9 
Heart rate (b·min-1) 0.89 3.3 9.2   0.83 4.4 12.3   0.88 3.8 10.6   0.85 4.0 11.0 
AP (mmHg) 0.76 2.8 7.8   0.66 3.0 8.4   0.72 3.5 9.7   0.71 2.9 8.1 
AIx (%) 0.81 3.7 10.3   0.66 5.1 14.0   0.78 5.1 14.2   0.73 5.1 14.1 
AIx75 (%) 0.81 4.7 12.9   0.70 5.6 15.4   0.78 6.2 17.1   0.74 5.8 16.1 
Abbrevs: AIx – Augmentation index, AIx75 – Augmentation index @ 75b·min-1, AP – Augmented pressure, cDBP – Central diastolic blood 
pressure, cPP – Central pulse pressure, cSBP – Central systolic blood pressure, DBP – Diastolic blood pressure, F – Fasted, ICC – Intraclass 
correlation coefficient, MAP – Mean arterial pressure, NF – Non-fasted, SDC – Smallest detectable change,  SEM – Standard error of 





Table 4.3: Mean and SD for peripheral and central haemodynamic variables 
    Total   Supine   Seated   Interaction   Posture   Fasted 
       Fast Non   Fast Non   P η2p   P η2p   P η2p 
MAP (mmHg) 𝑋𝑋� 99   102 93   105 96   .86 .00   <.01 .34   <.01 .52 
 SD 14   14 13   13 15                   
SBP (mmHg) 𝑋𝑋� 142   146 136   149 138   .82 .00   .09 .14   <.01 .48 
  SD 19   19 20   17 19                   
DBP (mmHg) 𝑋𝑋� 78   81 73   84 76   .90 .00   <.01 .43   <.01 .53 
  SD 12   11 10   11 12                   
PP (mmHg) 𝑋𝑋� 66   67 65   67 64   .57 .02   .33 .05   .04 .20 
  SD 16   16 17   16 17                   
cSBP (mmHg) 𝑋𝑋� 129   134 122   136 124   .82 .03   .06 .16   <.01 .59 
  SD 17   16 17   14 17                   
cDBP (mmHg) 𝑋𝑋� 80   82 74   85 77   .95 .00   <.01 .43   <.01 .50 
  SD 12   11 11   11 12                   
cPP (mmHg) 𝑋𝑋� 50   52 48   51 47   .71 .01   .06 .16   <.01 .55 
  SD 10   10 11   10 10                   
Heart rate (b·min-1) 𝑋𝑋� 67   65 68   66 70   .30 .05   .04 .19   <.01 .60 
  SD 11   10 11   11 10                   
AP (mmHg) 𝑋𝑋� 16.6   20 15   18 14   .65 .01   .02 .22   <.01 .61 
  SD 6.4   7 6   7 6                   
AIx (%) 𝑋𝑋� 32.3   36 31   34 29   .97 .00   .02 .22   <.01 .43 
  SD 10   9 10   11 10                   
AIx75 (%) 𝑋𝑋� 28.6   31 28   29 27   .54 .02   .08 .14   .03 .20 
  SD 11.3   11 11   13 11                   
Abbrevs: AIx – Augmentation index, AIx75 – Augmentation index @ 75b·min-1, AP – Augmented pressure, cDBP – Central diastolic blood pressure, 
cPP – Central pulse pressure, cSBP – Central systolic blood pressure, DBP – Diastolic blood pressure, F – Fasted, N – Non-fasted, MAP – Mean 
arterial pressure, PP – Pulse pressure, SBP – Systolic blood pressure 
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4.4.2 Arterial stiffness 
When assessing AIx and AIx75, the SphygmoCor XCEL device reported excellent between-day 
reliability in both fasted postures (ICC = 0.78 – 0.81) and moderate reliability in both non-
fasted postures (ICC = 0.66 – 0.74 [Table 4.2]). Posture had a significant main effect on AIx, 
with a significant decrease observed in the seated posture (p = 0.02; 2pη  = 0.22) but not in 
AIx75; suggesting that these differences were mainly due to the significant changes in heart 
rate observed in this study. Fasting state had a significant main effect on both AIx and AIx75 
with significant decreases reported after food consumption (p < 0.05; 2pη  = 0.14 – 0.22 [Table 
4.3 & Supp. Table, Appendix 2d). 
 
4.5 Discussion 
The SphygmoCor XCEL exhibits high between-day reliability in different fasting states and 
postures when assessing peripheral and central BP measures, but arterial stiffness variables 
were more reproducible in a fasted than non-fasted state. Fasting state was demonstrated to 
have a large influence on both peripheral and cBP and arterial stiffness measures, whereas 
posture significantly influenced DBP, CDBP and AIx, but no other variables recorded. The lack 
of statistical differences in AIx75 between postures suggests that differences in AIx are caused 
by fluctuations in heart rate caused by postural change. This is in line with previous research 
showing that AIx is confounded by the timing of the reflected wave (Stoner et al., 2017). When 
measuring peripheral and central BP in a stroke population, patients should be in a fasted 
state to optimise the accuracy and reliability of collected data. If patients are non-fasted, it is 
important that researchers and clinicians are aware of the immediate effects of food intake 
on these measures and analyse these blood pressure measures accordingly. Due to the high 
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reliability and the demonstrated effect of posture and fasting state on central haemodynamic 
variables, the experimental hypotheses of this study were accepted. 
 
4.5.1 Central and peripheral blood pressures 
High between-day reliability was reported when assessing central and peripheral blood 
pressure measures, with ICCs exceeding the 0.75 criterion of excellence in all conditions. 
These ICCs (0.77 – 0.90) are consistent with, but slightly better than, previous work examining 
the reliability of the SphygmoCor XCEL in a younger, healthy population which reported ICCs 
of 0.68 – 0.90 for peripheral and central measures (Young et al., 2015). No work found during 
an extensive literature review has investigated the reliability of this device in an acute stroke 
population. Based upon the ICC analysis, this study suggests that non-invasive measures may 
be suitable for the assessment of central haemodynamics. However, it is interesting to note 
that the SDCs were wider than those reported using the same device in a young, healthy 
population (Young et al., 2015). 
No significant interaction effects were reported. Significant main effects were observed for 
both posture and fasting state on peripheral and central BP. Due to technological advances, 
the measurement of these variables non-invasively may become widespread. As a result, 
research into factors influencing central measures is of great importance. It is possible that 
medications may induce different responses between peripheral and central BP measures 
(McEniery et al., 2014). The significant increase in DBP and cDBP in a seated position 
compared to supine mirrors the findings of previous work (Cavelaars et al., 2004; Cicolini et 
al., 2011). This, alongside a non-significant change in systolic measures, caused a non-
significant decrease in cPP. Due to the fact that cPP is recognised as being extremely relevant 
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to vascular ageing (Xiao et al., 2015), the significant influence of posture on cDBP is 
particularly relevant.  
Fasting state was demonstrated to cause significant decreases in SBP, DBP, pPP, cSBP, cDBP 
and cPP. A post-prandial decrease of ~10 mmHg was reported in SBP and ~12 mmHg in cSBP. 
A smaller decrease in DBP (8 – 9 mmHg) and cDBP (8 mmHg) caused a large change in pPP 
and cPP to occur. Significant decreases in cBP after food consumption have been observed in 
a non-clinical population over the age of 50 (Mitchelmore et al., 2018 [Chapter three of this 
thesis]) but not in a young, healthy sample (Young et al., 2015). This suggests that healthy 
populations may be able to make necessary autonomic adjustments to redirect blood flow 
without a drop in cBP, but older and clinical populations may be less able to do so effectively. 
A post-prandial drop in central variables was observed by Ahuja et al (2009) who reported a 
decrease of 6.1 mmHg after food and water consumption compared to water alone but 
recruited a wide-ranging sample aged 21 – 80 years old. After food consumption, this 
decrease in blood pressure may be due to a post-prandial reduction in arterial stiffness in the 
splanchnic bed, allowing cardiac output to be maintained alongside a decrease in blood 
pressure. Ahuja and colleagues (2009) suggest a peak timeframe of 45 minutes for a blood 
pressure drop after food intake; indicating that the data reported in this study may reflect the 
greatest changes in a post-prandial state. It is worth noting that as well as physiological 
adaptations, these changes in blood pressure may be contributed to by the presence of 
regression to the mean effect due to the repeated measures taken; a potential bias which is 
inevitably present for as long as there is less-than-perfect repeatability in the measurement 
of blood pressure (Atkinson, 2015). It should be at the discretion of consultants as to how 
these optimal operating conditions are balanced against practical patient care, with 
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nutritional strategies adopted to avoid poor outcomes and prolonged stays in hospital 
(Aquilani et al., 2011). 
 
4.5.2 Arterial stiffness 
This study reports that the SphygmoCor XCEL has high between-day reliability when reporting 
AIx and AIx75, particularly in fasted participants. ICCs of 0.78 – 0.81 were observed when 
recording AIx and AIx75 in a fasted state, whereas this lowered to 0.66 – 0.73 and 0.70 – 0.74 
for AIx and AIx75, respectively, when participants were non-fasted. The digestive process 
causes alterations in vasodilation which may vary on a day-to-day or meal-to-meal basis 
depending on extraneous factors (e.g., meal composition, temperature, hydration status). 
This may cause the assessment of AIx and AIx75 to become less stable when the body is not 
at rest as it would be more likely to be in a fasted state. The significant main effect observed 
for posture in AIx but not in AIx75 may add credence to the concept that AIx and HR may not 
be entirely linearly related; a suggestion which reduces the propriety of AIx75 being reported 
without AIx alongside (Stoner et al., 2013). Significant changes to AIx and AIx75 in different 
postures have not been observed in previous work in a healthy, young population (Young et 
al., 2015). However, a significant change in AIx but not AIx75 has also been reported in 
hypertensive participants over the age of 50 (Mitchelmore et al., 2018 [see chapter three of 
this thesis]) but not in the normotensive sample in the same study, who demonstrated 
significant differences in both AIx and AIx75 in supine and seated postures. A reduction in 
AIx75 has been reported in a supine state compared to a seated position in a female-only 
population (Jaccoud et al., 2012). Such a finding was not mirrored in this study, with 
measurements of AIx and AIx75 being 1-2% lower in the seated posture compared to supine. 
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This finding was not statistically significant (p = 0.08), whilst wide ranges in the reported 95% 
confidence intervals were reported (see Supp Table, Appendix 2d). This may be due to a 
potential lack of statistical power to detect an association of this magnitude in this sample of 
22 stroke patients. The finding that fasting state had a significant main effect on AIx and AIx75 
with post-prandial reductions observed in both measures aligns with previous research and 
may be a result of increased arterial compliance due to tone alterations in the small vessel 
beds, large artery function and large artery geometry (Young et al., 2015). 
 
4.5.3 Clinical significance 
This study suggests that non-invasive cBP assessments provide reproducible measurements 
of peripheral and central haemodynamics. Significant decreases in peripheral and central BP 
were observed after food consumption. During hospitalisation after stroke, assessments of 
central and peripheral BP should therefore be assessed in a fasted state to reduce the 
variability caused by food intake. This is particularly true when medication prescription is at 
least partially based on these routine blood pressure measures. The combined effect of post-
stroke medication and fasting state should also be considered when monitoring patient 
health, as both variables cause a decrease in peripheral and central BP measures. 
With regards to arterial stiffness, increased arterial stiffness is reported to be significantly 
associated with reduced cognitive function in stroke patients (Lee et al., 2014). Reporting this 
decrease in arterial stiffness in terms of prandial state may have some importance with 
regards to perfusion pressures and the timing and assessment of cognitive state examinations 
in a clinical setting around mealtimes. Further work should investigate any potential links 
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between arterial stiffness, perfusion pressures and cognitive performance both before and 
after food intake in clinical populations. 
 
4.5.4 Strengths and limitations 
The recognition of areas of strength and limitation is vital during the interpretation of results. 
Firstly, we did not recruit a unisex sample, a fact which may influence results due to potential 
differences in responses to postural changes in peripheral blood pressure between sexes 
(Gerber et al., 2015). Secondly, due to stringent exclusion criteria and subsequent slow levels 
of recruitment, we recruited a sample with a range of stroke subtypes and severity according 
to NIHSS (range: 1 – 18). Although the global burden of stroke is predicted to continue to 
increase as a greater proportion of patients survive their first stroke, fewer than half of all 
stroke trials recruit their target number of patients (Berge et al., 2016). Participant 
recruitment is arguably the most difficult part of research (Blanton et al., 2006), and if 
successful recruitment does not occur, there are implications for statistical power and 
internal and external validity (Berge et al., 2016). 
To optimise patient recruitment, Gorelick and colleagues (1998) proposed a recruitment 
triangle involving the patients themselves, their key family members and friends, and the 
primary doctors and other medical personnel. Each of these corners of the triangle were 
addressed throughout the research process, with consent taken from patients during visiting 
hours to allow family members to be a part of the decision-making process to minimise 
participant dropout. 
Further work should examine whether there are differences in the reliability of the 
SphygmoCor XCEL in more severe strokes, and between stroke subtypes. The study was also 
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not able to take into account the effect of body mass or body composition variables on 
changes of peripheral and central haemodynamics as patients were not routinely weighed on 
admission. Finally, the sample contained participants with and without atrial fibrillation; a 
condition which may lead to some inconsistencies in measured data due to inconsistent 
stroke volumes. Focusing on cBP assessments in those specifically with atrial fibrillation has 
the potential to be an interesting area of future study. However, the timeframes involved in 
the data collection process ensured that post-prandial measures after food consumption 
were in accordance with recommendations set out by Ahuja and colleagues (2009) in terms 
of capturing the peak effects of food intake on haemodynamic variables. Additionally, the in-
patient nature of the study ensured a controlled environment for data collection to occur. 
Furthermore, the randomisation of condition order and standardised overnight fast also 
contributed to a strong protocol. Finally, assessments occurred at the same time each day, 




In conclusion, this study demonstrates that the SphygmoCor XCEL, a non-invasive 
oscillometric PWA device, possesses high between-day reliability in assessing both central 
and peripheral BP measures in both fasted and non-fasted states, and good reliability when 
assessing markers of arterial stiffness, particularly in a fasted state. The current study 
demonstrates that posture has a significant effect on DBP, cDBP and AIx, whereas, fasting 
state significantly influences all peripheral and central variables, as well as both AIx and AIx75, 
in acute stroke patients. The findings of this study are pertinent to researchers and clinicians, 
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although consideration around the practicalities of implementing these measures within 
practice (e.g. optimising conditions for BP assessment whilst minimising adverse events 




Chapter 5: Study three - The acute effect of heel raises on central haemodynamics, arterial 





















Extended sedentary time is common after stroke and leads to increases in blood pressure (BP) 
and poor health outcomes. This study investigated whether intermittent heel raises could 
reduce these rises in BP over a three-hour time period and consequently improve cognitive 
function. Fifteen stroke survivors (69.3y ± 10.8y) took part in a randomised crossover trial. 
Participants attended a familiarisation session involving pulse wave analysis and pulse wave 
velocity measures using the SphygmoCor XCEL and five Stroop tasks. Participants then 
attended two sessions of three hours of stationary, seated time. In one of these visits, ten 
heel raises were completed at ten-minute intervals throughout. Measures of central 
haemodynamics and cognitive function at the ten-minute time-point and three-hour time-
point were compared. Intermittent heel raises had a large significant condition by time 
interaction effect on peripheral and cBP (p = 0.02 – 0.04; 2pη  = 0.28 – 0.32). Increases of 10.7 
mmHg and 9.6 mmHg were observed in peripheral and cBP over the sedentary three hours as 
opposed to increases of 5.2 mmHg and 5.6 mmHg respectively in the heel raise protocol. No 
significant changes in cognitive function were observed (p > 0.05). Intermittent heel raises 
significantly mitigated the rise in peripheral and cBP due to seated time, but an increase was 
observed in both conditions. 







Risk factor control in chronic diseases including stroke is poor (Ellis & Breland, 2014) and, 
although life expectancy continues to increase, a greater proportion of this lifespan is now 
spent in ill health (Newton et al., 2015). Treating elevated blood pressure (BP) may be the 
most important intervention when preventing second stroke (Kernan et al., 2014), but low 
adherence to anti-hypertensive therapy is one of the major contributors to low rates of blood 
pressure control (Peck, 2018). As such, implementing lifestyle interventions takes on a key 
role in improving vascular health after stroke and reducing secondary stroke risk. 
Hypertension is a potential risk factor for post-stroke cognitive impairment (Sun, Tan & Yu, 
2014), with arterial stiffness also linked to cognitive impairment in hypertensive individuals 
(Muela et al., 2017). The link between hypertension and cognitive impairment can be 
explained by a combination of impaired enthothelial function, reduced beta-amyloid 
clearance, excessive blood pressure dipping or non-dipping during sleep, white matter 
disease, abnormal insulin signalling in the brain and pharmacological factors (Gorelick et al., 
2012). However, improved cognition has been reported in centenarians with elevated blood 
pressure, (Richmond et al., 2011; Duarte et al., 2017), possibly due to increased maintenance 
of cerebral perfusion (Lima, 2018). Increased PP is a risk factor of white matter lesions and 
transient self-limited haemorrhage, both of which are related to cognitive decline (Mitchell, 
2008; Wei et al., 2018). 
Sedentary behaviour is characterised by an energy expenditure of ≤ 1.5 METs while in a seated 
or reclining posture (Barnes et al., 2012) and is frequently linked to low levels of physical 
activity, defined as “any bodily movement produced by skeletal muscles that results in energy 
expenditure” (Caspersen, Powell & Christenson, 1985 p.126). Increased incidence of 
sedentary time (involving prolonged sitting) and decreased levels of physical activity both 
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adversely affect BP (Larsen et al., 2014). Long periods of seated time are detrimental to 
health, even if adults meet the government recommended physical activity guidelines (Biswas 
et al., 2015). Little is known about the independent detrimental health effects of sitting 
(Stamatakis et al., 2019) and even less is known about sedentary behaviour and stroke, 
particularly sitting, although it is reported to slow recovery (Butler & Evenson, 2014). 
Nonetheless, low levels of physical activity are common after stroke (Field et al., 2013; 
Saunders et al., 2016) with individuals suffering from stroke likely to accrue half the daily step 
counts of their healthy counterparts (English et al., 2014) with significantly more seated time 
each day (English et al., 2015). This may be due to sedentary behaviours being perceived as 
normal or an important way of relaxing after a stroke (Ezeugwu et al., 2016). The prevalence 
of this issue has reached the extent that association guidelines for stroke survivors now 
include reducing sedentary behaviours (Billinger et al., 2014). After a stroke has taken place, 
focusing on the reduction of sedentary time is now a promising intervention target (Morton 
et al., 2018) as in-patient gains may be lost if sedentary behaviours are not addressed after 
hospital discharge (Ezeugwu et al., 2016). English and colleagues (2018) have reported SBP 
decreases of 3.5 mmHg while doing light intensity exercises whilst standing versus sitting for 
eight hours uninterrupted in stroke survivors – suggesting that relatively small movements 
may lead to noticeable changes in BP over an extended time period of seated time. However, 
stroke frequently causes impairments in sit-to-stand movements (Janssen et al., 2010). As 
such, investigating movements which may lead to similar improvements in BP for those 
unable to frequently transition from sit-to-stand is of importance. 
Sedentary individuals tend to present with elevated BP (Weisser, Hacke & Wegner, 2014). 
However, cBP may be more relevant to organ damage (Booysen et al., 2013; Zeigler et al., 
2018), cardiovascular risk and mortality (Roman et al., 2007; Ott et al., 2017). Although 
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previously an invasive procedure, the assessment of central pressures can now be completed 
using non-invasive methods (Agabiti-Rosei et al., 2007) through pulse wave analysis (PWA) 
which also allows for measures of AIx. Pulse wave velocity (PWV) is the gold standard for 
measuring arterial stiffness due to its simplicity, accuracy and predictive value (Laurent et al., 
2006; Diaz et al., 2017). Both of these measures can be ascertained using the SphygmoCor 
XCEL which has been demonstrated to be reliable in healthy young and older adults and acute 
stroke populations (Young et al., 2015; Mitchelmore et al., 2018 [see chapter three of this 
thesis]; Mitchelmore et al., 2018 {see chapter four of this thesis}). 
One possible intervention to reduce damaging increases to PWA and PWV caused by 
extended and uninterrupted sedentary time is the incorporation of low intensity movements 
such as intermittent heel raises. This movement is viable for all stroke survivors with the 
ability to plantarflex; a greater proportion than may be able to complete more intensive 
physical activity or exercise programmes. It has been previously reported that sedentary 
behaviours are linked to lower executive function (Steinberg et al., 2015) and lower cognitive 
performance (Falck, Davis & Liu-Ambrose, 2017). However, the acute impact of heel raises on 
vascular measures (PWA, PWV) and whether this translates into improved executive function 
has not been investigated. Lower limb physical activity may stimulate increased blood delivery 
to the periphery to provide oxygenated blood for ATP production at the muscle. 
Hypothetically, a consequential increase in the circulation of oxygenated blood to the brain 
may translate into improved executive function.  
This study will investigate the consequences of uninterrupted sitting time on measures of 
PWA, PWV and cognitive performance compared to a heel raise protocol to break up an 
identical period of sedentary time in chronic stroke patients. This study hypothesised that 
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completing a set of heel raises every ten minutes over a three-hour period would have a 
significant effect on peripheral and central BP, measures of arterial stiffness, and improve 
executive function at the end of the sedentary time. Conversely, our null hypothesis predicted 
that heel raises would have no significant effect on peripheral and central BP, arterial 





Fifteen chronic stroke patients (m=10, age: 69.3y ± 10.8y, 170.6cm ± 8.6cm, 75.5kg ± 9.7kg) 
were recruited to the study through stroke support groups. Participant demographics can be 
seen in Table 5.1. The University of Winchester Ethics Committee provided ethical approval 
(BLS/17/11). An information sheet (Appendix 3b) summarising the purpose of this study was 
provided to participants who provided informed consent (Appendix 3c) prior to the study 
commencing. Participants were eligible for this study if they were > 3 months and < 10 years 
after their stroke and able to walk independently (including use of a walking aid) with the 








Table 5.1: Participant demographics 
   n % 
Participants   15  
Age (y)   69.3  
Sex  Male 10 67 
  Female 5 33 
Descent  European 15 100 
Stroke type  Ischaemia 11 73 
  Haemorrhage 4 27 
Side affected  Left 6 40 
  Right 9 60 
Family history of 
CVD 
 Myocardial infarction 6 40 
  Heart surgery 5 33 
  Stent 3 20 
  Catheter 1 7 
  Heart defect 2 13 
  Stroke 3 20 
Personal history of 
CVD 
 Hypertension 8 53 
  High cholesterol 5 33 
  Diabetes 1 7 
  Coronary artery 
disease/heart failure 
7 47 
Comorbidities  Thyroid disease 0 0 
  Lung disease 0 0 
  Asthma 2 13 
  Cancer 1 7 
  Kidney disease 0 0 
  Hepatitis 1 7 
Lifestyle factors  Current smoker 0 0 
  Previous smoker 6 40 
  Current alcohol drinkers 14 93 
  Current weight loss plan 0 0 
Everyday activity  Sedentary 0 0 
  Lightly active 10 67 
  Moderately active 5 33 
  Vigorously active 0 0 
Medication  Statins 8 53 
  Anti-thrombotic 7 47 
  Calcium blockers 3 20 
  Alpha blockers 0 0 
  Beta blockers 2 13 
  ACE-I 3 20 
  ARB 2 13 
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5.3.2 Experimental design 
This was a randomised crossover trial involving three visits to the physiology laboratory at the 
University of Winchester. As in studies one and two, participants were fasted for 12 hours 
before each session and had abstained from caffeine and physical activity for 24 hours before 
each session. Participants first completed a familiarisation session involving baseline PWA and 
PWV measures to reduce any risk of a white coat response to having these measures assessed. 
These measures were taken on the symptomatic side of the body. At each time point, two 
measures of PWA were taken. If SBP was greater than 5 mmHg different and AIx was more 
than 4% different between the two readings, a third measure was recorded, and an average 
calculated of the closest two measures.  
Participants also completed five Stroop tasks to remove the risks of a learning effect from the 
second and third (sedentary and heel raise) visits. Previous literature has demonstrated a 
learning effect in Stroop tasks (Figure 5.1) in both mean response time and response error. 












Figure 5.1: Improvements in mean response time in older and younger adults across six practice blocks, 
each comprising of 128 questions. Interference represents colour-word interference (described as 
incongruent trials in this thesis), From Davidson, Zacks and Williams, 2003 
 
A computer-based randomiser then allocated participants to a sedentary (CON) or heel raise 
condition (HRC) first. After arrival, 15 minutes of seated time allowed BP to plateau before a 
three-hour timeframe began. The protocol is outlined as a schematic in Figure 5.2. Heel raises 
were undertaken at 60b·min-1. This was controlled using a metronome. Stroop tasks consisted 
of 48 questions on a laptop using a pre-created programme. One half of these questions were 
congruent (e.g. ‘Blue’ written in blue text [Figure 5.3]) and the other half were incongruent 
(e.g. ‘Blue’ written in yellow text). The order of these questions was randomised to ensure no 
learnable patterns in answer order. Correct score (out of 48), mean congruent response time, 






Abbrevs: CON – Control condition, HR – Heel raise, HRC – Heel raise condition, PWA – Pulse 
wave analysis, PWV – Pulse wave velocity 












Figure 5.3: Example of Stroop protocol question 
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CON: Sedentary time 





Analysis of variance for repeated measures with two within-participant factors (condition and 
time-point) was used to assess differences in peripheral and central haemodynamic 
parameters, PWV and cognitive performance between the first seated time-point (ten 
minutes) and final seated time-point (three hours). Effect sizes were calculated using partial 
eta squared ( 2pη ) with 0.01, 0.06 and 0.14 representing small, medium and large effects 
(Cohen, 1969). Statistical Package for Social Sciences v.22 (SPSS, Inc. Chicago, Illinois, USA) 




5.4.1 Central and peripheral blood pressures, arterial stiffness 
The effect of intermittent heel raises on PWA and PWV over a three-hour time-course can be 
seen in Table 5.2. Significant condition by time interaction effects were reported for SBP (F (1, 
14) = 6.5, p = .02, 2pη  = 0.32). This involved an increase of 10.7 mmHg between 10 minutes and 
three hours in CON, versus increases of 5.2mm Hg over the time-course in the HRC. Similar 
findings were observed for cSBP (F (1, 14) = 5.4, p = 0.04, 2pη = 0.28) with an increase of 9.6 
mmHg reported in CON vs. increases of 5.6 mmHg in HRC over the three hours of seated time. 
Whether or not participants completed heel raises, time had a significant main effect on 
peripheral and cSBP were observed (p < 0.01), but the interaction effects reported 
demonstrate that heel raises significantly mitigated this increase.  
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No significant interaction effects were observed for AIx or AIx75 (p = 0.18 – 0.79, 2pη  = 0.18 – 
0.35) but large effect sizes were noted with decreases in AIx of 1.2% reported in CON vs. 
decreases of 3.4% in HRC. Heel raises had no significant effect on PWV, although a large 
significant interaction effect was observed in heart rate (F (1, 11) = 7.5, p = 0.02, 2pη = 0.41). 
Decreases of 0.8 b·min-1 were observed in the CON over three hours versus decreases of 5.3 
b·min-1 after HRC. Significant interaction effects were observed for double product (DP) – the 
product of SBP and HR (F (1, 11) = 13.7, p < 0.01, 2pη  = 0.55), with an increase of 554.9 mmHg x 
b·min-1 between ten- and 180- minute time points in CON compared to a decrease of 162 












Table 5.2: Mean (SD) central and peripheral blood pressures and arterial stiffness values pre- 
and post- control and heel raise conditions 
   
Sedentary Vis 
 






Time    
10 Min 180 min 
 







MAP (mmHg) X 92 99  89 95  0.43 0.06  0.99 <.01  0.01 0.49   
SD 15 14  12 11          
SBP (mmHg) X 130 141  131 136  0.02 0.32  0.48 0.04  0.02 0.31   
SD 20 23  23 21          
DBP (mmHg) X 75 79  76 79  0.39 0.05  0.93 <.01  0.05 0.26   
SD 13 12  13 9          
cSBP (mmHg) X 121 131  122 127  0.04 0.28  0.57 0.02  0.02 0.32   
SD 18 21  21 20          
cDBP (mmHg) X 76 81  77 80  0.29 0.08  0.88 0.02  0.06 0.23   
SD 13 12  13 9          
cPP (mmHg) X 45 50  45 48  0.21 0.11  0.47 0.04  0.14 0.15   
SD 14 19  13 16          
AP (mmHg) X 17 19  17 18  0.33 0.07  0.47 0.04  0.55 0.03   
SD 9 11  8 10          
AIx (%) X 37 35  38 35  0.35 0.06  0.79 0.01  0.24 0.1   
SD 15 14  15 13          
AIx@75 (%) X 28 27  31 25  0.18 0.13  0.64 0.02  0.04 0.27   
SD 16 15  17 15 
         
HR (b·min-1) X 58 57  59 54  0.02 0.41  0.74 0.1  0.11 0.22 
  SD 7 10  7 8          
PTT (ms) * X 44 37  41 40  0.33 0.19  0.65 0.05  0.21 0.29 
  SD 15 9  6 5          
PWV (m·s-1) * X 11 13  12 12  0.34 0.18  0.94 <0.01  0.19 0.32 
  SD 3 3  2 2          
DP X 7096 7651  7398 7236  <.01 0.55  0.79 .01  0.38 .07 
  SD 1185 1544  1146 1663          
 
*Measures of PWV/PTT reported for seven full data sets due to lack of clean pulse waves on 
affected side of stroke patients 
Abbrevs: AIx – Augmentation index, AIx75 – Augmentation index @ 75 b·min-1, AP – 
Augmented pressure, cDBP – Central diastolic blood pressure, cPP – Central pulse pressure, 
cSBP – Central systolic blood pressure, DBP – Diastolic blood pressure, DP – Double product 
(HR*SBP), HR – Heart rate, MAP – Mean arterial pressure, PTT – Pulse transit time, PWV – 




5.4.2 Cognitive performance 
Table 5.3 displays data representing cognitive performance in the 48-question Stroop tests. 
No significant interaction effects were observed (p > 0.05) with improvements in all 
parameters observed between ten minutes and three hours in both conditions.  




Heel raises at ten-minute intervals throughout a three-hour period of sedentary time 
significantly mitigated the increases in blood pressure that were observed in both conditions 
and are therefore of sufficient intensity to act as a form of physical activity and reduce the 
damage caused by extended sedentary time. These improvements in peripheral and central 
haemodynamics did not translate to improved executive function at the end of the three-
hour time course. 
 












   
X 
 
10 Min 180 min 
 










Mean Correct X 47  46.9 47.2  46.8 47.2  .58 .03  .7 .01  .21 .13 
  
SD 1.9  2 1.5  2.4 1.7          
Mean Congruent (ms) X 1623  1840 1641  1512 1499  .46 .05  .03 .34  .21 .13 
  
SD 682  931 611  542 600          
Mean Incongruent (ms) X 1975  2296 1949  1911 1743  .38 .06  .03 .34  .12 .19 
  
SD 1060  1523 935  962 691          
Mean Response (ms) X 1880  2173 1871  1801 1676  .40 .06  .02 .36  .12 .19 
  
SD 936  1349 826  800 659          
Total Time (s) X 100.5  114.6 99.8  96.1 91.3  .36 .07  .04 .31  .15 .17 
  
SD 46  67.8 40  37.7 32.1          
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5.5.1 Central and peripheral blood pressures, arterial stiffness 
This study suggests that intermittent heel raises may significantly mitigate the damaging 
effects of sedentary time on BP through a three-hour time course. The focus on reducing 
sedentary time after stroke is now a promising intervention target (Morton et al., 2018) with 
reducing sedentary behaviours a goal in association guidelines post-stroke (Billinger et al., 
2014). This study supports these suggestions, as even with the incorporation of heel raises, 
SBP increased by an average of 5.2 mmHg (4%) over three hours and central by an average of 
5.6 mmHg (4.6%); both demonstrating significant main effects of time (p = 0.02). Without the 
incorporation of heel raises, peripheral and central BP increased by 10.7 mmHg (8.2%) and 
9.6 mmHg respectively (7.9%).  Nevertheless, large significant condition by time interaction 
effects were reported for the use of heel raises, suggesting that these simple movements 
significantly alleviate the increase in BP seen during extended sedentary time. Brooks and 
colleagues (2004) note that substantial fidgeting may contribute to physical activity level but 
may not produce the health benefits of sustained and vigorous exercise, but this study 
demonstrates that heel raises may be of a vigorous enough intensity to cause acute benefits 
in central haemodynamics. Double product is the product of SBP and HR and is a well-
established measure expressing the load on the heart (Domka-Jopek et al., 2018).  
It has been previously reported that healthy individuals are significantly less sedentary than 
stroke survivors (English et al., 2015). Supplementary Figure 3e depicts a common pattern of 
sedentary behaviour across a twelve-hour period including a gym or rehabilitation visit for a 
stroke survivor based on estimates that stroke patients are sedentary for around 20.4h per 
day versus 17.4h in a healthy population (Paul et al., 2016). Sedentary behaviours are 
associated with poor health, regardless of the level of outside physical activity (Martin et al., 
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2015), with prolonged sitting particularly bad for health (Dunstan et al., 2012). As such, even 
individuals attending rehabilitation sessions but being sedentary for the rest of the day (for 
example, the pattern created in Supplementary Figure 3e) may still be demonstrating 
increases in peripheral and cBP whilst sedentary before and after rehabilitation sessions. 
Movements such as heel raises may therefore be relevant to all stroke survivors, whether or 
not they are actively pursuing rehabilitation programmes throughout the chronic recovery 
process. Previous work has reported that double product (DP) may be more associated with 
mortality than SBP or HR alone (Inoue et al., 2012) but other studies have suggested SBP as a 
stronger predictor of CV events and stroke (Schutte et al., 2013). This study reports that 
intermittent heel raises over the course of a three-hour bout of sedentary time may 
significantly improve DP in chronic stroke patients. 
When considering arterial wave reflection, no significant interaction effects were observed. 
Despite this, there were encouraging trends in the data in favour of HRC, as supported by the 
moderate-large effect sizes observed in this study (η2p = 0.06 – 0.13). This is supported by 
descriptive statistics which demonstrate that AIx decreased by an average of 1.2% in the CON 
vs. 3.4% in the HRC, and AIx75 decreased by 1.8% in CON compared to 5.8% in HRC. A previous 
meta-analysis (Pierce, Doma & Leicht, 2018) has reported overall AIx decreases of 4.54% after 
aerobic exercise (18 studies, n = 396) and increases of 1.63% after resistance exercise (five 
studies, n = 83). As such, these results suggest that similar benefits in AIx can be accrued 
through heel raises than through aerobic exercise in a population who are largely unable to 
undertake more intense exercise. The similarities in our results with the findings of the 
aerobic studies examined by Pierce and colleagues may be due to lower intensities of exercise 
relying on lipid metabolism and, therefore, aerobic pathways of energy production. As such, 
intermittent heel raises may influence arterial stiffness, with the stimulation of the lower 
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limbs leading to increases in arterial compliance, potentially due to the significant decreases 
in HR observed in HRC. Future work should address whether upper body movements may 
accrue similar benefits in BP control. 
 
5.5.2 Cognitive performance 
No significant interaction effects were observed in this study, suggesting that intermittent 
heel raises had no significant effect on cognitive performance involving a 48 question Stroop 
protocol. Longer term exercise may improve executive functions (Predovan et al., 2012) but 
a single bout of aerobic exercise has been reported to have no effect on executive function in 
Stroop performance (Vincent & Hall, 2017); work our findings would corroborate.  
Condition had a significant main effect on mean congruent response time, mean incongruent 
response time and mean overall response time (p = 0.02 – 0.03), with these variables 
significantly improved in the HRC. Due to the fact that the ten-minute Stroop task was 
completed before the first set of heel-raises, this condition main effect demonstrates that 
results were improved as a whole in the heel-raise visit, not because of the heel-raises 
themselves. The order of conditions in this study was randomised, so the reasons for this are 
unclear. As a whole, results are inconclusive from this study and further research is needed 
to investigate whether improvements in cognitive function result from the benefits in arterial 
health observed due to interrupting sedentary time with heel raises. 
5.5.3 Strengths and limitations 
It is important for strengths and limitations to be identified to allow contextualisation of any 
conclusions drawn from a research study. One limitation of this work was the duration of 
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sedentary time undertaken by participants. Previous work in the area has observed eight 
hours of sedentary time (English et al., 2018), whereas this study only incorporated a three-
hour protocol. Whilst this allowed us to observe how quickly increases in SBP and cSBP can 
take place, this restricted us in terms of observing the longer effects of seated time. 
A second limitation was the wide range of cognitive abilities recruited as demonstrated by the 
wide range of standard deviations in the reported Stroop data. This study did not control for 
cognitive ability, which is a consideration with a sample size of 15. There may also have been 
a learning effect in place even during the Stroop protocols even with the incorporation of the 
initial familiarisation session and the randomisation of the condition order. Nevertheless, the 
chronological improvements in performance across both conditions suggest a learning effect 
may have been present. The mean age for first stroke has dropped to 68.2y in males and 73y 
in females (Public Health England, 2018b) and the mean age recruited to this study was 69.3y; 
demonstrating a close match with the ‘average’ sufferer of a first stroke. This study was also 
highly controlled. Timings were exact, all sessions took place in the same laboratory at the 
same time of day. The speed at which heel raises were undertaken was also standardised due 
to the use of a metronome and all data was collected by one researcher, removing the risk of 
inter-researcher bias.  
 
5.6 Conclusion 
There is an epidemic of sedentary time after stroke leading to increases in BP, particularly 
during extended seated time. This study demonstrates that three hours of seated time is 
enough to cause large increases in peripheral and cBP and that intermittent heel raises have 
the potential to alleviate some of this damage by significantly reducing this rise in arterial 
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stiffness. Even stroke patients attending daily rehabilitation sessions should incorporate low 
intensity activities such as heel raises to improve vascular health during spells of sedentary 



























Chapter 6: Study four - The effects of a ten-week heel raise programme on central 






























Background: Excessive sedentary time after stroke is extremely common and a risk factor for 
poor health outcomes in the long run. As such, identifying simple movements to interrupt 
bouts of extended sedentary time may be beneficial to vascular health and cognitive function. 
Methods: This pilot study recruited eight chronic stroke patients (age 72y ±11.6y; 167.1cm 
±6.8cm; 75.2kg ±9.4kg) into a randomised, crossover trial involving a ten-week control period 
and a ten-week heel raise intervention involving 180 heel raises over the course of three hours 
of sedentary time, six days per week. Results: No significant improvements were observed in 
measures of body composition (body mass, waist and hip circumferences, calf circumferences 
[p > 0.05]). The heel raise protocol also had no significant effect on peripheral or central 
haemodyamics (assessed using the SphygmoCor XCEL). Significantly greater improvements in 
cognitive performance (repeated Stroop tasks) were observed in the control condition, but 
this may have been due to worse initial performances in the pre- control condition vs. the 
pre- intervention condition. Conclusion: Previous work has suggested that intermittent heel 
raises may lead to acute improvements in the parameters investigated in this study. However, 
this work suggests that these acute improvements may not translate into persisting gains in 










With the burden of disease caused by stroke expected to double by 2030, there is good 
evidence to support interventions in stroke rehabilitation (NICE, 2018) to counter risk factors 
of primary and recurrent stroke. Controlling peripheral and central BP after stroke has the 
potential to be the mainstay of secondary prevention. The SphygmoCor XCEL has been shown 
to be reliable in both healthy (Young et al., 2015; Mitchelmore et al., 2018a [see chapter 
three]) and acute stroke (Mitchelmore et al, 2018b [see chapter four]) populations when 
measuring peripheral and central haemodynamics with excellent reliability being defined as 
an ICC > 0.75. As well as SBP and cSBP, the SphygmoCor XCEL provides cPP. This variable has 
also been associated with poor cognition and low memory scores (Hanon et al., 2005; Scuteri 
et al., 2005; Mitchell et al., 2011). Poor cognition has been linked to depressive symptoms 
and decreased quality of life after stroke (Nys et al., 2006), which in turn have been associated 
with increased mortality 12- and 24- months post- stroke (House et al., 2001) 
Behaviourally modifiable risk factors such as physical inactivity, overweight and obesity, 
cigarette smoking, alcohol consumption and diet can be targeted through lifestyle changes. 
One aspect of lifestyle which is relatively easy to target post-stroke is the application of 
interventions that may decrease sedentary time. Around 70% of stroke survivors suffer from 
lower limb weakness (Lawrence et al., 2001) and, due to poor balance, more than 50% of 
survivors have falls within a year of their stroke (Weerdesteyn et al., 2008). Functional balance 
is the capacity to maintain various positions, to make automatic postural responses to 
voluntary changes in the body and its segments to react to external disturbances (Berg et al., 
1989, p. 304). As this functional balance is impaired by stroke, low levels of physical activity 
and high levels of sedentary time are common after stroke (Saunders et al., 2016). Stroke 
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survivors typically spend 11 hours per day in a seated position (75% of waking hours), many 
during prolonged bouts of sitting (English et al., 2016). Sedentary time after stroke is seen as 
‘normal’ and may be perceived by stroke survivors as a relaxing part of the recovery process 
(Ezeugwu, Garga & Manns, 2017). This may manifest as prolonged time watching the 
television, which has been linked with increased blood pressure (Beijer et al., 2018) with a 
significant increase in biomarkers of diabetes risk observed for every five hours of extra 
television viewing each week (Hansen et al., 2012). However, prolonged bouts of sedentary 
time are particularly harmful (Healy et al., 2008; Healy et al., 2011) and may lead to increase 
hospitalisations, increased dependence on medications and a subsequent greater reliance on 
the health service. 
Cognitive deficits after stroke are common, with concentration (Rasquin et al., 2002), mental 
speed (Winkens et al., 2006), executive functioning (Poulin et al., 2012) and memory 
impairment (Novitzke, 2008). Sedentary behaviour has itself been linked with mild cognitive 
impairment (Falck, Davis & Liu-Ambrose, 2017); thus, interventions to counter sedentary 
behaviours should be put in place. If not, the physiological and cognitive improvements that 
may be observed during in-patient stays may be lost in the months and years that follow 
hospital discharge (Ezeugwu et al, 2017). Physical activity is now the cornerstone of risk 
reduction therapy for the prevention and treatment of stroke (Gordon et al., 2004). 
Movement patterns such as heel raises may reduce the physical damage caused by extended 
sedentary time.  
Chapter five of this thesis demonstrated that intermittent heel raises (every ten minutes over 
a three-hour time course) significantly mitigated the rises in peripheral and central BP that 
were observed during extended sedentary time. These benefits may have been due to 
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improved circulation (arterial delivery and venous return) and reducing pooling in the lower 
extremities.  
Heel raises have been demonstrated to elicit physiological changes over the course of a 
prescribed programme in elderly populations. Daily bouts of 100 heel raises over 40 days 
(Fujiwara et al., 2010), six weeks (Lee et al., 2017), and two months (Fujiwara et al., 2011) 
have been reported to show significant improvement in plantarflexor strength, balance, gait 
speed, improvements in ankle movement and decreases in postural fluctuation. The effect of 
resistance-free heel raises on physiological measures such as peripheral and central BP and 
arterial stiffness has not, to our knowledge, been investigated, despite each of these 
measures being indicative of cerebrovascular risk both before and after stroke.  
This pilot study will investigate whether a daily, ten-week, heel raise intervention affects 
peripheral and central haemodynamics and cognitive performance. Based on the findings of 
chapter five of this thesis, we hypothesised that a daily, ten-week heel raise protocol would 
have a significant effect on peripheral and central BP, arterial stiffness, and executive 
functioning in individuals living with stroke. As such, our null hypothesis was that a ten-week 
heel raise programme would have no significant effect on peripheral and central BP, arterial 











Eight participants (age 72y ±11.6y; 167.1cm ±6.8cm; 75.2kg ±9.4kg) were recruited from 
community-based stroke support groups. The information sheet and consent form for this 

















Table 6.1: Participant demographics 
   n % 
Participants   8  
Age (y)   72  
Sex  Male 5 62.5 
  Female 3 37.5 
Descent  European 8 100 
Stroke type  Ischaemia 4 50 
  Haemorrhage 4 50 
Side affected  Left 2 25 
  Right 6 75 
Family history of 
CVD 
 Myocardial infarction 5 62.5 
  Heart surgery 2 25 
  Stent 2 25 
  Catheter 0 0 
  Heart defect 0 0 
  Stroke 4 50 
Personal history of 
CVD 
 Hypertension 5 62.5 
  High cholesterol 3 37.5 
  Diabetes 0 0 
  Coronary artery 
disease/heart failure 
3 37.5 
  Atrial fibrillation 5 62.5 
Comorbidities  Thyroid disease 0 0 
  Lung disease 0 0 
  Asthma 1 12.5 
  Cancer 1 12.5 
  Kidney disease 0 0 
  Hepatitis 1 12.5 
Lifestyle factors  Current smoker 0 0 
  Previous smoker 2 25 
  Current alcohol drinkers 7 87.5 
  Current weight loss plan 1 12.5 
Everyday activity  Sedentary 0 0 
  Lightly active 3 37.5 
  Moderately active 5 62.5 
  Vigorously active 0 0 
Medication  Statins 4 50 
  Anti-thrombotic 4 50 
  Calcium blockers 2 25 
  Alpha blockers 0 0 
  Beta blockers 2 25 
  ACE-I 1 12.5 
  ARB 2 25 
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The inclusion and exclusion criteria were as follow: 
Inclusion criteria 
o Over the age of 50 years 
o Diagnosed with stroke by a stroke consultant from a UK National Health Service 
Foundation Trust three months to five years before study start date 
o Patients who were cognitively aware and able to provide informed consent 
o Patients who were currently medically stable 
o Patients who were able to complete the full range of motion in plantarflexion when 
seated (heel raise) 
Exclusion criteria 
o Unresolved deep vein thrombosis 
o Dementia or an inability to provide informed consent 
o Type I or II diabetes or unstable glycaemic control 
 
6.3.2 Experimental design 
Participants were fasted for twelve hours before each visit and had not undertaken strenuous 
exercise for 24 hours before their visits. All visits occurred between 07:30 and 09:30 in the 
physiology lab at the University of Winchester. Participants completed an initial 
familiarisation visit to the physiology laboratory where they undertook Stroop tasks and 
PWA/PWV measures to reduce the likelihood of a white-coat response to blood pressure 
measures and to reduce the learning effect of Stroop protocols (outlined in chapter five). After 
this familiarisation session, they were randomised into a control-first or intervention-first 
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condition. During each subsequent visit, two supine measures of PWA and PWV were taken 
using the SphygmoCor XCEL (AtCor, Sydney). If cSBP was > 5 mmHg different and AIx was > 
4% different between the two measures, a third was taken (as per manufacturer guidelines 
outlined in previous chapters). Five Stroop tests were administered during each visit. Stroop 
protocols are a test of selective attention and interference susceptibility (Rasquin et al., 2004) 
and have been used widely to assess executive function and overall cognitive function after 
stroke (Pohjasvaara et al., 2002; Rand et al., 2010; Park et al., 2011). This Stroop protocol was 
as used in chapter five of this thesis (48 questions on a pre-programmed computer 
programme; 24 congruent and 24 incongruent questions). Measures of body mass, affected 
calf circumference and unaffected calf circumference were also noted. 
In the control condition, participants continued their usual care for ten weeks before a follow-
up session was conducted. In the heel raise intervention, participants completed a total of 
180 heel raises each day. This volume had been demonstrated in chapter five of this thesis to 
have a significant acute effect on measures of peripheral and central BP. These heel raises 
were completed on six days per week (one day of rest to avoid dropout due to fatigue) for 
ten weeks. Participants completed these in sets of ten at ten-minute intervals over the course 
of three hours of seated time. Tick sheets were provided to allow participants to self-monitor, 
and participants were contacted at the half way point to ensure adherence. After one 
condition was completed, a two-week wash-out period took place before the second 
condition commenced. Washout periods are used in crossover studies to avoid carryover 
effects from one condition to the other (Spieth et al., 2016). One-week washout periods have 
been used in previous exercise-based crossover trials (Page et al., 2008; Lamina, 2010; Zeigler 
et al., 2018b) so two weeks was deemed sufficient for this study. 
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Ethical approval was provided by the University of Winchester Ethics Committee (BLS/17/11) 
and the study was registered with the clinicaltrials.gov system (NCT03423433). Informed 
consent was provided by all participants and the right to withdraw was always maintained.  
 
6.3.3 Statistics 
Descriptive statistics (Mean, SD) were calculated before a repeated measures analysis of 
variance with between- (Condition; heel raise intervention, control) and within- (Time; 
baseline, follow-up) subjects factors was used to identify whether a heel raise programme 
had a significant effect on all outcome measures. Statistical significance was be set at P < 0.05 
using Statistical Package for Social Sciences v.22 (SPSS, Inc., Chicago, Illinois, USA). Effect sizes 
were calculated using partial eta squared ( 2
pη ) with 0.01, 0.06 and 0.14 representing small, 




6.4.1 Peripheral and central blood pressure, arterial stiffness 
Statistical analysis for PWA and PWV is displayed in Table 6.2. No significant interaction 
effects were observed for any peripheral or central BP variables. Significant main effects by 
condition were observed for DBP, cDBP, AIx and AIx75. Baseline peripheral and central SBP in 
the control condition (mean 138.8 mmHg [±12.2] and 129.8 [±11.6] mmHg respectively) were 
noticeably different to the heel raise condition (mean 131.8 mmHg [±12.1] and 122.1 [±12.7] 
mmHg respectively), a demonstrable difference between the two conditions despite the 
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randomised crossover design. Despite the randomising of condition order, this may imply that 
the two-week washout was insufficient to nullify any effects of the heel raise programme 
which did occur. No significant main effects for any variable were observed for time. 
Additional pulse wave measures can be seen in the Supplementary Table (Appendix 4d). 
Table 6.2: Mean (SD) central and peripheral blood pressures and arterial stiffness values pre- 
and post- control and heel raise intervention conditions  
   Total  Control  Intervention  Interaction  Condition  Time 
   X  Pre- Post-  Pre- Post-  P η2p  P η2p  P η2p 
MAP (mmHg) X 94.2  95.9 98.3  91.1 91.3  .12 .41  .12 .42  .46 .12 
  SD 9.4  7.1 7.2  10.1 12.1          
SBP (mmHg) X 135.8  138.8 139.9  131.8 132.9  .99 <.01  .13 .30  .51 .07 
  SD 11.8  12.2 10.2  12.1 12.8          
DBP (mmHg) X 75.4  77.1 78.9  73.4 72.3  .23 .20  .03 .50  .84 .01 
  SD 9.1  8.7 8  8.4 11.2          
cSBP (mmHg) X 126.3  129.8 130.4  122.1 122.9  .93 <.01  .08 .39  .65 .03 
  SD 11.9  11.6 10.9  12.7 12.1          
cDBP (mmHg) X 76.5  78.3 80.2  74.3 73.2  .27 .17  .04 .49  .76 .01 
  SD 9.1  8.6 7.1  8.9 11.3          
cPP (mmHg) X 49.8  51.6 50.2  47.8 49.7  .37 .12  .41 .01  .84 .01 
  SD 11.1  14.7 11.2  10.1 9.9          
AP (mmHg) X 18.7  21.5 20.5  15.3 17.3  .12 .31  <.01 .74  .65 .03 
  SD 7.4  8.1 7.8  7.4 5.6          
AIx (%) X 37  41.3 39.9  31.6 35.3  .26 .18  <.01 .76  .50 .07 
  SD 9.7  8.2 9.6  9.5 10.1          
AIx@75 (%) X 29.6  33.5 32.9  25.1 26.7  .69 .03  .01 .66  .76 .14 
  SD 10.8  9.4 10.5  10.1 12.4          
HR (b·min-1) X 59.7  57.9 60.4  61.6 58.4  .30 .21  .98 <.01  .30 .21 
  SD 6.1  4.8 5.9  7.9 5.7          
PTT (ms)* X 46.1  47.5 41.1  44.8 52.5  .03 .94  .01 .98  .81 .04 
  SD 7.7  5.8 7.2  6.5 8.4          
PWV (m/s)* X 10.1  9.5 11.7  9.9 9.2  .33 .44  .41 .36  .07 .87 
  SD 2  1.4 2.9  1.4 1.7          
*Measures of PWV/PTT reported for three full data sets due to lack of clean pulse waves on 
affected side of stroke patients 
Abbrevs: AIx - Augmentation index, AIx75 - Augmentation index @ 75 b·min-1, AP – 
Augmented pressure, cDBP – Central diastolic blood pressure, cPP – Central pulse pressure, 
cSBP – Central systolic blood pressure, DBP – Diastolic blood pressure, HR – Heart rate, MAP 





6.4.2 Body mass and circumferences 
There were no significant interactions or main effects were observed for the heel raise 
programme vs control condition (p > 0.05; Table 6.3). Large non-significant interaction effects 
were reported for body mass (-0.7kg in heel raise programme vs +0.4kg in control) and 
affected calf circumference (-0.3cm in heel raise programme vs +0.1cm in control [Table 6.3]).  
Table 6.3: Mean (SD) body composition variables pre- and post- control and heel raise 
intervention conditions 
   Total  Control  Intervention  Interaction  Condition  Time 
   X  Pre- Post-  Pre- Post-  P η2p  P η2p  P η2p 
Body Mass (kg) X 75.2  75.6 76.0  75.0 74.3  .15 .27  .17 .25  .49 .07 
  SD 9.4  9.8 10.3  9.9 9.2          
Affected Calf Circum (cm) X 34.6  34.4 34.5  34.9 34.6  .24 .19  .74 .02  .38 .11 
  SD 3.1  3.9 3.8  2.6 2.2          
Unaffected Calf Circum 
(cm) X 35.8  35.7 35.5  36.1 35.8  .72 .02  .61 .04  .51 .06 
  SD 3  4 3.2  2.6 2.3          
Waist Circum (cm) X 93  94.8 88.8  96 92.3  .76 .01  .52 .06  .26 .18 
  SD 17.1  13.6 24.9  15.9 14          
Hip Circum (cm) X 102.2  103.2 104.2  101.3 100.2  .43 .09  .16 .26  .97 0 
  SD 11.8  13.1 13  12.8 9.8          
 
 
6.4.3 Cognitive performance 
Table 6.4 presents Stroop data for this study. Significant interaction effects were observed for 
mean congruent response time (p = 0.01), overall mean response (p = 0.03) and total time (p 
= 0.02). Participants improved significantly more in the control condition than the heel raise 
condition, although improvements were made between first and second sessions for all 





Table 6.4: Mean (SD) Stroop responses pre- and post- control and heel raise intervention 
conditions 
  Total  Control  Intervention  Interaction  Condition  Time 
  X  Pre- Post-  Pre- Post-  P η2p  P η2p  P η2p 
Total Correct X 236.6  236 236.8  236.4 237.1  1 0  .7 .02  .2 .22 
 SD 5.5  5.6 4.3  5.7 7.3          
Mean Correct X 47.3  47.2 47.4  47.3 47.4  .99 0  .71 .02  .19 .23 
 SD 1.1  1.1 .9  1.2 1.5          
Mean Congruent (ms) X 1486.7  1795.3 1337.8  1502 1311.9  .01 .63  .08 .37  .15 .27 
 SD 717.9  1058.8 469.8  787.5 388.4          
Mean Incongruent (ms) X 1730.7  1995.6 1710.1  1641.6 1575.6  .05 .44  .02 .54  .15 .27 
 SD 835.9  1336.3 763.2  832.3 641.1          
Mean Response (ms) X 1661.1  1942.3 1615.4  1606.3 1480.5  .03 .53  .04 .49  .16 .26 
 SD 790.2  1101.8 684.7  820.5 505.4          
Total Time (s) X 89.7  102.7 87.5  86 82.5  .02 .55  .02 .57  .14 .29 





6.5.1 Peripheral and central blood pressures, arterial stiffness 
Despite a heel raise intervention significantly mitigating increases in peripheral and central 
BP acutely (See chapter five), long term exposure to these exercises in a ten-week heel raise 
protocol yielded no significant benefits. Peripheral SBP increased by 1.1 mmHg between pre- 
and post- visits in both conditions (interaction 2pη : < 0.01), whilst cSBP increased by 0.6 mmHg 
in the control condition vs 0.8 mmHg in the heel raise condition over the time-course. 
Increases in cPP were observed after the heel raise condition of 1.9 mmHg as opposed to a 
decrease of 1.4 mmHg in the control condition. Thus, in this group of chronic stroke patients, 
a ten-week heel raise programme to interrupt sedentary time caused no benefits in peripheral 
or central haemodynamics. Exercise programmes of a higher intensity in chronic stroke 
patients have been shown to lead to significant decreases in peripheral BP (Rimmer et al., 
2009; Wang et al., 2018) but high-intensity activities are physically not an option for all stroke 
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survivors. It appears that heel raises are not of sufficient intensity to accrue these benefits. 
Although the incorporation of heel raises for stroke patients may be acutely worthwhile due 
to the findings in chapter five, exercises of a greater intensity must be incorporated to cause 
more chronic benefits. It should be noted, however, that large within-subject differences can 
be observed between conditions. Mean differences of 7 mmHg in SBP, 7.8 mmHg in cSBP and 
10% in AIx between the pre- control and pre- intervention measures can be seen with 
condition main effects approaching significance for SBP and cSBP (p = 0.08 – 0.13; 2pη  = 0.30 
– 0.39). The reasons for this are unclear and, due to the small sample size of this pilot study, 
make strong conclusions difficult to draw. 
 
6.5.2 Body mass and circumferences 
This pilot study found no significant condition by time interaction effects for any body mass 
or body circumference measures. However, an increase of 0.4kg was observed in body mass 
after the control condition versus a decrease of 0.7kg after the experimental condition. 
Although this does not reach significance, a large effect size was reported of ( 2pη  = 0.27). This 
may have been due to differing levels of physical activity outside of the intervention. In future 
work investigating these parameters and lower intensity movements, an objective measure 
of physical activity would be advised.  
As there were no significant interaction effects were observed for affected and unaffected 
calf circumferences, this study suggests that improvements in key body composition 




6.5.3 Cognitive performance 
This study demonstrated significant interaction effects for mean congruent response times, 
mean response time and total time, with greater improvements made in the control condition 
than the intervention condition. It is worth noting, however, that mean incongruent, mean 
response and total time scores were significantly better in the intervention condition (across 
both visits) than the control condition (p < 0.05). This may imply that the pre- control figures 
were anomalously poor in the pre- control session compared to all other timepoints. Follow-
up studies with larger sample sizes to build on the findings of this pilot study will allow 
confirmation of whether reducing extended bouts of sedentary time over a longer time-
period leads to improvements in cognitive functioning.  
 
6.5.4 Strengths and limitations 
It is important for studies to acknowledge strengths and weaknesses to allow appropriate 
interpretation of results. This study was designed to be a pilot study leading into future work 
and, as such, offers a low sample size. The purpose of this pilot study was to demonstrate 
potential trends, but results should be taken with caution. Participants were, however, well 
age-matched to the average age of first stroke (average age of 72y in this study vs. average 
first stroke at 73y in females and 68y in males [Public Health England, 2018b]) As with any 
prescribed programme, confirming adherence can be problematic. Brown and Bussell (2011) 
report that up to half of all patients with chronic disease do not take their medication as 
prescribed. If patients are unable to adhere to prescribed medications, the likelihood of their 
keeping to programmes requiring more physical effort could be questioned. To counter this, 
self-monitoring sheets were provided to participants in this study to aid with tracking 
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progress. Participants were also contacted at the half-way stage (five weeks) to verbally 
confirm they were continuing the heel raises. 
The data collection sessions in this study had high control. Participants attended in a narrow 
time-window (07:30 – 09:30) and were explicitly asked to attend in a fasted state after 
drinking only water and having prescribed medications before attending. Participants had also 
abstained from any exercise for 24 hours before their sessions.  
 
6.5.5 Study processes 
A pilot study focuses on the processes of a potential main study, including ensuring recruitment, 
randomisation, and follow-up assessments run smoothly (National Institute for Health Research 
[online]). This study was classed as an internal pilot study as key outcomes of interest (i.e. SBP, cSBP, 
AIx, AIx75, executive function) were assessed, with the intention of continuing data collection to a 
greater degree to establish a well-powered study. Randomisation and follow-up assessments ran 
smoothly, but recruitment was slow for this study. Although this was executed as a pilot study, some 
aspects of a feasibility study have also been addressed. Recruitment was slow to this study, which is 
unsurprising bearing in mind that fewer than half of all stroke research studies recruit their target 
sample size (Berge et al., 2016). Once recruited, however, only one participant out of the nine 
originally recruited failed to complete the study (due to reported time demands). Adherence to any 
prescribed intervention is difficult to confirm through self-report measures, but participants were 
provided with tick-sheets to aid adherence and were contacted halfway through the ten--week 
intervention period to discuss any difficulties (none were noted except for one dropout). Some 
participants reported negative preconceptions as to whether they would be able to complete a high 
number of heel-raises each day due to fatigue, but after beginning the interventions, the acceptability 
of the intervention was high, with fatigue less of an issue than expected.  
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6.5.6 Future sample size calculations 
It is of great importance for research studies to be adequately powered. Statistical   power   is   
defined   as   the   probability   of detecting   as   statistically   significant   a   clinically   or 
practically important difference of a pre-specified size, if such a difference truly exists 
(Batterham & Atkinson, 2005). The effect sizes recorded in this pilot study, combined with 
error calculations from this thesis, can be used to determine the adequate sample size for 
future work using the SphygmoCor XCEL for interventional studies of this nature.  
Based on an SEM of 5.8 mmHg (chapter three of this thesis, a subsequent SD of changes 
(SDchange = SEM * √2) of 8.2 mmHg, and a minimal clinically important change in BP of 4 
mmHg (Stuckey, Gill & Petrella, 2015), a sample size of 28 participants would be required to 
achieve statistical power of 0.8 in future studies of this nature with an effect size of 0.49. A 
10% dropout rate was recorded in this pilot study, demonstrating that the heel-raises were 
of an appropriate intensity to allow stroke participants to complete the prescribed course of 
physical activity. This 10% dropout rate suggests that investigators running a full study based 
on this protocol should aim to recruit around 31 participants. 
 
6.6 Conclusion 
This pilot study demonstrated that interrupting sedentary time with heel raises daily over a 
time period of ten weeks may not elicit significant benefits in peripheral and central 
haemodynamics, or cognitive function. It is important for future work to determine what the 
minimum intensity of movement is to elicit such benefits and ensure that the burden of 




Chapter 7: Discussion 
The purpose of this thesis was to investigate the use of non-invasive oscillometric measures 
of cBP in non-clinical and stroke populations. It was initially important to evaluate the 
reliability of the SphygmoCor XCEL in recording measures of central haemodynamics in 
populations where these variables are of the utmost importance. Once this had taken place, 
the thesis focused on sedentary time – one of the primary areas of current research in chronic 
stroke. The acute and chronic effects of interrupting extended seated time with intermittent 
heel raises was investigated, with acute benefits noted, but chronic benefits not observed. 
 
7.1. The reliability of the SphygmoCor XCEL 
When assessing central haemodynamics and variables representing arterial stiffness, it is 
imperative that measures are both valid and reliable for results to be credible. Validity refers 
to how well a tool measures an underlying outcome (Sullivan, 2011) and essentially refers to 
the accuracy of a device. Reliability refers to the reproducibility of values of a test in repeated 
trials on the same individuals (Hopkins, 2000) and this reliability of measurements is key 
knowledge to allow practitioners to decide whether measurements are of value (Koo & Li, 
2016). 
Intraclass correlation coefficients have been used to classify between-day reliability with ICCs 
of > 0.75 representing excellent reliability. Young and colleagues (2015) investigated the 
reliability of the SphygmoCor XCEL in a young, healthy population (28y, 24kg·m2) and reported 
excellent between-day reliability with ICCs of 0.76 – 0.90 for pSBP, 0.73 – 0.89 for cSBP, 0.71 
– 0.82 for AIx and 0.75 – 0.84 for AIx75 in different postures and fasting states. Similar findings 
were reported in work by Stoner et al (2015) who also recruited a young, healthy population 
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(26y, 24.7kg·m2) and examined the reliability of this device at rest and in response to an 
orthostatic challenge. Excellent ICCs were reported for pSBP (0.75 – 0.84), cSBP (0.80 – 0.87), 
AIx (0.79 – 0.82) and AIx75 (0.81 – 0.88) in supine and tilted positions. As such, the 
SphygmoCor XCEL clearly possesses strong between-day reliability in younger, non-clinical 
populations. However, measures of central haemodynamics and arterial stiffness are 
particularly relevant to the population over the age of 50 years, as stroke risk more than 
doubles in each successive decade over the age of 55 (Wolf et al., 1992; Brown et al., 1996). 
Accordingly, Chapter three and chapter four assessed the reliability of the SphygmoCor XCEL, 
firstly with an older, healthy population, and then with individuals who had recently been 
diagnosed with stroke and were inpatients in a hype-acute stroke unit. 
In this thesis, strong ICCs (> 0.75) were presented for healthy older individuals (normotensive 
and hypertensive) and individuals diagnosed with stroke. This was evident for peripheral and 
central BP, and for measures of arterial stiffness (AIx, AIx75). A comparison of ICCs across 
populations from chapters three and four can be seen in Table 7.1 with previous data from a 






Table 7.1: ICCs of key variables in different postures and fasting states (seated/supine, 
fasted/non-fasted [Young et al. 2015; chapters three and four {Excellent reliability = ICC ≥ 
0.75}]) 
 Healthy younger 














SBP 0.76 – 0.90 0.90 – 0.92 0.51 – 0.76  0.82 – 0.87 0.83 – 0.85 
cSBP 0.73 – 0.89 0.89 – 0.92 0.58 – 0.77 0.85 – 0.88 0.81 – 0.85 
cPP 0.61 – 0.84 0.83 – 0.86 0.76 – 0.78 0.79 – 0.84 0.79 – 0.88 
AIx 0.71 – 0.82 0.77 – 0.85 0.77 – 0.86 0.73 – 0.87 0.66 – 0.81 
AIx75 0.75 – 0.84 0.75 – 0.87 0.76 – 0.86 0.74 – 0.88 0.70 – 0.81 
Abbrevs: AIx – Augmentation index, AIx75, Augmentation index @75b·min-1, cSBP – Central 
systolic blood pressure, cPP – Central pulse pressure, SBP – Systolic blood pressure 
 
Chapters three and four of this thesis demonstrate that non-invasive measures of cBP can be 
assessed as reliably as peripheral BP. Central blood pressures have been reported to be more 
relevant to the workload of the ventricles and coronary arteries (Croymans et al., 2014; Burns 
et al., 2018) and make an additional contribution to the prediction of cardiovascular 
outcomes, above and beyond peripheral blood pressure (Cheng et al., 2013). This work builds 
on previous literature in younger populations (Stoner et al., 2015; Young et al., 2015) to 
suggest that the SphygmoCor XCEL is reliable in a range of populations. When combined with 
strong validity results from previous work (Butlin et al., 2012; Hwang et al., 2014), the 
evidence from this thesis is the first to suggest that the SphygmoCor XCEL is a suitable tool 
for assessing central haemodynamics and measures of arterial stiffness in both research and 
clinical practices, including stroke. If, as these chapters suggest, central measures can be 
assessed as reliably as peripheral measures in older and clinical groups, the process of 
incorporating these central measures into clinical practice becomes of even greater 
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importance. The cost of these devices currently limits the availability of non-invasive 
measures of central haemodynamics in non-private clinical environments. As a result, 
collaborations between researchers and clinicans are particular great importance to 
introduce this technology as a diagnostic tool in the hospital setting. 
 
7.2 The effect of posture and fasting state on peripheral and central haemodynamics and 
arterial stiffness 
Blood pressure in humans is influenced by a wide range of factors, one of which is posture 
(Sala et al., 2006) and, as such, it is important to consider what posture is adopted when trying 
to accurately measure blood pressure (Cavelaars et al., 2004). For example, measures in a GP 
surgery may tend to take place in a seated posture, whereas inpatient settings are more likely 
to involve a supine posture, particularly early in the morning. The influence that posture has 
on blood pressure is dependent on the amount of time after a postural change has taken 
place. Research from Eser and colleagues (2006) reported significantly higher brachial blood 
pressure in a supine position compared to stood, seated and seated with legs crossed 
postures after one minute of time in each posture. Similar results were found by Cicolini et al. 
(2011), who incorporated a five-minute timeframe in sitting and supine postures and found 
significantly lower brachial blood pressure in a seated position compared to supine. After rest 
periods of 15 minutes in seated and supine postures, however, Young and colleagues (2015) 
found significantly increased SBP and cSBP in the seated posture. This highlights the 
importance of allowing blood pressure to normalise before measures are taken.  
In the studies conducted during this thesis, posture had no significant effect on SBP or cSBP 
in the overall non-clinical cohort over the age of 50. Once this sample had been split into 
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normotensive and hypertensive groups, some differences did become apparent. Whilst 
changes in posture caused no difference in SBP or cSBP in the normotensive group, 
hypertensives showed an increased response compared to normotensivse (1.5 mmHg 
increase in SBP when seated, 2.5 mmHg increase in cSBP when seated). Although statistical 
significance was not demonstrated (p = .06 – .09), moderate to large effect sizes ( 2
pη = 0.12 – 
0.13) were observed, suggesting a possible link between posture and SBP in the hypertensive 
population.  
Measures of DBP were, on average, ~2.5 mmHg higher in a seated posture compared to 
supine (a significant interaction effect of posture and fasting state), in agreement with work 
by Netea et al. (1998) and Young et al. (2015). These results mirror Cicolini’s findings (2011) 
who found increases of 2 mmHg in the seated posture compared to supine. In the acute stroke 
population, posture had asimilar effect on peripheral and central BP. Significant increases 
with a large effect size in DBP and cDBP were observed in the seated posture versus supine 
with an average difference of ~3 mmHg between the two postures. Increases in DBP from 
supine to standing postures have been previously observed due to excessive orthostatic 
pooling causing decreases in cardiac output and subsequent arteriolar constriction (Sparrow 
et al., 1984). When looking at the first two research studies in this thesis, posture clearly has 
a moderate impact on both peripheral and central BP readings. Blood pressures are assessed 
in a range of postures in GP surgeries and hospital environments depending on patient 
preference, clinician preference, and individual circumstance. An awareness of the changes 
caused by postural change is important to ensure accurate interpretation of these results, 
which medical decisions are frequently at least partially based upon. 
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Posture and fasting state had a large, significant interaction effect on AIx for the population 
of over 50s as a whole and the hypertensive group, with this measure of arterial stiffness 
lower in a seated posture than supine. This finding was mirrored in the population of acute 
stroke patients, suggesting an increase in elasticity of small arteries and arterioles. This finding 
is in opposition to previous work using a young, healthy population (Young et al., 2015) who 
reported no significant effect of posture on AIx. This suggests that the vascular reactions to 
postural changes in older age groups are more sensitive than in younger individuals; 
potentially reflecting less stability in vascular control. Age leads to the loss of arterial elasticity 
and a subsequent reduction in arterial compliance (Jani & Rajkumar, 2006). Age-related losses 
in vascular function and blood vessel tone (including vasodilation capacity) due to a lack of 
nitric oxide bioavailability may lead to less consistent and efficient responses to food 
consumption, resulting in these increased responses. 
The first two studies of this thesis also report posture to have a moderate-to-large effect on 
cPP. Both peripheral (Takahashi et al., 2018) and central (Shoji et al., 2016) PP may be superior 
to SBP in predicting cardiovascular risk as PP are associated with increased arterial stiffness, 
causing pressure overload on the heart (Boutouyrie et al., 1995). Significant increases in cPP 
in a supine posture compared to a seated posture were observed in the overall non-clinical 
sample in the first study of this thesis and for both blood pressure classification groups. In the 
acute stroke population, figures approaching significance were reached (p = 0.06) with an 
increase in cPP was observed in the supine condition with a large effect size ( 2
pη = 0.16); 
suggesting that a relationship may exist between posture and cPP that could be significant 
with a larger sample size (and subsequently more statistical power).  These findings agree 
with previous work from Vrachatis and colleagues (2014) who found significant increases in 
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cPP in a supine posture in a sample group with an average age of 50 years. Young et al. (2015), 
however, reported no significant differences in cPP between postures in a sample with an 
average age of 28 years. Again, when pulse pressures used as a diagnostic tool after blood 
pressure is assessed in multiple postures based on the previously mentioned criteria, an 
awareness of the impact of posture on these measures should be ensured in clinicians. The 
strength of the link between cPP post- stroke and long-term outcomes compared to 
traditional BP measures is an area of research which should be addressed in the future. 
There is limited literature investigating vascular responses to changes in fasting state, 
meaning comparative data is in short supply. In the short-term, 48-hour fasting has been 
linked to significant decreases in blood pressure (Eser et al., 2007). Longer-term fasting 
(specifically intermittent fasting) has been shown to significantly decreased body mass over 
twelve weeks (Varady et al, 2013) and, in turn, systematic reviews have linked these 
decreases in body mass with lower blood pressure (Aucott et al., 2009). However, the acute 
effects of food intake on peripheral and central measures have not been widely investigated. 
Literature from Young and colleagues (2015) found food intake to have no significant effect 
on SBP or cSBP, but to cause significant decreases in AIx and AIx75 (drops of ~4.5% after 
consumption). In contrast, research from Ahuja et al. (2009) reported significant drops in non-
invasively measured cSBP of 7% after food and water intake; concluding that central measures 
were more sensitive to food consumption than peripheral measures. This may have been due 
to sudden reductions in arterial stiffness in the splanchnic bed in response to nutrient delivery 
leading to smooth muscle relaxation. 
Fasting state was found to influence measures of blood pressure and arterial stiffness in the 
research studies conducted in this thesis. No significant difference was found for SBP in the 
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overall sample of the healthy population study. However, a large, significant main effect was 
found for cSBP with food intake leading to an average 2 mmHg decrease in the healthy sample 
as a whole. The acute stroke sample reported drastic effects of food intake on peripheral and 
central measures. Significant decreases in SBP (~9.5 mmHg) and cSBP (~12 mmHg) were 
observed after food consumption, representing a ~9% drop in cSBP – similar to the 7% 
reported by Ahuja and colleagues (2009). Consuming a meal may influence the tone of small 
vessels and large artery function (Young et al., 2015) due to nutrient delivery leading to 
smooth muscle relaxation, culminating in changes to peripheral and central BP. Smaller 
changes due to prandial state in central pressures were noted in a supine position. This may 
be due to gravity causing a slightly greater speed of early-stage digestion when seated. 
Posture has been found to have an effect on digestion speed, with studies as dated as early 
as 1918 reporting accelerated barium emptying when supine on the right side compared to 
other postures (Queckenberg & Fuhr, 2008). Gastric emptying (in the later stages of digestion) 
is delayed in the supine posture (Moore et al., 1988; Asado et al., 1989; Spiegel et al. 2000). 
This may translate to the earlier stages of digestion, which would explain the more stable 
results found in the supine posture immediately post- food consumption.  It may therefore 
be optimal to measure blood pressure in a supine state to minimise the influence that fasting 
state has on these variables.  
The findings that post-prandial decreases in cSBP were greater in the stroke population than 
the healthy population over 50 years in age, which were greater than the changes observed 
in a young healthy population (Young et al., 2015), may indicate impaired vascular responses 
to food consumption. In a healthy individual, post-prandial vasoconstriction would be 
expected to occur to maintain a stable BP. In an older population, these responses may be 
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blunted, and in a stroke population, baroreceptor sensitivity may be severely impaired. This 
impairment would lead to sub-optimal maintenance of BP.   
The elevated response of cSBP compared to SBP after food consumption is also an example 
of how peripheral and central measures should not be assumed to react in the same way to 
changeable variables. McEniery and colleagues (2014) report that cBP may respond 
differently to medications than peripheral blood pressures, so peripheral measures are not 
necessarily an appropriate surrogate for measuring the effects of medication on the central 
arteries (Williams et al., 2006). This also seems to be the case for alterations such as change 
of fasting state, with minimal changes observed in SBP but large decreases reported in cSBP. 
This thesis has demonstrated that fasting state has a large effect on the peripheral and central 
vasculature through non-invasive oscillometric measures of central haemodynamics. 
Uncontrolled blood pressure leading to hypertension is the largest risk factor for premature 
mortality worldwide (Lim et al., 2012) and control of blood pressure begins with accurate 
measurements leading to appropriate diagnoses and treatment decisions (Jones et al., 2003). 
The results of these studies demonstrate the necessity for the general public, researchers and 
clinicians to understand the importance of standardising blood pressure measuring protocols 
at home and in clinical environments.  
 
7.3 Breaking up sedentary time with intermittent heel raises 
Despite encouraging findings regarding the acute effect of intermittent heel raises on 
peripheral and central haemodynamics in breaking up sedentary time after stroke, there was 
no chronic benefit to these parameters after a prolonged, ten-week intervention.  
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In the acute heel raise study (chapter five), intermittent heel raises significantly mitigated the 
rises in SBP and cSBP observed between ten-minute and three-hour time points. During the 
control (sedentary) visit, increases were observed of 10.7 mmHg (+ 8.2%) in SBP, 9.6 mmHg 
(+ 7.9%) cSBP and 555 in double product (DP [HR x SBP], + 7.8%). Heel raises significantly 
mitigated this damage to vascular health, with increases of 5.2 mmHg (+ 4%) in SBP and 5.6 
mmHg (+ 4.6%) in cSBP over the three-hour time course. The observed increase in DP during 
the control period was completely negated by the heel raise protocol, with a decrease of 162 
(HR x SBP, - 2.2%). As DP has been significantly associated with mortality over a 12-year follow 
up in a sample of over 2,500 participants (Inoue et al., 2012), this is a finding of particular 
interest. 
This study reported that SBP increased by 5.5 mmHg less during the heel raise condition than 
the seated condition. These findings can be directly contrasted with work by English and 
colleagues (2018) who incorporated an eight-hour seated period with light-intensity bouts of 
stood exercise every 30 minutes (marching on spot, small amplitude squats, calf raises). 
English et al. reported decreases of 3.5 mmHg in the standing-exercise condition compared 
to a seated condition. The greater decreases in SBP in this study may highlight the importance 
of continually interrupting seated time. Although the exercises in the study by English et al. 
were of a higher intensity, the lower-intensity exercise implemented more frequently in this 
thesis led to greater reductions in blood pressure. The heel raises integrated into this thesis 
also offer benefit to those stroke survivors who are unable to engage in activities while 
standing due to difficulties completing sit-stand transitions. 
Even though heel raises significantly mitigated raises in SBP and cSBP, there was a significant 
main effect of time on these variables, suggesting that even with intermittent activity, 
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vascular damage takes place in just three hours of sedentary time. Heel raises only mitigate 
this damage; they do not prevent it completely. No other research found during the literature 
review of this thesis has found work investigating the effects of sedentary time on central 
haemodynamics.  
The precise mechanisms leading sedentary time to have a negative effect on health are not 
fully understood (English et al., 2018) but this thesis demonstrates that acute increases in 
blood pressure at the central organs may be a large contributor to this damage. Chapter five 
of this study demonstrates that the damage caused by sedentary time extends to the central 
arteries, not purely the periphery as has been demonstrated previously.  
However, the mitigation in blood pressure increases throughout the sedentary time did not 
translate into improved executive function. Previous work has found conflicting results, with 
some work reporting improvements in executive function (specifically processing speed and 
incongruent trials of the Stroop protocol) after 30 minutes of stair-climbing exercise (Tam, 
2013). Other research suggests that single bouts of aerobic exercise (of greater intensity than 
was studied here) have no effect on executive function in Stroop performance (Vincent & Hall, 
2017). It may be the case that the heel raises implemented here simply were not of a great 
enough intensity to elicit benefits leading to improved executive functioning. Hypoxia has 
been directly linked to reduced executive functioning (specifically, Stroop performance 
[Genta et al., 2018]), so stimulating skeletal muscle and consequently increased levels of O2 
circulating to the periphery (and brain) may have the potential to improve executive function. 
Longer term exercise interventions may improve executive function (Predovan et al., 2012), 
but these gains were not observed in this acute environment. 
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The natural progression of this research was to see if the acute improvements in SBP and cSBP 
translated into more chronic benefits. As a result, chapter six involved a pilot study to 
investigate potential benefits of a ten-week period of breaking up sedentary time each day 
through an identical number of heel-raises as were shown to acutely benefit central 
haemodynamics in chapter five. This pilot study concluded that the improvements 
demonstrated in chapter five did not translate into more chronic benefits with no 
improvements observed in any peripheral or central haemodynamic variable, or in any 
measures of arterial stiffness.  
Sedentary behaviour refers to activities not increasing energy expenditure substantially 
above resting levels and includes activities like sleeping, sitting, lying down and watching 
television (Pate et al., 2008). The link between this sedentary time and stroke is well 
established, with sedentary individuals 25 – 30% more likely to have a stroke than their less 
sedentary peers (Goldstein et al., 2011). After stroke has occurred, excessive time is spent 
sedentary as in-patients (Mattlage et al., 2015; Barrett et al., 2018), with one study of 104 
hospital-based stroke rehabilitation patients finding 74% of the observed day to be spent 
sedentary (Sjoholm et al., 2014). After discharge, these sedentary behaviours tend to 
continue, with survivors extremely sedentary during a year of follow-up after leaving hospital 
(Tieges et al., 2015). This sedentary time tends to take place in longer bouts after stroke than 
sedentary time does in the general population (English et al., 2018), with this prolonged sitting 
particularly bad for an individual’s health (Dunstan et al., 2012). Traditionally, research has 
traditionally focused on the higher end of the activity intensity spectrum, but an equal 
amount of research should be focused on the lower end of this spectrum (Pate, O’Neill & 
Lobelo, 2008). English and colleagues (2016) note that research is necessary to investigate 
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whether light intensity activities are beneficial when breaking up sedentary time after stroke 
and this is the research gap which the latter part of this thesis aimed to investigate. 
 
7.4 Real-world thesis relevance 
Measures of cBP and arterial stiffness are likely to become commonplace in clinical settings 
in the future as the cost of the devices capable of measuring these begins to decrease. Central 
blood pressure may be more relevant to the workload of the ventricles and coronary arteries 
(Croymans et al., 2014; Burns et al., 2018) and purely measuring peripheral blood pressure 
neglects valuable information (Williams et al., 2006). It is therefore a huge step forward in 
medical care for cuffs able to non-invasively estimate cBP in clinical settings.  
This thesis contains work which demonstrates for the first time that the SphygmoCor XCEL 
can reliably assess central haemodynamics and measures of arterial stiffness in populations 
who are more likely to have vascular impairments (i.e. those over 50 years of age, acute stroke 
patients). This is a major step towards incorporating the SphgmoCor XCEL into clinical use for 
diagnostic and prognostic purposes. 
The first two studies of this thesis also demonstrate the importance of standardising posture 
and, in particular, fasting state when assessing peripheral BP and cBP. After comparison with 
previous work, these results suggest that this standardisation of procedure is particularly 
important in an older and clinical population. The assessment of cBP is particularly relevant 
in these higher-risk populations, so an awareness of how unstable BP responses to food are 
is key. Nurses and clinicians should, as a minimum, be noting the posture of stroke patients 
and time since last meal when adding to hospital notes. If standardising posture is a realistic 
option, this should take place in a supine position as this minimises the changes caused by 
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prandial state and has previously been suggested to maximise the reliability of the 
SphygmoCor XCEL (Young et al., 2015).  
It is widely accepted that stroke causes individuals to be less physically active and to live more 
sedentary lifestyles, with these periods of sedentary time being longer in duration than in 
healthy individuals. This thesis contains work which may be the first to demonstrate that just 
three hours of sedentary time causes significant increases in peripheral BP and cBP. Increases 
in cBP have been strongly suggested to increase the risk of a wide range of clinical conditions 
including stroke. As a result, these increases in BP may provide a causal explanation for the 
link between sedentary time and stroke incidence. This thesis demonstrates that breaking up 
sedentary time using low-intensity activities (such as heel raises) has the potential to mitigate 
the damaged caused by this lack of physical movement. After stroke, patients are extremely 
sedentary as in-patients and as these behaviours translate into lifestyle habits after hospital 
discharge. Chapter five of this thesis provides evidence that this is specifically damaging to 
BP, a major risk factor of morbidity and mortality in the months and years following stroke.  
Evidence is provided here that instructions to in-patients to keep moving, even in a hospital 
bed, may be beneficial to recovery. Although acute benefits have been observed as a result 
of intermittent heel raises, chronic improvements were not reported over a ten-week period. 
This suggests that to attain longer-term benefits, exercise programmes may need to be of a 
greater intensity than prescribed in chapter six of this thesis.  
 
7.5 Strengths and limitations of this thesis 
The studies compiled in this thesis provide novel information about the use of the 
SphygmoCor XCEL, the variables assessed by this device, and the effect of sedentary time on 
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these measures of central haemodynamics in participant demographics where these variables 
are particularly relevant. 
Throughout this thesis, all possible measures were taken to ensure accurate and reliable 
results. There was extremely high control throughout the data collection sessions of these 
studies. All studies were conducted in the same physiology laboratory (chapters three, five 
and six) or in a hyper-acute stroke ward (chapter four) at the same time of day (beginning 
07:30 – 08:30), in fasted conditions with the same practitioner recording data. This minimised 
the effect of extraneous variables on the independent variables being examined and 
strengthened these studies greatly.  
Chapters three and four of this thesis investigated the effect of posture on a variety of 
peripheral and central haemodynamic variables using mixed-sex samples. Previous work has 
reported that responses of peripheral blood pressure to postural changes between sexes may 
differ (Gerber et al., 2015), with DBP reported to rise significantly in a standing position versus 
supine in males, but not in females. Future work involving a similar protocol should recruit a 
unisex sample to check for sex-related differences in central haemodynamic responses to 
postural change. 
Difficulties recruiting from stroke populations were encountered during this doctoral 
research. Fewer than half of all stroke trials recruit their target sample size (Berge et al., 2016). 
The recruitment triangle outlined by Gorelick et al. (1998) consists of involving the patients 
themselves, key family members and friends, and the primary doctors and other medical 
personnel. Throughout this thesis, each of these corners of the triangle were addressed 
during recruitment. Acute stroke patients were visited in person during visiting hours, when 
family and friends were frequently present. A rapport was built with these individuals to 
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maximise the likelihood of recruitment. Positive relationships were also fostered with the 
clinicians and nursing staff on the ward to allow for a seamless process where possible. The 
seven key issues causing poor recruitment in stroke research reported by Alexandrov (2006) 
are as competing trials, slow start (insufficient site recruitment, unforeseen obstacles, etc.), 
complex protocols, trial fatigue by investigators, patients not willing to participate, excessive 
(though necessary or often unavoidable) and lengthy regulatory work, and regulatory issues 
with drugs and devices, their combinations, and evolving technologies 
These were all considered throughout the research process, with competing trials and 
unforeseen obstacles (a lack of patients meeting the inclusion criteria) the primary limiting 
factors to recruitment. Due to the study taking place around breakfast times, the presence of 
diabetes mellitus was added as an exclusion criterion. This proved to be a common condition 
which restricted participants from qualifying for the study, even though breakfast times were 
not manipulated at any time in this work. 
Chapter six of this thesis involved a ten-week heel raise programme. Whilst participants were 
contacted at the half-way mark to check for adherence to this programme, they were not 
physically monitored on a day-to-day basis for practical reasons. Low adherence to anti-
hypertensive therapy is a major contributor to low blood pressure control (Peck, 2018). If 
patients are reportedly struggling to adhere to something as physically easy as taking 
medications, it is plausible that they are not adhering to interventions that require more 
effort, such as heel raises over a course of ten weeks. The studies also required patients to 
attend sessions in a fasted state, without having consumed caffeine or having completed any 
exercise. This was purely based on self-report and a reliance on the participants. In future 
work, resting blood glucose measures will be taken to ensure participants are in a fasted state. 
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All participants who completed these studies reported that they had adhered to all that was 
requested. 
Overall, the studies in this thesis provide novel findings in relation to the non-invasive 
assessment of central haemodynamics in healthy individuals and stroke patients. These 
studies were conducted in highly controlled environments and contribute useful data as cBP 
assessment moves towards becoming common practice in research and clinical 
environments. 
 
7.6 Future research 
 
Longitudinal studies have demonstrated that central haemodynamic indexes are independent 
predictors of future cardiovascular events and all-cause mortality (Vlachopoulos et al., 2010). 
As a result, the assessment of cBP is likely to become more common in daily practice (Bulas 
et al., 2017). In the past decades, stroke incidence has remained fairly stable, but a 
remarkable increase in the number of stroke survivors has been observed (Wijkman, 2018). 
The hyper-acute treatment of stroke has clearly improved greatly, but as a result, the overall 
burden of stoke has increased. Therefore, a key focus in future research must be determining 
the optimal methods of managing risk factors of recurrent stroke.  Treating elevated BP may 
be the most important intervention when preventing second strokes (Kernan et al., 2014) and 
if cBP are as superior as the data would suggest, a focus on cBP after stroke is imperative in 
the immediate and future literature. 
The current cost of non-invasive estimation of central haemodynamics through oscillometric 
methods vastly exceeds brachial measures, with the SphygmoCor XCEL costing approximately 
£19,400 and the Vicorder (another device offering measures of similar parameters) retailing 
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at approximately £15,000. Conversely, Omron brachial cuffs vary from around £39.39 
($49.99) to around £86 ($109.99 [Omron Online, 2019]). The potential use of non-invasive 
cBP monitoring opens up a variety of avenues of investigation. However, this disparity in price 
means that a large number of questions must be answered in the research setting before 
these devices can be utilised in a clinical environment.  
Firstly, data is needed to determine whether central haemodynamic measures are 
significantly better than traditional BP measures in predicting short- and long-term outcomes 
after stroke has occurred. If they are, it becomes imperative to identify optimal cBP targets in 
the hours, days and weeks after stroke has occurred. The focus on BP targets for stroke has 
been identified as a critical global need (Feigin et al., 2017), and the identification of cBP 
targets may be even more critical as it is the central arteries that supply the brain, not the 
brachial artery. This focus links in with optimising lowering BP strategies after stroke to 
determine whether aggressive or cautious approaches are optimal. A collection of 
longitudinal data is required which collects cBP, AIx and PWV at regular time-points post- 
stroke whilst collecting data for a variety of endpoints (e.g. mortality, recurrent stroke). 
Secondly, the relevance of central BP variability after stroke must be examined. Brachial BP 
variability in the 24 hours after stroke has been associated with a higher risk of death within 
90 days (de Havenon et al., 2019). This is due to the fact that increased arterial stiffness due 
to hypertension and ageing amplifying random BP changes and consequently increasing BP 
variability (Yang et al., 2018). Whether similar or magnified results are observed when 
monitoring central pressures is an interesting area of future investigation.  
A third area of research to be undertaken relates to circadian rhythms. Circadian rhythms 
relating to peripheral BP are well established, with a 10-20% decrease in SBP observed 
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nocturnally (Rodrigues et al., 2018). Those who categorise as non-dippers (nocturnal SBP 
decrease < 10%) or as extreme dippers (nocturnal SBP decrease >20%) are well recognised to 
be at elevated risk of cardiovascular disease and premature mortality. Nocturnal BP and BP 
variability may even be more closely associated with target-organ damage than awake BP and 
awake BP variability (Boggia et al., 2007; Palatini et al., 2014). Ambulatory monitoring of cBP 
would allow researchers to determine whether the nocturnal response of cBP is 
comparatively muted or exaggerated, with further longitudinal data demonstrating the use 
of circadian rhythm assessments involving cBP. 
Fourthly, investigations into sedentary time after stroke (for example the sixth chapter of this 
thesis) could be improved through the collection of a wider range of variables. For example, 
this thesis focused on central haemodynamics and executive function over a period of 
sedentary time. The use of near infra-red spectroscopy would allow the monitoring of 
cerebral perfusion throughout a sedentary time-course. Reduced cerebral perfusion in the 
frontal gyrus has been linked to impaired attention and cognition (Craggs et al., 2014) and the 
assessment of this variable alongside executive functioning tasks and BP measures may 









Chapter 8: Summary and conclusions 
This thesis initially aimed to ascertain the reliability of the SphygmoCor XCEL and examine the 
effect of posture and fasting state on peripheral and central haemodynamics, and measures 
of arterial stiffness. Previous literature had investigated young, healthy populations but there 
was a lack of research involving older and clinical populations, where blood pressure is 
particularly important. The SphygmoCor XCEL was demonstrated to have generally excellent 
reliability in a population over the age of 50 and in an acute stroke population (mean age = 
57y). Fasting state in particular was demonstrated to have a large effect on cBP and measures 
of arterial stiffness, with significant decreases seen after food consumption in healthy and 
stroke populations. Central blood pressure was more sensitive to fasting state than peripheral 
blood pressure and stroke patients reported greater changes in haemodynamics than their 
non-clinical counterparts. As blood pressure is assessed in a range of postures and fasting 
states at home and in clinical settings and cBP may be the future of cardiovascular risk 
management, these findings have importance to patients and clinicians alike. 
This thesis also investigated the effect of sedentary time on central haemodynamics – an 
avenue of research which was not found to have been addressed in the literature review 
conducted for this doctoral paper. The effect of breaking up sedentary time with intermittent 
light activities is a necessary avenue of research, particularly in stroke rehabilitation. Stroke 
survivors are sedentary as inpatients and continue these sedentary behaviours long into their 
recovery. These behaviours may be perceived as a restful recovery but are damaging to long 
term prognoses. Whilst many stroke survivors are not physically able to undertake high-
intensity exercise programmes to benefit their health, identifying lower-intensity activities 
which are able to break up extended sedentary time has the potential to improve health in 
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the long term. Peripheral and central BP increased significantly due to three hours of 
sedentary time, with intermittent heel raises significantly mitigating this damage (but not 
eliminating it), and significantly reducing double product (HR * SBP). The general population 
and clinicians should be aware of how quickly peripheral and central pressures begin to rise 
during sedentary time. Stroke patients should be staying active with simple movements from 
their bed or seat throughout the day to prevent the rises in blood pressure which may 
increase the risk of recurrent events. 
Although the acute benefits of heel raises were demonstrated, there was no effect of long-
term exposure. Although this pilot study only offers tentative conclusions due to the low 
sample size, it seems likely that heel raises are not of the intensity required to elicit 
improvements after a prescribed programme. Future work should endeavour to find lower 
intensity movements that the majority of stroke survivors are able to complete that may 
break up sedentary time and lead to some of the physiological improvements caused by 
higher-intensity exercise.  
This thesis has furthered our knowledge and understanding surrounding the assessment of 
cBP in individuals with stroke, and the consequences of sedentary time on these measures. 
Non-invasive measures of central haemodynamics have the potential to be an integral part of 
recurrent stroke risk reduction and research into their prognostic value in stroke must be 
taken through its infancy. As the acute clinical treatment of stroke continues to improve, 
control of risk factors through lifestyle changes also grows in importance. Identifying methods 
to reduce these lifestyle factors, including reducing sedentary time, may be the cornerstone 
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Appendix 1a: Reliability of oscillometric central blood pressure and central systolic loading in 




































Abbrevs: AIx - Augmentation index, AIx75 - Augmentation index @ 75 b·min-1, AP – Augmented pressure, cDBP – Central diastolic blood pressure, 
cPP – Central pulse pressure, cSBP – Central systolic blood pressure, DBP – Diastolic blood pressure, ICC – Intra-class correlation coefficient, F – 





Appendix 2a: Oscillometric central blood pressure and central systolic loading in stroke 

























Appendix 2d: Supplementary table from acute stroke study: Mean values and 95% confidence intervals for outcome variables  
 
 
a. Abbrevations: Abbreviations: AIx - Augmentation Index, AIx75 - Augmentation Index @ 75bpm, cDBP - Central Diastolic Blood Pressure, C.I – 
Confidence Interval cPP - Central Pulse Pressure, cSBP - Central Systolic Blood Pressure, DBP - Diastolic Blood Pressure, PP – Pulse Pressure, SBP - 
Systolic Blood Pressure 
b. Bolded P<.0
         
   Posture     Fasting state   
Variable Supine 𝑋𝑋� Seated 𝑋𝑋� 𝑋𝑋� difference 
P value for 
posture 
Posture 95% 
C.I Fasted 𝑋𝑋� Non-fasted 𝑋𝑋� 𝑋𝑋� difference 




SBP (mmHg) 141.4 143.2 1.8 .09 -4.0 - .29 147.5 137.1 10.4 < .001 5.5 – 15.3 
DBP (mmHg) 77.0 79.8 2.8 .001 -4.2 - -1.3 82.4 74.4 8.0 < .001 4.6 – 11.6 
PP (mmHg) 66.3 65.4 0.9 .33 - 1.0 – 2.8 67.0 64.6 2.4 .04 .2 – 4.7 
cSBP (mmHg) 128.2 130.0 1.8 .06 -3.7 - .09 135.0 123.1 11.9 < .001 7.4 – 16.3 
cDBP (mmHg) 78.0 81.0 3.0 .001 -4.5 - -1.4 83.5 75.6 7.9 < .001 4.3 – 11.5 
cPP (mmHg) 50.2 49.1 1.1 .06 -.1 – 2.4 51.8 47.6 4.2 < .001 2.5 – 5.9 
AIx (%) 33.4 31.3 2.1 .02 .3 – 4.0 34.8 29.9 4.9 .001 2.4 – 7.5 




Appendix 3a: Letter to the Editor based on sedentary time and stroke – International Journal 
























Appendix 3d: Supplementary variables from pre- and post- sedentary and heel raise visits 
 











Time    
X 
 
10 Min 180 min 
 







ED (ms) X 340.
4 
 333.6 342.3  333.3 352.8  0.02 0.39  0.76 0.01  0.03 0.36 
  SD 30.3  25.6 36.2  32.1 25.1          
AT2 (ms) X 235  233.3 233.4  234.3 239.8  0.16 0.17  0.9 0.01  0.28 0.11 
  SD 16.1  16.1 15  18.9 15.1          
P1 (mmHg) X 34.8  33.9 38.3  31.1 35.7  0.87 0.01  0.3 0.1  0.04 0.32 
  SD 11.9  10.4 14.2  9.2 13          
SEVR (%) X 164  163.5 163.1  161.5 167.4  0.51 0.04  0.53 0.04  0.92 0.01 
  SD 27.2  18.2 25  27.7 38          
ESP (mmHg) X 112  110.8 118.2  106 112.2  0.32 0.09  0.58 0.03  0.01 0.45 
  SD 16.7  17.8 17.9  14.8 15.4          
Pf (mmHg) X 28.5  28.1 31.3  26.2 28.4  0.23 0.13  0.18 0.16  0.07 0.28 
  SD 7.7  7 9.3  5.2 8.6          
Pb (mmHg) X 20.1  19.4 21.1  19.3 20.7  0.58 0.03  0.91 0.01  0.15 0.18 
  SD 6.3  6.2 7  5.4 7.2          
RM (%) X 70.6  68.6 67.9  73.8 72.5  0.86 0.01  0.06 0.28  0.8 0.01 
  SD 10.8  10.8 10.6  13.1 8.2          
Abbrevs: AT2 – Aortic T2, ED – Ejection duration, ESP – End systolic pressure, P1 – Peak 1 
height, Pb – Reflected pulse height, Pf – Forward pulse height, RM – Reflection magnitude, 












Appendix 3e: An example pattern of sedentary time across a 12-hour period for a stroke 
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Appendix 4a: Effects of a heel raise program on central on central hemodynamics and 
cognitive performance in chronic stroke: study protocol for a randomized, controlled, 









































Appendix 4d: Mean (SD) supplementary pulse wave analysis values pre- and post- control and 
heel raise intervention conditions 
   Total  Control  Intervention  Interaction  Condition  Time 
   X  Pre- Post-  Pre- Post-  P η2p  P η2p  P η2p 
ED (ms) X 352  357 356  347 346  .66 .04  .24 .26  .82 .01 
  SD 26  20 35  29 15          
AT2 (ms) X 237  239 238  234 237  .94 <.01  .21 .29  .62 .05 
  SD 13  10 13  17 12          
P1 (mmHg) X 37  38 36  37 35  .99 <.01  .52 .09  .07 .51 
  SD 9  11 8  7 11          
SEVR (%) X 141  142 137  141 143  .88 .01  .50 .10  .97 <.01 
  SD 14  20 15  10 10          
ESP (mmHg) X 111  114 115  108 108  .18 .33  .09 .46  .85 .01 
  SD 11  10 10  11 14          
Pf (mmHg) X 31  32 31  29 30  .65 .04  .08 .49  .85 .01 
  SD 7  8 6  5 8          
Pb (mmHg) X 21  23 22  20 20  .65 .05  .11 .43  .13 .39 
  SD 5  6 5  5 5          
RM (%) X 70  71 69  70 69  .31 .20  .51 .09  .32 .20 
  SD 8  6 6  11 10          
 
Abbrevs: AT2 – Aortic T2, ED – Ejection duration, ESP – End systolic pressure, P1 – Peak 1 
height, Pb – Reflected pulse height, Pf – Forward pulse height, RM – Reflection magnitude, 
SEVR – Subendocardial viability ratio 
 
  
